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1. INTRODUCTION 
 
The word “Siddha” comes from the word “Siddhi” which means “an object to be 
attained” or “perfection” or “heavenly bliss”. Siddhi generally refers to Ashtama Siddhi 
i.e., the eight great super natural powers. Those who attained or achieved the above said 
powers are known as Siddhars. Siddha system of medicine is one of the very ancient 
Indian Systems of Medicine, widely practiced in southern states of India especially 
Tamil Nadu.  Siddhar who defied death, preached the philosophy of  Siddha medicine 
and theory of immortality. Agasthiyar is believed to be the founding father of Siddha 
medicine. Eighteen  siddhars are considered to be important in Siddha medicine. Siddha 
system of medicine is vast ocean of internal and external medicines. Most of these 
therapies are aimed at maintaining a healthy balance of three humours Vatham, Pitham 
and Kabam.      
                                                     
           Science of Siddha states that the 5 elements of Nature viz., earth, water, heat, air 
and space (panchapoodham) were the fundamentals of all the corporeal things in the 
world. It also states that there exists a close relationship between the external world and 
the internal system of human. According to panchapoodha pancheekaranam theory, each 
of these five elements said to posses‟ two properties viz. Subtle and gross. Thus, this 
theory proposes that 96 basic factors exist, which is the basic concept underlying this 
holistic medical science. The human body formed by these 96 basic factors. These 96 
factors include physical, physiological, psychological, intellectual aspect of every 
human.   
 
        Man is said to be Microcosm (Pindam) and the world is Macrocosm (Andam) i.e., 
there is nothing in the Macrocosm of nature that is not contained in man. Disease, 
according to modern science is only a departure from a state of health and more 
frequently a kind of disturbance of the healthiness of the body to which any particular 
case of sickness is assigned. According to Siddhars Philosophy diseases in man do not 
originate in himself, but from the influences which act upon him. As already stated, man 
is compared to the world because the elements that exist in the world exist in man as 
well; and therefore any change in the elementary condition of the external world has its 
corresponding change in the human organism. There is the feeling of oneness between 
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the external and the internal world of man; and it is upon this oneness that the doctrine of 
Humoral Pathology i.e., the theory of Tridosha is based. 
The siddha medicine also recognises the role of three Humours  (Vatham, Pitham 
and Kabam). These humours remain in a balanced state in normal healthy person and 
disturbance in their equilibrium leads to ill health. The characteristic of the three humors 
in the constitution of human beings is either hereditary or atavic. In scientific parlance, 
Vatham comprehends all the phenomena which come under the functions of the central 
and the sympathetic nervous system; Pitham, the functions of thermo genesis or heat-
production, metabolisation within its limits, the process of digestion, coloration of blood, 
excretion and secretion etc., and  Kabam, the regulation of the heat and the formation of 
the various preservative glands. When deranged, they bring about diseases peculiar to 
their influence; when in equilibrium, freedom from disease; and when one or the other of 
the humours combine in such a way as to get deranged by aggravation, diminution etc., 
and disease may result. In Siddha, diagnosis is based on three humours. 
 
        “Special children” is an umbrella term used to classify conditions that childhood 
disability caused by neuronal damage. The proportion of disabled children in developing 
countries is generally higher than in developed countries, it is estimated that 6 to 10% of 
children in India are born disabled. Developmental disabilities are some of the most 
upsetting for a family to deal. Diagnoses like cerebral palsy, Autism, Down syndrome, 
ADHD and intellectual disabilities often cause children to be removed from the 
mainstream, and parents must be brutal advocates to make sure their children receive the 
services, therapy and inclusion they need and deserve. At present, no health care 
profession has convincingly assumed the responsibility of the health for special children. 
Although drug therapy may not completely correct complications associated with 
childhood disability, evidence does show that it helps to manage problems. There are 
many physical disabilities that can affect children. But cerebral palsy is the most 
common mental disability in childhood. 
 
Cerebral palsy is a persistent but not unchanging disorder of movement and 
posture due to a defect or lesion of the developing brain. It is accepted that children, who 
acquire permanent motor impairment due to non-progressive neurological insults, have 
cerebral palsy.
(1)
 There are many causes, a wide range of manifestations of the motor 
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disorder and various associated problems. Cerebral palsy is not a single disorder but a 
group of disorders with diverse implications for children and their families.  
               
 In our siddha classical pediatric book, the definition for Siravatham has been 
described as “siravatham  enbathu thalai nadukkam, kaium kaalum asaithidathu, nadakka 
siramam, mulai unnathu”(2). The symptoms of Siravatham are nearly correlated with 
Cerebral palsy. Signs and symptoms of cerebral palsy vary between people. Often, 
symptoms include poor coordination, stiff muscles, weak muscles, and tremors. There 
may be problems with sensation, vision, hearing, swallowing, and speaking disorder. 
Often babies with cerebral palsy do not roll over, sit, crawl or walk as early as other 
children of their age. Difficulty with the ability to think or reason and seizures each 
occurs in about one third of people with Cerebral palsy. 
 
              While the symptoms may get more noticeable over the first few years of life, the 
underlying problems do not worsen over time. Most often the problems occur during 
pregnancy; however, they may also occur during child birth or shortly after birth. Risk 
factors include preterm birth, being a twin, certain infections during pregnancy such 
as toxoplasmosis or rubella, exposure to methyl mercury during pregnancy, a difficult 
delivery and head trauma during the first few years of life, among others. About 2% of 
cases are believed to be due to an inherited genetic cause. 
 
The prevalence of cerebral palsy is estimated to be 1.5-3 per 1000 live births, 
with variations possibly reflecting true differences or differences in ascertainment and 
classification 
(3)
. During the last years, focus of care for children with cerebral palsy has 
shifted from a main emphasis on motor function, towards participation and minimizing 
limitations of activity, in line with the World Health Organization (WHO) framework; 
the International Classification of Functioning, Disability and Health (ICF). Around 
8,000 to 10,000 babies and infants are diagnosed per year with Cerebral Palsy. About all, 
spastic cerebral palsy is common in children and its range is 61%. Children with cerebral 
palsy will have altered because of their brain abnormality, however still make functional 
improvements due to brain maturation
(4)
. Oral Baclofen, Tizanidine, Dantrolene, 
Diazepam and Gabapentin are widely used for spasticity in cerebral palsy. Not all 
patients with spasticity beneﬁt from this treatment(5) and oral baclofen may cause 
considerable side effects such as sedation, respiration problems and muscular weakness. 
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Tizanidine is limited by side effects such as dry mouth, sedation, prolonged QT interval 
and hallucinations. A meta-analysis concluded that effect of oral antispastic drugs is 
small and evaluation of the effect on children quality of life is lacking from the studies.
 
(6). 
The incidence of adverse drug effects (drowsiness, sedation and muscle weakness) 
was high. Childern with restricted or multifocal spasticity injections have beneﬁt of 
Botulinum toxins
(7). 
Formation of antibodies against botulinum toxins has been 
demonstrated
(8)
. The risk for antibody formation Botulinum toxin therapy must be 
restricted to localized spasticity
 (9)
. Neurosurgery such as rhizotomy and orthopaedic 
surgery may be the options
(10)
. 
 
             Medical issues still remain important factors in enabling children with cerebral 
palsy to participate functional domains. Throughout the years a large number of 
treatment options have been available for children with cerebral Palsy. Today the 
ultimate aim with therapy is to promote activity and participation in everyday life 
according to the child‟s and family‟s priorities. In view of all of the above, an immediate 
and urgent need exists to look for an alternative form of therapy such as natural products. 
Plants have been the companions of man since time immemorial and have formed many 
useful drugs as they are much less toxic than synthetic drugs. Screening of medicinal 
plants presents an avenue for the identification of new drugs.  In India, Siddha system of 
medicine owes its origin to medicinal ideas and practices of a class of Tamil sages. In the 
Siddha system of medicine, herbs, minerals, metals and salts all have been used for 
pediatric population. However, scientific research, using modern techniques is needed to 
provide additional evidence on the drug standardization. The major challenges include 
the authentication as to the quality, quantity i.e. dosage, safety and efficacy, especially in 
regard to single or minimal drug combinations of herbal products. In this context, the 
need exists to evaluate many Siddha drugs and therapies in contemporary use. In 
conducting research and evaluating traditional medicine, knowledge and experience 
obtained through the long history of established practices have to be retained. 
 
            There has been much discussion about the role of Siddha System of Medicine in 
the evaluation, management and treatment of special children. The purpose of this 
project is to develop recommendations on “best practices” related primarily to evaluate 
Siddha methodologies and medicines. Different treatment modalities can improve the 
quality of life to the disabled children and these can include for reduced spasticity 
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(muscle tone), internal medication and external therapies like Thokkanam (Massage) and 
Podithimirthal. 
 
              Because children with CP have multiple symptoms for which no curative 
treatment exists, their families seek therapies from many sources. Some look for cures, 
while others seek therapies that will improve the way their child functions or feels. 
Siddha system of medicine includes, 1) Mind–body interventions 2) Biological based 
therapies such as formulations and diets 3) Manipulative   and body based methods such 
as Thokkanam and 4) Energy drink medications kudineer.  The external therapies such as 
thokkanam and kollu podithimirthal are to reduce the spasticity of muscle. Thus the aim 
and objectives of the present study were to test the efficacy of the Siddha 
medicines/methodologies in cerebral palsy children. In this regard, the investigator 
decided to take up a combination of Siddha formulation and therapy for the study. The 
drugs chosen for this dissertation includes Kurunthotti Kudinee
(11)
 as internal medicine, 
Vasuvu Ennai 
(12)
  for thokkanam and Kollu  Podithimirthal 
(13)
 therapy as external, all of 
which have been used in the Siddha system of medicine for many centuries, either singly 
or in various combination.  From those, the author has selected the above medicines to 
study its safety and efficacy and hopes it will give fruitful results.   
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2. AIM AND OBJECTIVES 
AIM 
The purpose of this study is to Evaluation of Siravatham (Cerebral Palsy) by 
clinical assessment with Siddha Therapeutic Management in children. 
 
OBJECTIVES 
Primary Objectives 
 To study the evaluation of Siddha trial drug “Kurunthotti Kudineer” for 
Siravatham. 
 To evaluate the safety profile like Acute toxicity of the trial drug in animal 
models as per WHO guidelines. 
Secondary Objectives 
 Collection of various Siddha literatures of the study. 
 Herbal identification and authentication of the trial drug. 
 To prepare the trial drug "Kurunthotti Kudineer" as per Standard 
operating procedure drug preparation. 
 To evaluate the Biochemical, Physico-chemical analysis of the trial drug. 
 To correlate the Siddha aspects of Siravatham to Cerebral palsy of modern 
medicine with respect to causes, pathology, and clinical features. 
 To gather the Siddha diagnostic parameters by Mukkutram,  
Udal thathukkal, Uyir thathukkal and En vakai thervugal. 
 To use modern Clinical parameters to confirm the disease.  
 To make a clinical observation about the disease in relation of age, sex, 
occupation, Socio-economic status. 
 To subject all patients are to through clinical parameters before and after 
treatment. 
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3. REVIEW OF LITERATURE 
 
3.1. SIDDHA ASPECT: 
 
 In Siddha system of medicine the diseases are classified into 4448 types 
according to our ancient siddha literatures, based on vatha, pitha, kaba theory. Vatha 
diseases get a major role among that. By such classification there are 80 types of 
vatha diseases. Among Siravatham is one of them. 
Before reviewing the specific signs and symptoms of Siravatham, the details 
of vatham is described here under the following headings. 
 
VATHAM: 
Other names of vatham: 
Vaayu, Vali 
 
Definition: 
Vatham or vaayu is not mere a wind, but also causes motion, energy and sensation 
of every cell in the body. Hence vatham is one of the three humours (vatham, pitham, 
kabam) which is responsible for construction nature of works in the human body. In 
physiological conditions, the existence of three thadhus is in ratio of 1, 1/2, 1/4 
respectively. This ratio is altered when there is disturbance of normally existing, thadhus 
by the environmental factors, diet, habits etc., and vathadhosam may be increased or 
decreased. 
 
Physiology of Vatham: 
The three basic factors vatham, pitham and kabam working in physiological 
condition are called three thadhus and uyirthadhus. These factors are working through an 
internal instrument called andhakaranam, which is composed of manam, puthi, siddham 
and agankaram. So, mind is the receptor of all sorts of impulses produced within the 
body. 
Kundalini sakthi, an enormous power is kept in the mooladharam like a sleeping 
snake. It can be revitalized and fully utilized by yoga and meditation. When this aanma 
sakthi is stimulated by the external factors, the kundalini goes upwards like an angered 
snake and produces motor (seiunarvu) and sensory (meiunarvu) functions.  
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This is otherwise called as kanmaindhiriyam and gnanaindhiriyam respectively. 
These are closely associated with nervous system of the body and this is discussed in 
vingnanamaya kosam in detail. 
In human body, the locomotor activity functions through voluntary muscles and it 
is controlled by nervous system called kanmaindhiriyam.  Likewise, the sensation and its 
activities are known as gnanaindhiriyam. These types of activities are governed by the 
vatha humour among the three thadhus. 
 
Locations of vatham: 
Seats of vatham: Below the naval. Generally, vatham lives in 
1. Abanan 
2. Edakalai 
3. Kaamakodi 
4. Undhiyinkeezhmoolam 
5. Muscles 
6. Bones 
7. Hair follicles 
8. Nerves 
9. Skin 
10. Joints 
11. Stools 
 
Physiologically, vatham which has no alteration lives in GI tract, bones, ear, 
thigh, hip and skin. 
 
Natural properties of Vatham: 
1. Giving briskness 
2. Expiration and inspiration 
3. Functioning the seven udal kattugal uniformly 
4. Functioning the mind, thoughts and body 
5. Regulation of 14 physiological reflexes 
6. Protection and strengthening of the five sensory organs. 
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Imbalance of Vatham: 
1. Body ache 
2. Tearing pain 
3. Pricking pain 
4. Nerve weakness 
5. Dryness 
6. Movements 
7. Shivering 
8. Mental distress 
9. Weakness 
10. Traumatic pain 
11. Joint pain 
12. Dislocation of joints of upper & lower limbs 
13. Weakness of organs 
14. Pilo-erection 
15. Paralysis of the limbs 
16. Polydipsia 
17. Bony pricking pain 
18. Severe pain in calf and thigh muscles 
19. Anuria and constipation 
20. Unable to do flexion and extension of limbs 
21. All tastes to be like astringent 
22. Astringent salivation 
 
Qualities of Vatham - Own Qualities: 
1. Kadinam –hardness 
2. Varatchi –dryness 
3. Elesu –lightness 
4. Kulirchi – coolness 
5. Asaidhal – mobility 
6. Anuthuvam – subtleness 
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Opposite Qualities: 
1. Miruthu – soft 
2. Parumai – unctuous 
3. Paluvu –heavy 
4. Akkini –hot 
5. Sthiram – stable 
6. Katti -solid 
 
Relation with five elements: 
Vatham – kaatru + aahaayam 
 
Vatham has kaatru and aahaayam as its elemental constituents. If kaatru and 
aahaayam or any of them is decreased or increased from the normal level, it will 
surely lead to pathological state of vatham. 
Regarding diet, bitter, pungent and astringent tastes contain vali and bitter alone 
contains aahaayam. So if these are consumed in large amounts this results in the 
vitiation of vatham and eventually vatha diseases. The six tastes and their 
constituents elements are as follows. 
 
1. Sweet = earth +water,  
2. Sour = earth + fire,  
3. Salt = water + fire,  
4. Bitter = air + sky,  
5. Pungent= air + fire,  
6. Astringent = earth + air 
Vatham = air + sky, Pitham = fire, Kabam = water + earth 
 
Description of vatham: 
The siddha classical texts divide the general principles of vatham into ten 
subsidiary forms that differ from one another by their localization in the body 
and by their particular functions.  
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They are, 
1. Pranan (Uyirkaal): 
It corresponds to the cardiac plexus and refers to the chest. It regulates the 
respiratory system and helps the digestive system. Its derangement causes 
respiratory disorders. 
 
2. Abanan (Kizhnokkum kaal): 
It corresponds to the pelvic plexus and expels fecal matter and urine. It 
constricts the anal spinster. It helps to spread the digestive food all over the body. It 
is also responsible for the expulsion of sperm and menstrual flow. Its derangement 
leads to diseases of the bladder, rectum and reproductive system. 
 
3. Viyanan (Paravu Kaal): 
It corresponds to the vaso-ciliary at the root of the nose and base of the skull. 
Viyanan spreads over the body in all endings and causes constriction and relaxation 
of both voluntary and involuntary muscles. This is responsible for the movements of 
the body and sensory perceptions. 
It causes flow of fluids, flow of sweat, opening and closing of eyes etc., it is 
responsible for taking the absorbed essence of the food to the different parts of the 
body. The neurological problems of the body are basically because of the 
derangement of viyanan. 
 
4. Udhanan (Melnokkum Kaal): 
It corresponds to the pharyngeal in the throat region and regulates the higher 
functions of brain like speech. Its derangement causes symptoms of upper gastro 
intestinal tract diseases, problems in speech etc. It is also responsible for the 
physiological reflex actions like vomiting, hiccup, cough, sneezing etc. 
 
5. Samanan (Nadu Kaal): 
It corresponds to the solar plexus in the naval region and controls digestion. It 
acts as a neutralizing air for the upward and downward air (abana & udhana). Its 
derangement will cause gastrointestinal symptoms and neurological, respiratory 
symptoms as this vaayu are the neutralizing force for the other four vaayus. 
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6. Nagan: 
  Nagan is responsible for the intelligence of an individual. It causes opening and 
closing of eyelids. Its derangement causes impaired memory and lack of coherent. 
 
7. Koorman: 
 This causes yawning and closure of eyelids. This is responsible for vision 
lachrymal secretion is also attributed to koorman. It gives energy to the body and helps in 
body building. 
 
8. Kirugaran: 
 This lies in the tongue, salivary glands, nasal secretion, hunger, concentration of 
the mind on one particular thing, sneezing, cough are all attributed to kirugaran. 
 
9.  Devadhathan: 
 Laziness is attributed to this vaayu. The ocular movements, human passions like 
anger are attributed to this vaayu. 
 
10. Thananjeyan: 
  It produces swelling all over the body and leaves from the body by blowing of the 
Cranium only on the third day after death. This vaayu is responsible for decay of the 
body after death. 
 
FACTORS WHICH ALTER VATHAM: 
 
a. When hot food are mixed with vatham, vatham gets thannilai valarchi 
b. When cold is mixed with vatham, vatham gets vetrunilai valarchi 
c. And when oily foods with hotness are mixed with vatham, vatham neutralizes in 
its own property that means healthy conditions. 
d. Vatham is specialized in aadi, aavani, purattasi and ippasi physiologically. 
Pathologically, the three humours are affected either themselves or with udal- 
thaadhukal. 
 
The types of alterations of vatham are; 
Thannilai valarchi:  
Definition: 
  A kutram, which is provoked in its own locations, is called “Thannilai valarchi” 
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Limitations: 
Hatefulness of the things which are causing thannilai valarchi and likeness of 
the things which are getting opposite properties are the limitations of thannilai 
valarchi. 
 
Duration: 
  Vatham gets thannilai valarchi during mudhuvenil kaalam (Aani and Aadi) 
 
Vetrunilai valarchi:  
Definition: 
  A kutram, which is provoked in its other locations, is called “vetrunilai valarchi”. 
 
Limitations: 
  Signs and symptoms of the other kutram and the pathological conditions of 
the udal thaadhukkal give the details of the limitations. 
 
Duration: 
  Vatham gets “vetrunilai valarchi” during kaar kaalam (Aavani and Purattasi) 
 
Udal Thaadhukkal: 
 
1. Saaram  –  it strengthens the body and mind 
 
2. Seneer  –  it gives power, knowledge and boldness to the mankind. 
 
3. Oon  -  it gives a structure and shape to the body and is                 
              responsible for the movement of the body. 
4. Kozhuppu –  it lubricates the joints and facilitates their functions. 
 
5. Enbu  –  it protects the all internal organs and gives structure to the  
         body 
 
6. Moolai  –  it is present in the bones and gives strength. 
 
7. Sukkilam or  Suronidham  –  mean for reproduction 
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Udal Kattukkal 
Elevated 
Characteristics 
Depressed  
Characteristics 
1. Saaram 
     Leads to a disease identical to the 
increase in kabam like loss of 
appetite, profuse salivation, 
depression etc., 
 Dryness of skin, tiredness, 
diminished activity of 
sense organs, loss of 
weight, lassitude and 
irritability while hearing 
louder sounds. 
2. Senneer 
    Boils in eye brow, scalp, neck, lips 
and legs, jaundice, haematuria, 
colic pain and redness of skin 
 Eagerness to sore and 
foods, Tiredness, 
lassitude, cold 
  and anemia 
3. Oon 
     Deposition of fat around the neck, 
cheeks, abdomen, thigh and 
genitalia. 
 Tiredness and muscle 
wasting 
4. Kozhuppu 
     Identical feature of increased oon,  
     Associated with dyspnoea on 
exertion. 
  Loin pain, spleenomegaly 
and  
  Emaciation. 
5. Enbu 
     Excessive bone growth and  
     Dentition. 
 Joint pain, falling of teeth, 
falling and splitting of 
hairs and nails. 
6. Moolai 
      Heaviness of the body and eyes, 
oliguria and non-healing ulcers. 
  Osteoporosis & Blurred  
vision. 
7. Sukkilam 
(or) 
suronitham 
      Increased sexual activity and  
      Urinary calculi. 
  Pain in the genitalia and 
failure in reproduction. 
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Piniyari  Muraimai: 
Pini means the disease which affects the body and any interruption of the normal 
functions of any body part, organ or system. 
Ari means identify,  Muraimai means Rules 
 
Piniyari muraimai is the method of diagnosing the disease affecting the people. It 
is based upon the following aspects: 
 
1. Poriyal arithal 
 
2. Pulanaal arithal 
 
3. Vinaathal 
 
The above principles correspond to the methodology of inspection, palpation and 
interrogation of modern medicine. 
 
Poriyalarithal and Pulanalarithal: 
 
Gnanaindhiriyam: 
 
Organ Sense 
Mei (skin) Touch 
Vaai (Mouth-tongue) Taste 
Kan (Eye) Vision 
Mookku (Nose) Smell 
Sevi (Ear) Hearing 
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          Kanmaindhiriyam: 
 
Organ Sense 
Kai (Upper limb) Movements of the Upper limbs 
Kaal (Lower limb) Movements of the Lower limbs 
Vai (Mouth) Speaking 
Eruvaai (Anal orifice) Defecation 
Karuvaai (Reproductive orifice) Reproduction 
 
Pori is considered as the five sense of perception namely Nose, Tongue, Eye, Skin 
and Ear. While Pulan are five object of senses. They are smell, Taste, Vision, Sensation 
and sound. Physician‟s pori and pulan are used as the tools for examining the pori, pulan 
of the patient. Vinaathal is obtaining  informations  regarding the history of the disease, 
its clinical features etc., from the patient or his immediate relatives who are taking care of 
him, when the patient is not in a position to speak or if the patient is a child. 
 
Vinaathal: 
It has a procedure for gathering information about the patients name, age, 
occupation, nativity, socio economic status, family history, dietary habits, allergic factors, 
period of suffering from the complaints, history of previous episodes, relevant history of 
habits and treatment etc., from the patient or from his immediate relatives, if the patient is 
not in a position to speak or if the patient is child. 
 
In Siravatham, vinaathal is very much useful for Piniyari muraimai, occupation, 
family history, dietary habits, proper treatment and socio economic status are very 
important for Siravatham. 
 
Envagai Thervugal: 
Eight different kinds of test to be applied or attended by a physician before 
arriving a correct diagnosis. Envagai thervugal is considered as physician‟s Instruments. 
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In Agathiyar vallathi 600, Envagai thervugal has been mentioned as Atta vitha 
Paritchai. 
 
1. Naadi (Pulse) 
 
2. Sparisam (Palpation) 
 
3. Naa (Tongue) 
 
4. Niram (Color of the body) 
 
5. Mozhi (Speech) 
 
6. Vizhi (Eye) 
 
7. Malam (Fecal) 
 
8. Moothiram (Urine) 
 
Therefore to arrive at the diagnosis for any disease, it is imperative to apply the 
Envagai thervugal. 
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SIRAVATHAM 
Definition: 
  Siravatham is characterized by since not attained head control, head gets shaking, 
in ability to use both upper limbs and lower limbs, Difficulty in walking , Feeding 
difficulties, Fear and Anxiety due to deranged Vatham. 
 
SIRAVATHAM– A REVIEW: 
 Siravatham is a Vatha disease explained by T.Mohanaraj in Mathalainoi 
Maruthuvam part III.  The deranged Uyirthathu in Siravatham is Vatham. 
 
Signs and Symptoms: 
 
 Since not attained head control, head gets shaking, In ability to use both upper 
limbs and lower limbs, Difficulty in walking, Feeding difficulties, Fear and Anxiety, 
Loss of eye to eye contact. Hence the children turn the face one side to see the objects.  
 
Clinical features of Siravatham in Pothu Maruthuvam: 
 
  The main clinical features are, over sleeping, shivering of head and neck, 
yawning and deafness, numbness of lower and upper limbs. 
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Piniyari Muraimai (Diagnosis): 
 It is very important part of the treatment; it is helpful to select the correct line of 
treatment and good prognosis. It is based upon the following diagnosis methods. 
 
1. Poriaalarithal: 
  The physician should examine the patient‟s porigal by his porigal. 
 
1. Mei -  Feels a type of sensation 
 
2. Vaai – For knowing taste 
 
3. Kan –  Meant for vision 
 
4. Mookku –  For knowing the smell 
 
5. Sevi –  For hearing 
 
2. Pulanaalaridhal: 
  The physician should examine the patient‟s pulangal 
 
1. Hearing - Ear 
 
2. Vision  - Eye 
 
3. Taste  - Tongue 
 
4. Sensation - Skin 
 
5. Smell  - Nose 
 
2. vinaadhal: 
  The physician should interrogate about the patients name, age, occupation, 
native, socio-economic status, diet habits, prone to any allergens, complaints, 
history of previous illness, history of present illness, family history, habits and 
frequency of attacks, if the patient is in the stage of inability to speak or a child, 
physician should interrogate the details with his immediate relatives who are taking 
care of him. 
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Envagai thervugal: 
            The prime method adopted to diagnose the disease is by mean of envagai 
thervugal. The value of Envagai thervugal is very important for diagnosing 
purpose, which is the unique and special method describing in Siddha system of 
medicine. Hence the diagnosis is made by the following. 
 
1. Naadi (pulse): 
 The study of naadi is the important factor in Envagai thervugal which gives 
almost the correct diagnosis, Naadi may be studied at 10 points which are Heel, 
Genital organ, Abdomen, Chest, Ear, Nose, Neck, Hand, Eyebrow and Vertex. But 
the study of naadi at hand is the best because the radial artery is located here 
superficially. The unique factor which pertaining the soul in the body is known 
Naadi. 
 Naadi must be studied in right hand for men and left hand for women.  
The three uyir thaadukkal are formed by combination of      
Edakalai + Abanan => Vatham 
 Pinkalai + Piranan => Pitham 
 
 Suzhumunai + Samanan => Kabam 
 
 They can be felt one which below wrist on the radial side by means of  Palpation 
with Tips of the index, middle and ring fingers corresponding of vatham, pitham, kabam 
respectively, The three humours exists in the ratio of 1: ½: ¼ . Normally, Derangements 
of this ratio leads to various diseases.  
 
In cases of vatha diseases the following stages of naadi are seen. 
 
1. Exaggeration of vatham 
 
2. Vatha pitha thondha naadi 
 
3. Vatha kaba thondha naadi 
 
4. Kaba vatha thondha naadi 
 
5. Kaba pitha thondha naadi 
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Naadi is the first and foremost diagnostic parameter of the Siddhars. 
In Siravatham the following types of naadi can be commonly seen.  
  They are, 
 
 Vatha pitham 
 Vatha kabam 
 Pitha vatham 
 Kaba vatham 
 
In Siravatham 
 Vatham– increased. 
Followed by an increase in other two Kutrams (Pitham and Kabam). 
 
2. Sparisam (Palpation): 
  By sparisam, the temperature of skin (hot and cold), smoothness or roughness, 
sweat, dryness, hard patches, swelling, growth, of abdominal organ, tenderness, 
nourishment can be felt.  
     In Siravatham warmth is felt over the affected joints. Stiffness present in both 
lower joint and upper joint. 
 
3. Naa (Tongue): 
  By the examination of tongue, its color, coating, dryness, deviation, 
movements, Variation in taste and gums can be noted. 
 
4. Niram (Colour): 
  By the examination of niram the type of dhegam (Body), cyanosis, redness, 
pallor and yellowish discoloration can be noted. 
  Vatha dhegi            – Dark color 
 Pitha dhegi              – Yellow or Red color 
 Kaba dhegi               – White or Yellow color 
 
5. Mozhi (speech or voice): 
  In the examination of mozhi the pitch of voice (low or high) action of slurring 
and speech hallucination can be noted. 
  In Siravatham, there is difficulty in speech. 
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6. Vizhi (Eye):  
  By the examination of vizhi, pallor, redness, yellowishness, dryness, 
lacrimation, sharpness of vision must be noted. 
 
7. Malam (Stools): 
  By the examination of malam, its nature, color, quantity, presence of blood 
or mucous can be noted. 
  In Siravatham, Constipation will be present. 
 
8. Moothiram (Urine): 
  The examination of urine is classified in to two types Neerkuri and Neikuri 
 
Neerkuri: 
  It includes examination of color, odor, deposits, quantity and frothy nature.  
 
   In Siravatham, there would be normal straw yellow color of urine with decreased 
frequency of urine. 
 
Neikuri : 
  Preparation of patient: 
 
Prior to the day of urine examination for neikuri and neerkuri, the patient is 
advised to take the balanced diet and quantity of food must be proportionate into his 
appetite. He should have a good sleep. 
 
 Method - After waking up in the early morning urine collected in the glass 
container must be examined within 1 ½ hours, a drops of gingili oil is added 
through the side of vitreous without any disturbing. The nature of neikuri should 
notice in direct sunlight. 
 
Observation:- If the drop of oil, 
 
1. Lengthens like a snake –vatha neer 
 
2. Spreads like ring– pitha neer 
 
3. Appears like pearl–kaba neer 
 
4. Spreads like snake in ring, ring in pearl, snake in pearl – thondha neeer 
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Besides Envagai thervugal, a disease can also be diagnosed by means of other 
methods namely thinaigal, paruva kaalangal, uyir thaadhukkal, udal thaadhukkal, 
gnanaindhiryangal and kanmaindhiriyangal, hence through a knowledge about the 
disease can be studied out systematically and properly in Siddha system of medicine. 
  
  In siravatham, the pattern of Neikuri is often  
 
             “Aravena nendeen agthe-Vatham” 
 
Mukkutram: 
 
Vatham: 
In Siravatham 
1. Viyanan - Affected (produces restricted joint movements) 
2. Abanan      -          Constipation 
3. Samanan    - Affected (Due to derangement of other  vaayus),   
            Poor digestion 
4. Udanan   -         Difficulty in speech, Drooling of Saliva. 
 
Pitham: 
  Pitham is located in urinary bladder, heart, head, umbilicus, pinkalai, piraanan, 
abdomen, stomach, sweat, blood, eye and skin. 
  It is classified in to five types. They are 
 
1. Anar pitham  -  it digests all inserted particles 
2. Ranjaga pitham -  it gives color to the blood 
3. Saadhaga pitham –  it is used to complete the work properly what       
        he thinks in the mind 
4. Alosaga pitham -  it gives vision to the eyes 
5. Pirasaga pitham –  it gives color to the skin. 
 
In Siravatham 
  Saathagam - Difficulty in walking. 
  Ranjagam - Pallor 
  Anarpitham - Loss of Appetite 
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Kabam: 
   Kabam is located is samanan, semen, fat, bone marrow, nose, chest, bones, brain, 
large intestine, stomach and pancreas. 
  It is divided into five types they are 
 
1. Avalambagam - it controls the other four types of kabam 
 
2. Kiledhagam  - it moistens the food 
 
3. Podhagam  - it helps to know the taste 
 
4. Tharpagam  - it gives cooling effect to the eye 
 
5. Sandhigam  – it is gives lubricating effect to the joints. 
 
In Siravatham, 
 Santhigam is affected because of restricted joint movements. 
 Kilesagam is affected difficult to moisten the food. 
 
Udal Thaadhukkal: 
 
1. Saaram – it strengthens the body and mind 
2. Seneer  – it gives power, knowledge and boldness to the mankind 
3.   Oon  - it gives a structure and shape to the body and is         
    responsible for the movement of the body 
4.   Kozhuppu – it lubricates the joints and facilitates their functions 
5.   Enbu                – it protects the all internal organs and gives structure to  the body 
6.   Moolai  – it is present in the bones and gives strength 
7.   Sukkilam or Suronidham – mean for reproduction 
 
In Siravatham, 
1. Saaram -  Affected (Tiredness) 
 
2. Seneer -  Affected (Anemic) 
 
3. Oon -  Affected (Weight loss) 
 
4. Kozhupppu -  Affected (Weight loss) 
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5. Enbu -  Affected (Joint pain) 
 
6. Moolai -  Normal 
 
7. Sukkilam / Suronitham -  Normal 
 
Gnanaindhiriyangal: 
 The five gnanaindhiriyangal are:- 
 
1. Mei  –  feels all types of sensations 
 
2. Vai  –  for knowing taste 
 
3. Kan  –  meant for vision 
 
4. Mookku     –   for knowing the smell 
 
5. Sevi  –  for hearing 
 
 In Siravatham “Mei” is affected. This is due to stiffness and deformities,  
Vai - Affected (Drooling of saliva). 
 
Kanmaindhiriyangal: 
 The five kanmaindhiriyangal are: 
 
1. Kai   – majority of normal works are done by kai 
 
2. Kaal  – for walking 
 
3. Vaai  – for speaking 
 
4. Eruvaai – for defecation 
 
5. Karuvaai – for reproduction 
    
 In Siravatham– Kai and Kaal are affected. This is due to stiffness and 
deformities. Eruvai affected constipation. Vai affected difficulty in speech. 
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Thinaigal: 
 
1. Kurinji  –  Mountain and its surroundings, kaba noigal and    
               liver diseases are common. 
2. Mullai   –  Forest and its surroundings, pitha noigal, vatha  
    noigal, liver diseases are common. 
3. Marudham  –  Field and its surroundings, safest place to maintain good  
           health. 
4. Neidhal  –  Sea and its surroundings, vatha diseases and liver   
                    enlargement are common. 
5. Paalai  –   Desert and its surroundings, vatha, pitha, kaba noigal are  
    common. 
 
  Study five lands are very much needed, as some diseases are common in 
the particular lands. 
 
Paruvakaalangal: 
 
  A year is classified into six seasons, each constituting two months.  
 They are, 
1. Kaar kaalam  –  Aavani and purattasi 
 
2. Koodhi rkaalam  –  Iyppasi and karthigai 
 
3. Mupani kaalam  –  Maargazhi and thai 
 
4. Pinpani kaalam  – Maasi and panguni 
 
5. Elavenir kaalam  –  Chithirai and vaigaasi 
 
6. Mudhuvenir kaalam –  Aani and Aadi 
 
   Some of the diseases, during a particular season are commonly prevalent and 
study of it was also be much useful to diagnose. The final diagnosis is confirmed by 
summarizing all the clinical findings observed by the above methods. 
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   Noi Kanippu Vivaadham (Differential Diagnosis): 
 
There are certain other vatha diseases, which resemble the clinical symptoms As 
Siravadham, but they differ in some ways. The careful and clear History taking and 
Examination were revealing the correct diagnosis. They are 
Inoyil seththavanudaiya kaalpol kaal thuvandu asaika mudiyamalum, nadaka  
mudiyamalum,  kaigal ondraiyum pidika mudiyamalum unarchiyindri sorum. Andriyum 
mayirkoocheridhal, udal thimir koludhal, vaai koni umizh neer thanagavey vadidhal, 
udal pitham perugiyadhupol vepamadaidhal aagiya ikurugunangalai thotruvikum. 
Udal mutrum vaayumigundhu paravi, naadi melindhu asaivatru udalai 
naiyumbadi seidhu, udalil thaangamudiyadha valiyundaki pakathil isivu, kaikaal 
konudhal, udal veluththal, viyarthal ennum kurigunangalaiyum thotruvikkum noyaam. 
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Line of Treatment: 
 
  In Siddha system, the treatment is based upon the  Mukkutra principle. Treatment 
is not only for perfect healing but also for the prevention of disease and rejuvenation 
of Udal Kattugal. 
        
 
 While treating a disease, it is essential to know the etiology, the nature of the  
patient, severity of the illness, the seasons and the time of occurrence. 
Line of treatment is as follows: 
 
1. Neekam (Treatment) 
2. Niraivu (Restoration) 
3. Kaappu (Prevention) 
 
I. NEEKKAM (MANAGEMENT IN SIDDHA): 
          The aim of treatment is based on, 
a. to restore the three humors to normal equilibriumstate. 
b. to treat the patient by internal medicine. 
 
  To bring the three Thodams to normal equilibrium state, first the deranged 
Vatham has to be brought to its normal state by giving purgation .  
As it is said that 
 
  
 
Internal Medicine: 
 
1. Kurunthotti Kudineer : 
  2 to 4years - 30 ml (bds)  
                    5 to 7 years - 40 ml (bds) 
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External medicine: 
 
1. Kollu Podithimirthal 
   
  2.  Vasavu Ennai– External application 
 
Diet Restrictions: 
         Children with cerebral palsy may have a harder time getting sufficient nutrients due 
to the physical difficulties of chewing and swallowing.  Because chewing can be 
affected.  
 
The main goal in a diet is to provide high quality foods that are easy to eat or 
drink. Healthy, high calorie foods are especially important since it can be difficult for 
many children to physically eat enough to meet their nutrition requirements. 
Constipation and acid reflux are the most common physical symptoms.  
 
        This is due to poor muscle tone that affects the ability to push stool through the 
colon and of the lower esophageal sphincter, which causes the stomach‟s contents to 
wash back up into the esophagus causing acid reflux. 
 
        Make every bite count. Limit processed foods with low nutritional value as much as 
possible and focus on calorie dense, nutritious foods and high quality fats. 
 
        Consider adding calorie rich smoothies to the daily diet containing high calorie 
fruits (bananas, dates, mangos, avocados) and green leafy vegetables along with 
powdered greens for extra vitamins. 
 
       Healthy fats such as nut butters, coconut milk, and coconut oil will also instantly 
increase nutrition and calorie count and can be added to smoothies or used as a spread on 
bread. 
 
        Leafy greens such as kale, spinach and collards can be added to smoothies and also 
shredded and added to almost any food: meatballs, pasta, casseroles and sauces. Leafy 
greens will add extra vitamins and minerals as well as fiber and bulk which can help with 
constipation. 
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Foods To Avoid 
  
Low fiber foods tend to cause the most trouble with constipation, such as highly 
processed snack and junk foods, fried food, too much red meat, ice cream and cheese. 
These foods are also low in nutritional value and should be replaced with healthy 
alternatives that provide important fiber, vitamins and minerals. 
 
To reduce the likelihood of acid reflux, avoid citrus fruits, spicy foods, garlic, 
onions, fatty cuts of meat and carbonated beverages.   
 
II. Niraivu: 
 
 The patients are well motivated. The nature and course of the disease is 
explained to them, Life-style modification advised. Honey collected during summer, 
pepper, gingelly oil, asafoetida, castor oil and black gram are very useful in Vatha 
disease. 
 
III. KAAPPU (Prevention): 
  
 As per Siddha system, Vinaipayan or  Kanmavinai‟ (Genetic disposition) is a 
cause for certain disease. This type of kanmavinaigal is to be corrected not only by 
regular treatment but also by the following methods: 
1. Cultivating good mental thoughts by doing meditation 
2. Yogam 
 
EXTERNAL THERAPY FOR SIRAVATHAM 
 
1. Kollu podithimirmal 
 This is applying  Karunkollu powder (fine) from distal to proximal direction in 
all the limbs and trunk.  
 
2. Working principle of podithimirmal treatment 
 
1. In Pothimirthal, herbal powders (dry powders) are used. 
2. These powders are dry and rough in nature and hot in potency. 
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3. These properties create lightness, dryness, roughness, remove the blockages and 
stiffness, and also have a cutting or liquefying action on the fat tissue 
4. When rubbed on the body in a specific manner which Creates friction 
5. Open the pores 
6. Remove blockages in vessels 
7. Increase the heat in the tissues and 
8. Percolates inside to stimulate fat metabolism 
 
Conditions for patients: 
 Before podithimirthal 
1. Must come empty stomach. 
2. Early morning is preferable 
       After podithimirthal 
3. Should take bath with Hot water  
4. Should apply coconut oil after hot water bath.  
 
Benefits of podithimirthal: 
 
1. Pacifies the aggravated Kaba dhosam 
2. Reduces the excess fat accumulated in the subcutaneous tissues. 
3. Softens and exfoliates dead skin cells there by giving a lustrous glow to skin. 
4. Detoxification, purification, toning the skin. 
5. Eliminates bad body odor. 
6. Improves mobility of joints. 
7. Strengthens and tones the muscles. 
8. Refreshes and rejuvenates the body. 
 
3. Thokkanam ( Massage): 
 
           
  
32 
 
 Thokkanam is the Siddha way of touch therapy. It is the physical manipulation of 
the body usually done with or without oil application. It is very effective for 
neurological and musculoskeletal problems. It also promotes mental and physical 
fitness. According to Siddha, disease in the body occur due imbalance of three humours 
that is Vatham, Pitham and kabam which in turn are governed by five fundamental 
elements – Akayam (Space), Vaayu (Air), Theyu (Fire), Appu (Water) and Munn 
(Earth). Thokkanam is one of the 32 types of external medicines mentioned in siddha 
literature. In this technique, the physician uses his hands on the body of the patient in 9 
different unique ways with or without using medicated oil with a curative or palliative 
point of view.  
 
Thokkanam massage has consisted of nine types of technique which are 
performed in children once in a day.   
 
In Cerebral palsy children based on the classification different to be affected to a 
different extent. The Thokkanam was likely to be beneficial, it was considered important 
to whole body including all limbs. Throughout the series of studies whole body of the 
children were massaged.  When performing Thokkanam procedure we sure to practice 
safely, endeavoring to adhere to the specific guidelines, scope and ethics of the massage 
and have fun and be playful with the nine types of strokes and responsibility hold within 
fingertips.  
 
 The 9 different techniques in thokkanam which makes siddha medicine unique in 
all aspect are , 
 
1. Thattal or Patting technique 
2. Irukkal or Tightening 
3. Pidithal or Holding 
4. Murukkal or Twisting 
5. Kattal or Tying 
6. Azhuthal or Pressing 
7. Izhuthal or Pulling 
8. Mallathuthal or Supinating 
9. Asaithal or shaking 
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Benefits of Thokkanam : 
 
1. Helps to cure Vatha diseases even without internal medicines 
2. Chronic diseases like Spondylosis, Lumbago, Disc prolapse, Hemiplegia, 
Neurological conditions etc are managed well through Thokkanam 
3. Improves circulation 
4. Treats Obesity 
5. Helps in pain relief 
6. Removes Indigestion, Constipation and Flatulence 
7. Induce sleep 
8. Helps maintain normal blood pressure 
9. Restores Vatham, Pitham and Kabam in normal ratio 
10.  Regulates Vatha humour. 
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3.2. MODERN ASPECTS 
Cerebral  Palsy 
Cerebral palsy has affected humans since antiquity. A decorated grave marker 
dating from around the 15th to 14th century. The oldest likely physical evidence of the 
condition comes from the mummy of  Siptah, an Egyptian Pharaoh who ruled from about 
1196 to 1190 BCE and died at about 20 years of age. The presence of cerebral palsy has 
been suspected due to his deformed foot and hands.  
 
The medical literature of the ancient Greeks discusses paralysis and weakness of 
the arms and legs. The modern word palsy comes from the Ancient Greek word, meaning 
paralysis or paresis respectively. The works of the school of Hippocrates (460–c. 
370 BCE), and the manuscript On the Sacred Disease in particular, describe a group of 
problems that matches up very well with the modern understanding of cerebral palsy. 
The Roman Emperor Claudius (10 BCE–54 CE) is suspected of having CP, as historical 
records describe him as having several physical problems in line with the condition.  
The modern understanding of CP as resulting from problems within the brain began in 
the early decades of the 1800s with a number of publications on brain abnormalities 
by Johann Christian Reil, Claude François Lallemand and Philippe Pinel. Later 
physicians used this research to connect problems in the brain with specific symptoms. 
The English surgeon William John Little (1810–1894) was the first person to study CP 
extensively. In his doctoral thesis he stated that CP was a result of a problem around the 
time of birth. He later identified a difficult delivery, a preterm birth and perinatal 
asphyxia in particular as risk factors. 
 
In the early 20th century, the attention of the medical community generally 
turned away from CP until orthopedic surgeon Winthrop Phelps became the first 
physician to treat the disorder.  
 
Definition: 
 
Cerebral palsy is a non progressive disorder of posture and movement often 
associated with epilepsy and abnormalities of speech, vision and intellect.  It results from 
a defect or lesion of the developing brain
(20)
. 
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Clinical course: 
 
1. Delayed motor and mental milestones 
2. Abnormal reflexes: Persistence of primitive reflexes (such as 
Moro, asymmetric tonic neck, palmar grasp and placing reflexes), 
failure to develop maturational/postural responses ( Such as 
traction, Landau, parachute, head righting and trunk righting 
reflexes) 
3. Abnormal muscle tone (Hypotonic/Hypertonic)  
4. Abnormal movements/seizures 
5. Definite hand preference before 1 year (hemiplegia) 
6. Skeletal deformities and joint contractures 
7. Growth disturbances 
8. Gait abnormalities 
9. Problems with posture, balance, coordination, walking, speech, 
hearing, vision, swallowing bowel and bladder, etc.   
 
10. Early Markers of CP 
 
1. Delayed developmental mile stone 
2. Slow head growth 
3. Poor head control  
4. Irritability 
5. Poor Suck 
6. Poor quality of sleep 
7. Scissoring of lower limbs 
8. Toe walking 
9. Abnormal tone 
10. Extreme sensitivity to light 
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Epidemiology: 
 
The prevalence of cerebral palsy is estimated to be 1.5-3 per 1000 live births, 
with variations possibly reflecting if true deranges, or differences in ascertainment and 
classification
(3)
. During the last years, focus of care for children with cerebral palsy has 
shifted from a main emphasis on motor function, towards participation and minimizing 
limitations of activity, in line with the World Health Organization (WHO) framework; 
the International Classification of Functioning, Disability and Health (ICF). Around 
8,000 to 10,000 babies and infants are diagnosed per year with Cerebral Palsy. The rate 
is higher in males than in females; in Europe it is 1.3 times more common in males. As 
of 2005, advances in care of pregnant mothers and their babies have not resulted in a 
noticeable decrease in CP. This is generally attributed to medical advances in areas 
related to the care of premature babies (which results in a greater survival rate). As of 
2016, there is a suggestion that both incidence and severity are slightly decreasing - more 
research is needed to find out if this is significant, and if so, which interventions are 
effective.  
 
Prevalence of cerebral palsy is best calculated around the school entry age of 
about 6 years, the prevalence in the U.S. is estimated to be 2.4 out of 1000 children. 
About all, spastic cerebral palsy are common in children and its range is 61%. 
 
Etiology: 
     Factors may operate prenatally, during delivery or in the postnatal period. 
Cerebral malformations, Perinatal hypoxia, birth trauma, chorioamnionitis, 
prothrombotic factors, acid base imbalance, indirect hyperbilirubinemia, metabolic 
disturbances and intrauterine or acquired infections may operate. Most infants have 
multiple risk factors. Prematurity is an important risk factor for spastic diplegia while 
term weight babies get quadriparesis or hemiparesis. The mechanism of CP in a large 
proportion of cases remains unclear and primary neurological aberrations may be 
unfolded in future. The importance of role of birth asphyxia has been questioned by 
recent data and asphyxia may be manifestations of the brain damage rather than the 
primary etiology. A Variety of pathological lesions such as cerebral atrophy, 
porencephaly, periventricular leukomalacia, basal ganglia, thalamic and cerebellar 
lesions may be observed
(20)
. 
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Pathophysiology 
Preterm infants
(21)
 
 
The premature neonatal brain is susceptible to two main 
pathologies: intraventricular haemorrhage (IVH)  and periventricular leukomalacia 
(PVL). Although both pathologies increase the risk of CP, PVL is more closely related to 
CP and is the leading cause in preterm infants. The term PVL describes white matter in 
the periventricular region that is underdeveloped or damaged (“leukomalacia”). Both 
IVH and PVL cause CP because the corticospinal tracts composed of descending motor 
axons, course through the periventricular region. 
 
Intraventricular haemorrhage (IVH)
(21) 
IVH describes bleeding from the subependymal matrix (the origin of foetal brain 
cells) into the ventricles of the brain. The blood vessels around the ventricles develop 
late in the third trimester, thus preterm infants have underdeveloped periventricular blood 
vessels, predisposing them to increased risk of IVH. The risk of CP increases with the 
severity of IVH. 
 
Periventricular leukomalacia (PVL) 
(21)
 
IVH is a risk factor for PVL, but PVL is a separate pathological process.  
The pathogenesis of +PVL arises from two important factors:  
           (1) ischemia/hypoxia and  
(2) infection/inflammation 
 
Risk Factors: 
Maternal factors: 
1. Preterm labor 
2. Multiple pregnancy 
3. Smoking 
4. Infections: Toxoplasmosis, Rubella 
5. Drug abuse 
6. Preeclampsia 
7. Rh incompatibility 
8. Relative infertility 
9. Bleeding  during  pregnancy. 
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Fetal factors 
1. Fetal distress 
2. Fetal hypoxia 
3. Congenital anomalies 
4. Twins/triplets 
 
Neonatal factors 
1. Low birth weight babies in relation to gestational age 
2. Premature babies 
3. Birth asphyxia 
4. IUGR 
5. Congenital anomalies in brain 
6. Hyperbilirubinaemia 
7. Hyperglycaemia 
8. Intrauterine infections 
9. Neonatal seizures 
10. Injury: Head injury. 
 
Other risk factors: 
Genetic factors: About 2% of CP cases are inherited as autosomal recessive with 
both Parents carriers. 
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Causes 
 
Classification of CP 
Depending on anatomical topographical classification: 
I. This classification is based on the extent of involvement of the limbs. 
1. Monoplegic: Only one limb is paralyzed 
2. Diplegia: All the four limbs are involved; Lower limbs are involved 
more than the upper limbs. 
3. Paraplegic: Both the lower limbs are involved in the paralysis 
4. Triplegic: Three limbs are involved  
5. Hemiplegic: Both upper and lower limb involved are involved on one 
side 
6. Tetraplegic/Quadriplegia: All the four limbs are involved 
7. Double hemiplegic: All the four limbs are involved; upper limbs are 
involved more than the lower limbs. 
  
Pre natal        Peri natal        Post natal  
• Iron deficiency 
• Poor nutrition 
• Infection 
(STARCH) 
• UTI 
•  High grade 
fever 
• Chorioamniotis  
• HTN, DM 
• Poor ANC  
• Twins 
• Foetal 
• Vasculopathy  
• Birth asphyxia 
• Premature/LBW 
• IUGR 
• IVH 
• Hyperbilirubenemia  
• Sepsis 
• Pneumonia 
• Meningitis 
• Develop 
malformation  
•   CNS infection 
•   Meningitis and         
  Encephalitis  
•   Head injuries 
•    Seizures 
• Hypoxic damage 
• Hyperpyrexia  damage 
• Kernicterus  
• Vascular-Hemorrhage,  
• Thrombosis,   
• Embolism. 
• Trauma - Skull fracture. 
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II. Physiological Classification Spastic type of cerebral palsy (70-80% cases) 
1. Monoplegia  
2. Diplegia 
3. Paraplegia 
4. Triplegia  
5. Hemiplegia 
6. Tetraplegia 
7. Double hemiplegia 
8. Cerebral palsy with choreoathetoid type of movements (10-15%cases) 
9. Ataxic cerebral palsy (5%cases) 
10. Rigid cerebral palsy 
11. Hypotonic cerebral palsy 
12. Dystonic cerebral palsy 
13. Athetoid (dyskinetic) cerebral palsy 
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14. Ballistic cerebral palsy 
15. Cerebral palsy associated with tremors 
16. Mixed cerebral palsy 
17. Unclassified cerebral palsy.  
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Spasticity 
Spasticity has been defined as an increase in muscle tone due to hyper excitability 
of the stretch reflex and is characterized by a velocity-dependent increase in tonic stretch 
reflexes. 
 
Spasticity usually is accompanied by paresis and other signs, such as increased 
stretch reflexes, collectively called the upper motor neuron syndrome. Paresis 
particularly affects distal muscles, with loss of the ability to perform fractionated 
movements of the digits. 
 
 The upper motor neuron syndrome results from damage to descending motor 
pathways at cortical, brainstem, or spinal cord levels, and spasticity evolves in the days 
and weeks after injury. The interval between injury and the appearance of spasticity 
varies from days to months according to the level of the lesion. In addition to weakness 
and increased muscle tone, the signs in spasticity include clonus, the clasp-knife 
phenomenon, hyper reflexia, the Babinski sign, flexor reflexes, and flexor spasms. 
 
Pathophysiology  
 
The pathophysiologic basis of spasticity is incompletely understood. The changes 
in muscle tone probably result from alterations in the balance of inputs from 
reticulospinal and other descending pathways to the motor and interneuronal circuits of 
the spinal cord, and the absence of an intact corticospinal system. Loss of descending 
tonic or phasic excitatory and inhibitory inputs to the spinal motor apparatus, alterations 
in the segmental balance of excitatory and inhibitory control, denervation super 
sensitivity, and neuronal sprouting may be observed. 
 
Signs and symptoms:- 
Typically, the most common sign on exam is resistance to a passive change in a 
joint angle. It is most commonly noted in the flexor muscles of the upper extremities, the 
proximal extensor muscles of the lower extremities, and the distal flexor muscles of the 
lower extremities. As such, depending on the insult, specific patterns may arise that can 
aide in treatment. 
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Cerebral palsy: 
Children with cerebral palsy tend to exhibit one of the following spasticity patterns: 
1. Diplegic pattern: Scissoring, crouching, and toe walking 
2. Quadriplegic pattern: Diplegic patterning in addition to flexion of the elbow, 
flexion of the wrist and fingers, adduction of the thumb, and internal rotation, 
pronation, or adduction of the arms 
3. Hemiplegic pattern: Plantar flexion of the ankle, flexion of the knee, adduction of 
the hip, flexion of the wrist and finger, adduction of the thumb, and flexion, 
internal rotation, pronation, or adduction of the arms. Equinovarus positioning of 
the foot is a common posture in the lower extremity and it can be a major 
limitation to functional transfers or gait as a child grows older. 
 
Spasticity of the extremities: 
The following patterns present in patients with cerebral palsy 
1. Adduction and internal rotation of the shoulder 
2. Flexion of the elbow and wrist 
3. Pronation of the forearm 
4. Flexion of the fingers and adduction of the thumb 
 
The following flexor patterns can occur in patients with cerebral palsy 
1. Hip adduction and flexion 
2. Knee flexion 
3. Ankle plantar flexion or equinovarus positioning 
 
The following extensor patterns may be seen in patients  
1. Knee extension or flexion 
2. Equinus and/or valgus ankle 
3. Great toe dorsiflexion or excessive toe flexion. 
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Common Clinical Presentations 
Spastic Hemiplegia 
1. Affects one side of the body more than the other (though both sides may be 
affected). 
2. Upper limb affected more than lower. 
3. Hand preference obvious at an early age. 
4. Delayed walking (18-24 months) with a circumductive gait. 
• Circumductive gait: one leg is stiff and upon stepping it is rotated away from 
the body, and then towards it (i.e., a semicircle shape). The stiffness in the 
affected leg limits flexion and the patient has to raise the pelvis to swing the 
leg out to lift the leg enough to clear the ground. 
 
5. On examination: 
 Circumductive gait. 
 On affected side: 
 Growth differences of hand and thumbnail. 
 Tiptoe walking on one side, due to increased tone in the gastrocnemius 
muscles. Spasticity has a greater effect on the postural (antigravity) 
muscles, e.g., gastrocnemius and sartorius. 
 Unilateral ankle clonus (usually). 
 Babinski sign. 
 Brisk deep tendon reflexes. 
 Weakness of hand and foot dorsiflexors. 
 
6. Seizure disorder presenting before 2 years of age in 1/3 of children. Cognitive 
abnormalities in 25% of cases. 
 
Spastic diplegia 
 Bilateral spasticity of the limbs with legs more affected than arms. 
 First clinical signs appear around the time when the child starts to crawl. 
 Commando crawl: the child uses arms in a normal reciprocal manner but 
drags legs behind rather than using legs as well. 
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 On exam: 
 Spasticity of the legs. 
 Brisk reflexes. 
 Ankle clonus. 
 Bilateral Babinski sign. 
 Scissoring posture of legs when held in the air supported by the axillae due to 
spasticity in the hip adductor muscles. 
 Tiptoe walking. 
 Atrophy and impaired growth of legs in severe cases. 
 Strongly associated with white matter damage in utero between 20-34 weeks of 
gestation. 
 Most common neuropathologic feature is PVL. 
 Minimal risk of seizure disorder. 
 Normal intellectual development is common, but many children still have learning 
disabilities. 
 Other deficits in sensory areas, like vision, may be present. 
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Spastic quadriplegia (‘total body involvement’) 
 Most severe form of CP. 
 Motor impairment to all extremities. 
 High association with cognitive deficiencies and seizure disorders. 
 Increased difficulty swallowing due to supranu clear bulbar palsies, which can cause 
the child to have aspiration pneumonias. 
 Most common neuropathologic lesion is PVL, but may also include basal ganglia 
damage. 
 
 On examination: 
 Increased tone and spasticity in all limbs. 
 Decreased spontaneous movements. 
 Brisk reflexes and plantar extension responses. 
 Flexion contractures of knees and elbows commonly present in late 
childhood. 
 Delay in speech and the presence of visual abnormalities are common. 
 
Diagnosis:  
            The diagnosis of cerebral palsy should be suspected in a child with low birth 
weight and perinatal insult; clinically has an increased tone, feeding difficulties and 
global development delay. Abnormalities of tone posture, involuntary movements and 
neurological Deficits should be recorded. Evaluation includes perinatal history, detailed 
neurological and developmental examination and assessment of language and learning 
disabilities. Inborn Errors of metabolism may need to be excluded by screening of 
plasma amino acids and urine organic acid, reducing substance. CT and MRI help 
delineate the extent of cerebral damage in a case of cerebral palsy. 
 
Differential diagnosis: 
1. Neurodegenerative disorders. 
2. Hydrocephalus and subdural effusion 
3. Brain tumours or space occupying lesions 
4. Muscle disorders 
5. Ataxia telangiectasia. 
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Laboratory investigations: 
 
1. Urine screening tests to rule out inborn errors of metabolism 
2. CSF analysis 
3. X-ray skull intracranial calcification 
4. X ray spine 
5. TORCH Screening 
6. EMG 
7. EEG 
8. CT scan 
9. MRI  
10. Nerve biopsy 
11. Myelogram 
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3. 3. DRUG REVIEW 
3.3.1.Kurunthotti 
 
Sida cordifolia L. (Family: Malvaceae) is popularly known as “malva-branca” 
(white mallow) or “malva-branca-sedosa” (silky white mallow) in Brazil. It is widely 
distributed and common throughout the tropical and sub tropical plains all over India and 
Srilanka up to an altitude of 1050 m, growing wild along the roadside. It grows as 
wasteland weed. It is also known as the “Bala” in Hindi and Sanskrit.  The plant name 
Bala is coined on the name of „Parvati‟ (goddess of strength and beauty)(22). 
 
General characteristics: 
 
(23)
.
 
Kurunthotti is indicated for Athisuram . 
 
Organoleptic Character: 
 
• Taste :Thuvarppu 
• Potency : Thatpam 
• Division : Inippu 
• Useful part: Samulam 
• Actions : Emollient 
 
Chemical constituents: 
Phytosterol, ecdysterone, Alkaloids, β Phenethylamines Viz., phenethylamine, 
ephedrine and pseudoephedrine; carboxylated tryptamines viz.., S-(+)-Nb- methyl 
tryptophan methylester and hypaphorine ;quinazolines viz., vasicinone, vasicine, and 
vasicinol
(24)
. 
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Pharmacological activities: 
1. Anti spasmodic  
2. Anti inflammatory 
3. Hypoglycaemic 
4. Hepato protective 
5. Antibiotic 
6. Anti microbial 
7. Anti mutagenic 
8. Anti hyperglycaemic 
9.  Anti lipidemic(24)..  
 
             Internally, bala is the best nervine tonic and rasayana for all kinds of vatha 
disorders like paralysis, facial palsy, cervical spondylosis. In such conditions, the 
decoction of its root is given orally and bala siddha thaila, a medicated oil is used for 
massage. Root is regarded as a cooling, astringent, stomachic and tonic, aromatic, bitter, 
diuretic. It is also a rejuvunative, nutritive and stimulant to the heart.  It also promotes 
healing of tissue in chronic infectious diseases.  For that the decoction of its roots works 
well, when given with ghee and honey. It promotes the healing of lung tissue and cures 
the cavitations. As it helps building the muscle tissue, it boosts the strength and hence, 
imparts a rejuvunative action. As a tonic, it is commonly used in general debility
(25)
... 
 
3.3.2.Chukku 
       Zingiber officinale Roscoe, commonly known as ginger belongs to the family 
Zingiberaceae. It is cultivated commercially in India, China, South East Asia, West 
Indies, Mexico and other parts of the world. It is consumed world wide as a spice and 
flavouring agent and has many medicinal properties 
(26)
.  
 
General characters: 
 (27)
. 
 Chukku is indicated for Vatha diseases, sinusitis, head ache. 
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Organoleptic Character: 
• Useful part  :  Root tuber (dried) 
• Taste   :  Kaarppu(Acrid) 
• Potency  :  Veppam 
• Division  :  Kaarppu(Acrid) 
• Actions  :  Carminative, Stomachic , Stimulant  
 
Chemical constituents: 
        It contains 1-2% volatile oil, resinous matter, diarylheptanoid, gingerdione, 
starch, gingerol, mucilage, sesquiterpenes like zingiberine, bisabolene. 
 
It consists mainly of the mono- and sesquiterpenes, camphene, β-phellandrene, 
curcumene, cineole, geranyl acetate, terphineol, terpenes, borneol, geraniol, limonene, 
βelemene, zingiberol, linalool, α-zingiberene, β-sesquiphellandrene, β-bisabolene, 
zingiberenol and α-farmesene(28). 
 
Pharmacological activity: 
1. Anti spasmodic 
2. Anti inflammatory  
3. Antibiotic 
4. Anti microbial 
5. Anti mutagenic 
6. Anti hyperglycaemic 
 
Traditionally, ginger has been used in folk medicine for indigestion, flatulence, 
diarrhoea, malaria and fever. The ginger has been listed in document “Generally 
Recognized as Safe”. The British Herbal Compendium reported ginger acts as 
carminative, anti-emetic, spasmolytic, peripheral circulatory stimulant and anti 
inflammatory. The ginger contains minerals like iron, calcium and phosphorous and also 
contains vitamins such as thiamine, riboflavin, niacin, vitamin A and vitamin C
(29)
. 
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3.3.3. Thazhuthazhai 
       
           Clerodendrum  pholomidis is an important medicinal plant of Lamiaceae. It is a 
common shrub of arid plains, low hills, tropical areas and deserts. They are distributed 
throughout the drier parts of India, Pakistan, Srilanka, Myanmar and south East Asia. It 
has so many medicinal properties which have been used since very ancient times of 
Indian medicine. Roots are mainly exploited for medicinal purposes. Therefore there is 
an urgent attention require for conservation of C. phlomidis to meet the increasing 
demand for medicinal purposes(30). 
 
General Characteristics: 
(31)
.
Organoleptic Character: 
 
 Taste   :  Kaippu , Thuvarppu 
 Potency  :  Veppam 
 Division  :  Kaarppu(Acrid) 
 Useful part  :  Root tuber (dried) 
 Actions  :  Alterative, Astringent 
 
Chemical constituents: 
Ceryl alcohol, Clerodin, Clerosterol, Clerodendrin- A, Alkaloids, Saponins, 
Alkaloids, Flavanoids, Tannins, Carbohydrates, β-sitosterol, γ-sitosterol(32).. 
 
Pharmacological activities: 
1. Anti inflammatory 
2. Hepato protective 
3. Anti hypertensive 
4. Anti oxidant 
5. Cytotoxicity 
6. Anti tumour 
  
52 
 
Uses:  
1. Thazhuthazhai is indicated for 80 Vatha diseases, sinusitis 
2. It is used in preparations indicated for digestive disorders, acidity, gas, diarrhoea, 
laxative, liver tonic and general health tonic. 
3. Its root bark is used in cough, asthma, cold, anaemia, oedema, and nervous 
disorders. 
4. Whole plant is used as hypoglycaemic. It is also used for ailments involving 
swellings,  joint pains and inflammation. 
5. Root decoction is used as aromatic, astringent and demulcent in gonorrhoea 
6. Leaf juice is used to treat mental tension and mental disturbances in Tamilnadu. 
7. Leaf and roots are used for body ache, head ache and unconsciousness(32). 
 
3.3.4. Devadaru 
 
     Cedrus deodara  (Family: Pinaceae) is  commonly called as deodar, is a species of 
cedar native to the western Himalayas in eastern Afghanistan, Northern Pakistan, North-
central India, South western Tibet and western Nepal. It is a majestic and handsome tree, 
growing to a great height and wide girth and living to a great age. It is a pyramidal shape 
tree having soft greyish green or blue needles and drooping branches, growing rapidly to 
40-50 feet tall and 20-30 feet wide. It is an oldest tree of 745 years with 900 rings as 
described by Bhattacharya
(33)
. 
 
General characteristics: 
 § Å ý § ÅÇ  À£É¢  
 Å ¢ § À §Å - Á Å Å  
 Á £ § È  
 Å  Á È ¢ Á (34).
 
      Devadaru is indicated for Nadukku Vatha diseases, Suram,  
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Organoleptic Character: 
 
• Taste   : SiruKaippu ,  
• Potency  : Veppam 
• Division  : Kaarppu(Acrid) 
• Actions  : Astringent 
• Useful part  : wood 
 
Phytochemicals:- 
Cedrusinin, Dihydroflavonol, α and β himasecolone, Saponins, Oleo-resin, 
Sesquiterpenoid alcohols, Limonene, Carboxylic acid, Deodardione, The main 
components include α-terpineol, linalool, limonen, anethole, caryophyllene  and 
eugenol
(35)
.  
 
Pharmacological activities: 
1. Anti spasmodic 
2. Anti inflammatory 
3. Anti arthritic 
4. Anti secretory  
5.  Anti ulcer  
6. Immuno modulator 
7. Cytotoxicity 
8. Anti allergic  
 
               Traditionally the heartwood of C. deodara plant was used to enhance cerebral 
function, balance the nervous system and strengthens the brain. It was reported to 
possess CNS depressant and neuroleptic activity.  Himachalol is one of the major 
constituent of wood of plant, which is having anti spasmodic activity. The 
pharmacological studies of himachalol on various isolated smooth muscles and against 
different agonists (acetylcholine, histamine, serotonin, nicotine, and barium chloride) 
indicated spasmolytic activity.
 (34)
. 
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3.3.5. MAHIL 
         Mimusops elengi (Family: Sapotaceae) is considered as a sacred plant among 
Hindus and has obtained important place in religious texts as well as in ancient Sanskrit 
literatures. Plants have been an important source of medicine for thousands of years. Its 
fragrant flowers are celebrated in the Puranas and even placed amongst the flowers of the 
Hindu paradise. Krishna is said to have fascinated the milkmaids of Brindhavan on the 
banks of Yamuna by playing on his flute beneath a Mimusops elengi tree. It has made 
important contribution to the field of science from ancient times and also to modern 
research due to its large number of medicinal properties
(35)
 . 
 
General characteristics: 
     “
 (36)
 
Magizh is indicated for Udal Anal thanium 
 
Organoleptic Character: 
 
 Taste   : Thuvarppu 
 Potency  :  Veppam 
 Division  :  Kaarppu(Acrid) 
 Useful part  :  Flower 
 Actions  :  Astringent 
 
Chemical Constituents: 
D-mannitol, β-sitosterol, β-sitosterol-β-D-glucoside, quercitol, ursolicacid and a 
triterpene alcohol which was later, identified as lupeol, Tannin, Volatile oil.
 (37)
 
 
Pharmacological activities: 
1. Anti spasmodic 
2. Antibiotic 
3. Anti hyperlipidemic 
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5. Anti inflammatory 
6. Anti microbial  
7. Antioxidant 
8. Antipyretic  
9. Hypotensive activity. 
 
             The bark is used as a cardio tonic, stomachic, anti helmintic, tonic, astringent 
which cures biliousness, diseases of the gums and teeth. The flower is cooling, astringent 
to the bowels are used to cures the disease of blood, cure biliousness, liver complaints, 
diseases of the nose, headache, their smoke is good in asthma. The fruit is astringent to 
the bowel, good for the teeth and causes flatulence. The seed fixes loose teeth and used 
as a cure troubles in the head. The root is aphrodisiac, diuretic, astringent to the bowel, 
good for gonorrhoea and used as a gargle which cures relaxation of the gums
(35)
.  
 
3.3.6. Marukozhunthu 
          Majorana hortensis (M.) plant is an evergreen herbaceous plant belonging to the 
family Lamiaceae It is also known as Sweet marjoram. The genus Origanum houses 
around 900 different species and many species are extensively used for the flavouring of 
alcoholic beverages, food products and in perfumery owing to their spicy fragrance. In 
addition to their commercial importance, such plants have been traditionally used as 
condiments and spices for foods like salads, soups, sausages and meats. It is native to 
Asia, but was naturalized in Europe where it was a favourite of the Greeks and 
Romans.The branches have square stems and tiny, oval, gray-green leaves that may be 
fuzzy.  The branches and leaves are steam distilled to produce an essential oil with a 
warm, woody, spicy, slightly peppery and nutty aroma that is calming and comforting
(37)
.  
 
General characteristics: 
 (38)
Marukozhunthu is indicated for Udalukku oottathaium, miguntha pasiyaium 
undakkum. 
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Organoleptic Character: 
 
• Taste   : Kaippu,Karppu 
• Potency  :  Veppam 
• Division  :  Kaarppu(Acrid) 
• Useful part  :  Poondu 
 
Chemical Composition: 
Linalool, Limonene, Geranyl acetate, Caryophyllene, α- terpineol, geraniol, Citral 
eugenol, carvacrol, thymol, Monoterpenoids like   a-pinene,  sabinene,  myrcene, a-
terpinene, y-terpinene, Sesquiterpenoids like Beta-caryophyllene 2, a-humulene, 
Monoterpenol like Linalool, terpine-1-ol-4, terpine-1-ol-3 0.3%,
(37)
  
 
Pharmacological  activities: 
1. Anti spasmodic 
2. Antibiotic 
3. Anti microbial 
4. Anti mutagenic 
5. Anti hyperglycaemic 
6.  Anti lipidimic 
7.  Antiulcer  
 
Traditionally, the leaves are employed to cure diabetes, insomnia, catarrh, asthma 
and nervousness. The leaf extracts have been scientifically proved to be effective as an 
antioxidant 
(37)
. 
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3.3.7. AAMANAKKU 
Ricinus communis; Family: Euphorbiaceae popularly known as 'castor plant' and 
commonly known as „palm of Christ‟, Jada (Oriya), Verenda (Bengali), Endi (Hindi), 
Errandi (Marathi), Diveli (Guajarati). The plant is widespread throughout tropical 
regions as ornamental plants. The large family Euphorbiaceae contains nearly about 300 
genera and 7,500 species. Amongst all, the Ricinus communis or castor plant has high 
traditional and medicinal value for maintaining the disease free healthy life
(39)
. 
 
General characteristics: 
 
• Botanical name : Ricinus communis 
• Family   : Euphorbiaceae 
• Suvai   : kaippu 
• Thanmai  : Veppam 
• Pirivu   : Kaarppu 
• Parts used  : Leaves, root and seed 
 
Chemical constituents: 
1. Ricinine 
2. N-Dimethylricinine 
3. Asesquiterpenoid 
4. Ricinoleic acid 
5. Isoricinoleic acid 
6. Dyhydroxy stearic acid 
 
Pharmacological activities: 
1. Anti-vatha 
2. Immuno modulator 
3. Hepato protective activity 
4. Anticancer activity 
5. Anti-oxidant 
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6. Anti histamic 
7.  Anti asthmatic  
8. Anti ulcer 
9.  Anti diabetic 
10.  Anti inflammatory  
11. Anti microbial 
 
Castor oil is used topically to soften skin, bunions and corns; and to dissolve cysts, 
growths and warts. It is also applied to the skin for osteoarthritis.
 (39)
 The external 
application suggested by Cayce is that of a hot abdominal pack positioned over the right 
side of the abdomen covering the liver, small intestines, and ascending colon. Using the 
conceptual model from the Hagenfeldt et al.
41
 study, by comparing the levels of the 
epoxydicarboxylic acids in the urine followed by external and internal oral applications, 
the results hoped to be able to consistently enumerate the level of absorption of the oil 
through the skin. 
 
3.3.8 NALLENNAI 
Sesamum indicum or orientale cultivated for its seeds since ancient times,  
found chiefly in the tropics of Africa and Asia. Historically, sesame was cultivated more 
than 5000 years ago as a drought-tolerant crop and was able to grow where other crops 
failed. Sesame seeds were one of the first crops processed for oil as well as one of the 
earliest condiments. 
Sesame seeds, also called bennes or gingellies, are black or white and yield an oil
 that resiststurning rancid.  Sesame was introduced by African slaves to the U.S. South, 
where it sometimes becomes a weed. Sesame was cultivated during the Indus valley 
civilization and was the main oil crop. It was probably exported to Mesopotamia around 
2500 BC
(42)
 
 
General characteristics: 
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• Botanical name : Sesamumindicum 
• Family  : Pedaliaceae 
• Suvai  : Inippu 
• Thanmai  : Thatpam  
• Pirivu  : Inippu 
• Part used : Seed oil 
 
Chemical constituents: 
1. Alkaloids  
2. Flavanoids  
3. Tannins  
4. Phenol  
5. Phytate 
6. Tocopherol 
7.  Sesamol 
8. Sesamin. 
 
Actions: 
1. Demulcent 
2. Laxative 
3. Nutritive 
4. Emollient 
 
Pharmacological activities: 
1. Anti spasmodic 
2. Antioxidant  
3. Anti bacterial 
4.  Anti fungal  
5. Anti inflammatory  
6. Anti viral  
7. Immune stimulant 
8.  Anti rheumatic  
9.  Anti diabetic  
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      Sesame oil is rich in vitamin E (potent antioxidant), iron, omega-6 fatty acids, 
vitamin B6, magnesium, calcium, zinc, copper, dietary fibres, flavanoids and phenol 
antioxidants. All these enriching nutrients make Sesame oil as a powerful antioxidant 
with cardiac, dermatologic, laxative, emollient, carminative, tonic warming properties
..
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3.3.9 Elumichai 
Citrus Lemon Linn (Family: Rutaceae) is known as Elumichai. It is a perennial 
tree. Citrus cultivated more than 3000 years. At various times, citrus plants were thought 
to be native to asia (where they were first domesticated), Europe and Florida .The lemon 
reached Europe during the time of classical Rome. Lemon is Cultivated in India, 
common in the C.P; Kumaon and Northern India. The most recent research indicates an 
origin in Australia, New Guinea and New Caledonea. Citrus fruit has been cultivated in 
an ever –widening area since ancient times.. 
 
General characteristics: 
 
• Botanical name  : Citrus limon 
• Family   : Rutaceae 
• Suvai   : Pulippu 
• Thanmai   : Veppam 
• Pirivu   : Kaarppu 
• Part used  : Leaves, Fruit and Oil 
 
Chemical constituents: 
1. α- Pinene 
2. Sabinene 
3. β- Pinene 
4. α- Terpenene 
5. Limonene 
6. Linaly acetate 
7. Geraniol 
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Actions: 
1. Refrigerant 
2. Rubefacient 
3. Carminative 
 
Pharmacological activities: 
1. Anti bacterial  
2. Anti microbial 
3. Anti fungal 
4. Anti oxidant  
5. Anti mutagenic 
 
This is much used as sauce by Indians; a pickle of this fruit in its own juice and 
effectual remedy for indigestion caused by excess eating or by indigestible particle of 
food. Lemon plays an important part in perfumery also. The quality of Indian lemon peel 
is almost equal to the Sicilian variety and it has been estimated that if extraction of lemon 
oil is attempted from Indian lemon peel, it will not be a failure commercially. Lemon 
juice is one of the best remedies for scurvy and serves as a refrigerant in febrile and 
inflammatory affections, acute rheumatism, dysentery and diarrhoea
..
 Lemon juice 
extracts on wound healing and haemostasis activity provides physiological information 
on a proper blood assessment in the body.
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3.3.10. Vellai  Kungiliyam 
Shorea robusta   is a tree commonly known as sal or shala tree, belonging to the 
family Dipterocarpaceae. Shorea robusta is widely distributed in India, Nepal and 
Bhutan. In India, the species is distributed from Himachal Pradesh to Assam, Tripura, 
West Bengal, Bihar and Orissa, Eastern districts of Madhya Pradesh extending further to 
the Eastern Ghats of Andhra Pradesh
(46)
. 
 
General characteristics: 
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• Botanical name  : Shorearobusta 
• Family   : Dipterocarpaceae 
• Suvai   : Kaippu 
• Thanmai   : Veppam 
• Pirivu   : Kaarppu 
• Parts used  : Leaves, Fruit and Oil 
 
Chemical constituents: 
1. Mono terpenoids 
2. Sesquiterpenoids 
3. Ursolic acid 
4. Asiatic acid 
5. Benthamic acid 
6. Amyrin 
 
Actions: 
1. Stimulant 
2. Expectorant 
3. Diuretic 
4. Analgesic 
5. Hyper lipidemic 
 
Pharmacological activities: 
 
1. Anti inflammatory 
2. Analgesic 
3. Anti pyretic 
4. Anti Obesity 
5. Anti inflammatory  
6. Anti ulcer  
 
               
  
63 
 
S. Robusta is known by various vernacular names in different geographical 
regions. Shorea robusta has been traditionally used for various ailments. The leaves and 
bark are used to treat wounds, ulcers, leprosy, cough, gonorrhoea, earache and headache. 
The bark is also used to treat diarrhoea, dysentery and vaginal discharges. The fruits are 
useful in tubercular ulcers, seminal weakness, burning sensation and dermopathy. The 
oleoresin exuded from the plant has astringent, carminative and stomachic properties
(46)
.. 
 
3.3.11. Pasu Nei 
Cow Ghee is a semi-liquid form of butter without water content, lactose and other 
milk solids. It is prepared by gently heating butter until it becomes a clear golden liquid. 
Cow Ghee is light, pure and does not become rancid for a long time. Cow Ghee is sweet 
in taste, cold in nature and has a sweet after taste. It is considered soothing, soft and 
oily
(47)
. 
 
General characteristics: 
 
 
 
                Cow Ghee is known to be digested 96% which is highest as compared 
to all other vegetable or animal source fats. It contains anti oxidants like 
Vitamin E and beta carotene (600IU) besides other nutrients like phospholipids, 
diglycerides and triglycerides. Cow Ghee is excellent for balancing Vatha (air) and Pitha 
(fire) related doshas (humors). It is satvic (healthy) food, which has a pure influence on 
mind, body and spirit. Vatha type people can enjoy more 
ghee than Pitha (fire) type who in turn can enjoy more ghee than Kapha.(Water) 
types.Cow Ghee utilized in Ayurveda, used for numerous medical applications, including 
the treatment of allergy, skin and respiratory diseases.
 (49)
. 
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3.3.12. KOLLU 
           Horse gram Macrotyloma uniflorum (Lam.) verdc.] is extensively cultivated in 
South Indian States i. e, Karnataka, Andhra Pradesh and Maharashtra. It is also cultivated 
in parts of Bengal, Bihar, Himachal Pradesh,Orissa and foot hills of Uttar Pradesh.Horse 
gram species are tropical annuals or perennial herbs, usually prostrate or partly erect and 
normally have long runners. Seeds are small non-endospermous, flattened,rhomboidal, 3-
6 mm long, light red, brown, black or mottled, testa shiny, hilum small and 
inconspicuous.
(50)
  
 
General characteristics: 
 
• Botanical name : Macrotylomainiflorum 
• Family   : Fabaceae 
• Suvai   : Thuvarpu, Sirukaippu 
• Thanmai  : Veppam  
• Pirivu   : Kaarppu 
• Part used  : Seed, Samoolam 
 
Chemical constituents: 
1. Dolichin A 
2. Dolichin B 
3. Kaempferol-3-O-B-D-glucoside 
4. Stigmasterol 
5. β- sitosterol 
 
Actions: 
1. Astringent 
2. Diuretic 
3. Tonic 
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4. Anti obesity 
5. Anti Diabetic 
6. Anticalcifying 
7. Anti microbial 
 
Pharmacological activities: 
1.  Antispasmodic, 
2. Antioxidant activity, 
3. Antibacterial, 
4.  Antifungal,  
5. Anti-inflammatory,  
6. Antiviral,  
7. Immune-stimulant. 
 
The seeds of M. uniflorumare utilized as cattle feed. However it is consumed as 
whole seeds by a large population in rural area of southern India the seeds of M. 
uniflorumare used in traditional medicine as letter, thermo genic, astringent, 
anthelmintic, diaphoretic, diuretic, expectorant, ophthalmic and tonic.  the scientists 
made a comparative analysis between horse gram seeds and their sprouts and found that 
the seeds have greater beneficial effects on the health of  hyperglycaemic individuals. the 
majority of antioxidant properties are confined to the seed coat and its removal would not 
do any good. raw horse gram seed is rich in polyphenols, flavonoids, and proteins, major 
antioxidants present in fruits and other food materials. the seedhas the ability to reduce 
postprandial hyperglycemia by slowing down carbohydrate digestion and reducing 
insulin resistance by inhibiting proteintyrosine phosphatase 1 beta enzyme.
(50)
. 
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3.3.14. Spasticity: 
Spasticity has been defined as an increase in muscle tone due to hyper excitability 
of the stretch reflex and is characterized by a velocity-dependent increase in tonic stretch 
reflexes. Spasticity usually is accompanied by paresis and other signs, such as increased 
stretch reflexes, collectively called the upper motor neuron syndrome. Paresis 
particularly affects distal muscles, with loss of the ability to perform fractionated 
movements of the digits. 
 
 The upper motor neuron syndrome results from damage to descending motor 
pathways at cortical, brainstem, or spinal cord levels, and spasticity evolves in the days 
and weeks after injury. The interval between injury and the appearance of spasticity 
varies from days to months according to the level of the lesion. In addition to weakness 
and increased muscle tone, the signs in spasticity include clonus, the clasp-knife 
phenomenon, hyper reflexia, the Babinski sign, flexor reflexes, and flexor spasms. 
 
      The pathophysiologic basis of spasticity is incompletely understood. The changes in 
muscle tone probably result from alterations in the balance of inputs from reticulospinal 
and other descending pathways to the motor and interneuronal circuits of the spinal cord, 
and the absence of an intact corticospinal system. Once spasticity is established, the 
chronically shortened muscle may develop physical changes such as shortening and 
contracture that further contribute to muscle stiffness
(52)
. 
 
Spasticity may however aid stability and people can use the support it generates 
to aid anti-gravity activity and walking. Ashworth has described an ordinal grading scale 
for resistance encountered during such passive muscle stretching. Modified Asworth 
Scale
.53
 used method that has been recommended for measuring muscle spasticity 
involves manually moving a limb through the range of motion to passively stretch 
muscles. 
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4. MATERIALS AND METHODS 
4.1 PREPARATION OF TRIAL DRUGS 
4.1.1 Kurunthotti  Kudineer (Internal Medicine)
(39) 
  The required drugs were purchased from a reputed raw drug shop at kandha 
swamy Kovil Street, Paris corner, Chennai, Tamil nadu. Raw drugs were authenticated 
by the Medicinal Botanist and trial drug Kurunthotti kudineer was prepared at 
Gunapadam laboratory, National Institute of Siddha. 
 
S.no Name Botanical name  Part used Part 
1 Kurunthotti Sida Rhomphoidus Root 20.4 gm 
2 Thazhuthazhai Clerodendrum Phlomidis Root 10.2 gm 
3 Mazhil Mimusop Elengi Flower 20.4 gm 
4 Naagaram Zingiber officinalae Dried Rhisome 5.1 gm 
5 Maruvu Majorana hortensis Full plant 15.3 gm 
6 Devatharam Cedrus Deodara Wood 10.2 gm 
 
The raw drugs were purified as follows
(54) 
1. Kurunthotti ver (Sida Rhomphoidus)  
Cut into a small pieces, washed in  river water and dried  
2. Thazhuthazhai ver (Clerodendrum Phlomidis)   
Cut into a small pieces, washed in river water and dried  
3. Mahil (Mimusop Elengi)    
Remove calyx, androecium and stalk  
4. Naagaram (Zingiber officinalae )  
Add 2 part of sunnakkal to 1 part of .Zingiber officinalae. Dry it for 3 
hours, washed and then dried . After that external skin should be peeled off. 
5. Maruvu (Majorana hortensis) :  
Remove calyx, androecium and stalk. 
6. Devatharam (Cedrus Deodara) 
Roasted to golden colour.                                                                                 
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INTERNAL MEDICINE 
 
       Kurunthotti (Sida Rhomphoidus)   Thazhuthazhai (Clerodendrum Phlomidis) 
 
          Mazhil (Mimusop Elengi)          Naagaram (Zingiber officinalae) 
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INTERNAL MEDICINE 
 
         Maruvu (Majorana hortensis)           Devatharam (Cedrus Deodara) 
 
 
 
 
  Kurunthotti Kudineer Chooranam  
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All purified drugs are coarsely powdered and kept in a clean glass container. The 
prepared medicine also authenticated by the concerned head of the department for its 
completeness.          
Dosage : :  2 to 4years - 30 ml (bds);  5 to 7 years - 40 ml (bds) 
Duration: 2 Mandalam (90 days) 
Drug Storage:  Prepared medicine in coarse   powder form were stored in clean and dry 
container. 
Dispensing:  Prepared medicine of 52 gms would be given as coarse powder form in 
separate  air lock covers. 
 
4.1.2 External medicine I – வசவவண்வெய் (External Medicine) 
 
S.no Name Botanical Name Part used Part 
1 Amanakku ennai   Ricinus communis 
Linn 
Seed Oil 1 litre 
2 Nalla ennai            Sesamum indicum Seed Oil 1 litre 
3 Pasu nei                Cow Ghee Ghee 1 litre 
4 Lemon juice          Citrus aurantifolia Juice 1 litre 
5 Ponmezhugu   Care Wax Wax 51 gm 
6 Vellai kungiliyam   Shorea robusta Resin 30.6 gm 
 
(1 Padi= 1.34 litters)
 (55)            
(1 Kazhanju= 5.1 gm)
(55) 
Preparation Method; 
Take 1.3 litre (1Padi) of castor oil, gingelly oil, cows ghee in a bronze vessel and 
add (1Padi) lemon juice keep it under sunlight and stir. Take 50 gm of yellow wax get 
into small pieces, 30 gm powder of vellai kungiliyam is melted in the container and 
mixed with content in bronze vessel and well grinded kept under the sunlight. Water 
dried completely after preserve in container. 
 
4.1.3  External Medicine II- வ ொள்ளுவ ொடிதிமிர்தல் 
          
Kollu –  Macrotyloma uniflorumare 
               Ingredient mentioned above was made as a coarse powder. 
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i) EXTERNAL MEDICINE 
 
Amanakku ennai (Ricinus communis Linn)           Nalla ennai (Sesamum indicum) 
 
 
 
 
 
 
 
 
 
 
Pasu nei   (Cow Ghee)         Lemon juice  (Citrus aurantifolia ) 
 
  
72 
 
i) EXTERNAL MEDICINE 
 
       Ponmezhugu ( Care Wax )           Vellai kungiliyam (Shorea robusta ) 
 
 
 
 
 
 
 
 
 
 
வசவவண்வெய் 
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ii) EXTERNAL MEDICINE 
 
Kollu  – Macrotyloma uniflorumare 
 
 
 
 
 
 
 
 
 
 
 
 
வ ொள்ளுவ ொடி 
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4.1.4 External Therapy For Siravatham 
 I Podithimirmal  
  
 This is applying  Karunkollu powder (fine) from distal to proximal direction in 
all the limbs and trunk.In Pothimirthal, herbal powders (dry powders) are used.These 
powders are dry and rough in nature and hot in potency. 
 
 These properties create lightness, dryness, roughness, remove the blockages and 
stiffness, and also have a cutting or liquefying action on the fat tissue.When rubbed on 
the body in a specific manner which Creates friction. 
 
II  Thokkanam
(56) 
Thokkanam massage has consisted of nine types of technique which are 
performed in children once in a day.  The method included Thattal (friction/percussive 
strokes), Irukkal (wringing), Pidithal (draining), Murukkal (kneading), Alutthal (gliding), 
Iluthal (pulling), Kaikattal (cross arm position and flexion), Mallathuthal (supine 
position), Asaithal (vibration).  
 
Thokkanam was given for thirty minutes a day for 90 days. In Cerebral palsy 
children based on the classification different to be affected to a different extent. The 
Thokkanam was likely to be beneficial, it was considered important to whole body 
including all limbs. Throughout the series of studies whole body of the children were 
massaged.  When performing Thokkanam procedure we sure to practice safely, 
endeavoring to adhere to the specific guidelines, scope and ethics of the massage and 
have fun and be playful with the nine types of strokes and responsibility hold within 
fingertips.  
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i) EXTERNAL THERAPY 
Podithimirmal Procedure 
SUPINE POSITION LOWER LIMB 
 
 
 
 
 
 
 
 
 
 
 
SUPINE POSITION UPPER LIMB 
 
 
 
  
1 2 
3 4 
5 6 
7 
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i) EXTERNAL THERAPY 
Podithimirmal Procedure 
SUPINE POSITION LOWER LIMB  
 
 
 
 
 
 
 
 
 
 
 
SUPINE POSITION UPPER LIMB 
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ii) EXTERNAL THERAPY 
Thokkanam Procedure 
SUPINE POSITION  
 
 
 
 
 
 
 
 
 
 
 
 
SUPINE POSITION 
 
 
  
1 2 
3 4 
5 6 
7 8 
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4.2 PRECLINICAL STUDIES 
4.2.1 Analytical standardization of the Trial drug based on PLIM 
4.2.2 Phytochemical analysis 
4.2.3 Biochemical analysis 
4.2.4 Acute Toxicity study 
 
 4.2.1 Analytical Standardization  
1 Loss on drying: 
An accurately weighed 2g of  Kurunthotti Kudineer chooranam formulation was 
taken in a tarred glass bottle. The crude drug was heated at 105°C for 6 hours in an oven 
till a constant weight. The percentage moisture content of the sample was calculated with 
reference to the shade dried material. 
 
2. Determination of total ash: 
Weighted accurately 2g of Kurunthotti Kudineer chooranam formulation was 
added in crucible at a temperature 600°C in a muffle furnace till carbon free ash was 
obtained. It was calculated with reference to the air dried drug. 
 
3. Determination of acid insoluble ash: 
 Ash above obtained, was boiled for 5min with 25ml of 1M Hydrochloric acid and 
filtered using an ash less filter paper. Insoluble matter retained on filter paper was 
washed with hot water and filter paper was burnt to a constant weight in a muffle 
furnace. The percentage of acid insoluble as was calculated with reference to the air 
dried drug. 
 
4. Determination of water soluble ash: 
 Total ash 1mg was boiled for 5min with 25ml water and insoluble matter 
collected on ash less filter paper was washed with hot water and ignited for 15 min at a 
temperature not exceeding 450°C in a muffle furnace. The amount of soluble ash is 
determined by drying the filtrate. 
 
5. Determination of water soluble extractive: 
 5gm of air dried drug, coarsely powered Kurunthotti Kudineer chooranam was 
macerated with 100ml of distilled water in a closed flask for twenty- four hours, shaking 
frequently.  
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The solution was filtered and 25 ml of filtered was evaporated in a tarred flat 
bottom shallow dish, further dried at 100°C and weighed. The percentage of water 
soluble extractive was calculated with reference to the air dried drugs. 
 
6. Determination of alcohol soluble extractive: 
 2.5mg of air dried drugs coarsely powered Kurunthotti Kudineer chooranam was 
macerated with 50ml alcohol in a closed flask for 24 hrs. With frequent shaking, it was 
filtered rapidly taking precaution against loss of alcohol.10ml of filtrate was then 
evaporated in a tarred flat bottom shallow dish, dried at 100°C and weighed. The 
percentage of alcohol soluble extractive was calculated with reference to air dried drug. 
 
4.2.2 Phytochemical Analysis  
The preliminary phytochemical screening test was carried out for each extracts of 
Kurunthotti Kudineer Chooranam as per the standard procedure. 
 
1. Detection of alkaloids: 
      Extracts were dissolved individually in dilute Hydrochloric acid and filtered. 
a) Mayer‟ Test: Filtrates were treated with Mayer‟s reagent (Potassium Mercuric 
Iodide). Formation of a yellow colored precipitate indicates the presence of 
alkaloids. 
b) Wager‟s Test: Filtrates were treated with Wagner‟s reagent (Iodine in Potassium 
Iodide). Formation of brown/reddish precipitate indicates the presence of 
alkaloids. 
c) Dragendroff‟s Test: Filtrates were treated with Dragendroff‟s reagent (Solution of 
Potassium Bismuth Iodide). Formation of red precipitate indicates the presence of 
alkaloids. 
d) Hager‟s Test: Filtrates were treated with Hager‟s reagent (Saturated picric acid 
solution). Presence of alkaloids confirmed by the formation of yellow colored 
precipitate. 
 
2. Detection of carbohydrates: 
Extracts were dissolved individually in 5 ml distilled water and filtered. The 
filtrates were used to test for the presence of carbohydrates. 
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a) Molisch‟s Test: To 2ml of plant sample extract, two drops of alcoholic solution 
of α-naphthol are added. The mixture is shaker well and few drops of 
concentrated sulphuric acid are added slowly along the sides of test tube. A violet 
ring indicates the pressure of carbohydrates. 
b) Benedict‟s test: Filtrates were treated with Benedict‟s reagent and heated gently. 
Orange red precipitate indicates the presence of reducing sugars. 
 
3. Detection of glycosides: 
Extracts were hydrolyzed with dil.HCL, and then subjected to test for glycosides. 
a) Modified Borntrager’s Test: Extracts were treated with Ferric chloride solution 
and immersed in boiling water for about 5 minutes. The mixture was cooled and 
extracted with equal volumes of benzene. The benzene layer was separated and 
treated with ammonia solution. Formation of rose-pink color in the ammonical 
layer indicates the presence of anthranol glycosides. 
b) Cardiac glycoside (Keller-Killiani test): Extract was shaken with distilled water 
(5 mL). To this, glacial acetic acid (2 mL) containing a few drops of ferric 
chloride was added followed by H2SO4 (1mL) along the side of the test tube. 
The formation of brown ring at the interface gives positive indication for cardiac 
glycoside and a violet ring may appear below the brown ring. 
 
4. Detection of saponins: 
a) Froth Test: Extracts were diluted with distilled water to 20ml and this was shaken 
in a graduated cylinder for 15 minutes. Formation of 1 cm layer of foam indicates 
the presence of saponins. 
b) Foam Test: 0.5 gm of extract was shaken with 2 ml of water. If foam produced 
persists for ten minutes it indicates the presence of saponins. 
 
5. Detection of phytosterols: 
Salkowski‟s Test: Extracts were treated with chloroform and filtered. The filtrates 
were treated with few drops of Conc. sulphuric acid, shaken and allowed to stand. 
Appearance of golden yellow color indicates the presence of triterpenes. 
 
6. Detection of phenols Ferric Chloride Test 
Extracts were treated with 3-4 drops of ferric chloride solution. Formation of 
bluish black color indicates the presence of phenols. 
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7. Detection of tannins Gelatin test 
            The extract is dissolved in 5 ml of distilled water and 2 ml of 1% solution of 
Gelatin containing 10% NaCl is added to it. White precipitate indicates the presence of 
phenolic compounds. 
 
8.  Detection of Flavonoids: 
a) Alkaline reagents test: Extracts were treated with few drops of sodium hydroxide 
solution. Formation of intense yellow color, which becomes colorless on addition 
of dilute acid, indicates the presence of flavonoids. 
b) Lead acetate test: Extracts were treated with few drops of lead acetate solution. 
Formation of yellow color precipitate indicates the presence of flavonoids. 
 
9. Detection of proteins and amino acids: 
a) Xanthoproteic test: The extracts were treated with few drops of Conc. Nitric acid. 
Formation of yellow color indicates the presence of proteins. 
b) Ninhydrin test: To the extract, 0.25% w/v Ninhydrin reagent was added and 
boiled for few minutes. Formation of blue color indicates the presence of amino 
acids. 
 
10.  Detection of diterpenes copper Acetate test: 
           Extracts were dissolved in water and treated with 3-4 drops of copper Acetate 
solution.  Formation of emerald green color indicates the presence of diterpenes. 
 
11.  Gum and Mucilage: 
               To 1 ml of extract add 2.5 ml of absolute alcohol and stirring constantly. Then 
the precipitate was dried in air and examine for its swelling properties. Swelling was 
observed that will indicate presence of gum and Mucilage. 
 
12.  Test for fixed oils and fats: 
Spot test: A small quantity of extract is pressed between two filter papers. Oil 
stain on the paper indicates the presence of fixed oils. 
 
13. Test for Quinones 
                Extract was treated with sodium hydroxide blue or red precipitate indicates the 
presence of Quinones. The preliminary phytochemical studies of aqueous extract of 
Kurunthotti Kudineer Chooranam were done using standard procedures.  
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The results were presented in tables. The present study reveals that the bioactive 
compounds were present in all the extracts of Kurunthotti Kudineer Chooranam. 
 
4.2.3 Biochemical Analysis of Kurunthotti Kudineer: 
Chemical analysis of Kurunthotti Kudineer was done at the Biochemistry lab at National 
Institute of Siddha, Chennai.. 
 
Preparation of Extract: 
5ml of sample was taken in a 250ml clean beaker and added with 50ml of  
distilled  Water .Then it is boiled well for about 10 minutes. Then it is cooled and filtered 
in a 100ml Volumetric flask and made up to 100ml with distilled water. This preparation 
is used for the Qualitative analysis of acidic| basic radicals and biochemical constituents 
in it. 
 
Procedure 
Test for Silicate 
      2ml of the sample was shaken well with distilled water. 
 
Action of Heat 
      2ml of the sample was taken in a dry test tube and heated gently at first and then 
strong. 
 
Ash Test  
     A filter paper was soaked into a mixture of extract and dil. Cobalt nitrate solution and 
introduced into the Bunsen flame and ignited. 
 
1. Test for Acid Radicals 
 
Test for Sulphate 
     2ml of the above prepared extract was taken in a test tube to this added 2ml of 4% dil. 
ammonium oxalate solution. 
 
Test for Chloride 
     2ml of the above prepared extract was added with 2ml of dil.HCL is added until the 
effervescence ceases off. 
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Test for Phosphate 
2ml of the extract were treated with 2ml of dil. ammonium molybdate solution 
and 2ml of con.HNO3. 
Test for Carbonate 
2ml of the extract was treated with 2ml of dil. magnesium sulphate solution. 
Test for Nitrate 
1gm of the extract was heated with copper turning and concentrated H2SO4 and 
viewed the test tube vertically down. 
 
2. Test for Basic Radicals 
Test for Lead 
2ml of the extract was added with 2ml of dil. potassium iodine solution. 
Test for Copper  
One pinch (25mg) of extract was made into paste with con.HCL in a watch glass 
and introduced into the non-luminous part of the flame. 
Test for Aluminium 
       To the 2ml of extract dil. sodium hydroxide was added in 5 drops to excess. 
Test for Iron  
       a. To the 2ml of extract  add 2ml of dil. ammonium solution. 
       b. To the 2ml of extract 2ml of thiocyanate solution and 2ml of con.HNO3 is added. 
Test for Zinc 
To 2ml of the extract, dil.sodium hydroxide solution was added in 5 drops to 
excess and dil.ammonium chloride is added. 
Test for Calcium 
To 2ml of the extract was added with 2ml of 4% dil. Ammonium oxalate 
solution. 
Test for Magnesium 
To 2ml of extract dil.sodium hydroxide solution was added in drops to excess. 
  Test for Ammonium  
To 2ml of extract 1ml of Nessler‟s reagent and excess of dil.sodium hydroxide 
solution are added. 
Test for Potassium 
A pinch (25mg) of extract was treated of with 2ml of dil. Sodium nitrite solution 
and then treated with 2ml of dil. cobalt nitrate in 30% dil. glacial acetic acid. 
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Test for Sodium  
       2 pinches (50mg) of the extract is made into paste by using HCL and introduced into 
the blue flame of Bunsen burner. 
Test for Mercury 
       2ml of the extract was treated with 2ml of dil. sodium hydroxide solution. 
Test for Arsenic  
       2ml of the extract was treated with 2ml of dil. Sodium hydroxide solution. 
 
3. Miscellaneous 
Test for Starch 
        2ml of extract was treated with weak dil. Iodine solution. 
Test for reducing sugar 
        5ml of Benedict‟s qualitative solution was taken in a test tube and allowed to boil 
for 2 minutes and added 8 to 10 drops of the extract and again boil it for 2 minutes. The 
colour change is noted. 
Test for the Alkaloids 
1. 2ml of the extract was treated with 2ml of dil. potassium Iodide solution. 
2. 2ml of the extract was treated with 2ml of dil. picric acid. 
3. 2ml of the extract was treated with 2ml of dil. phosphotungstic acid. 
Test for Tannic Acid  
        2ml of extract was treated with 2ml of dil. ferric chloride solution. 
Test for Unsaturated Compound 
        To the 2ml of extract 2ml of dil. potassium permanganate solution is added. 
Test for Amino acid  
       2 drops of the extract was placed on a filter paper and dried well.20 ml of Burette 
reagent is added. 
Test for Type of Compound 
     2ml of the extract was treated with 2ml of dil. Ferric chloride solution. 
 
4.2.4. Acute  Toxicity  Study 
Toxicological Evaluation of Kurunthotti Kudineer (KK) 
            The following in vivo toxicity studies were carried out on by Kurunthotti 
Kudineer (KK) World Health Organization (WHO) guidelines.  
                          Acute Oral Toxicity study (WHO)   
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The toxicity studies were carried out at National Institute of Siddha. The study 
was done after getting permission from the Institutional Animal Ethical Committee.   
IAEC Approved No:  For acute toxicity study – NIS/IAEC-IV/07/05012017  
For Acute toxicity studies test animals were obtained from Tamil Nadu 
Veterinary and Animal Sciences University, Madhavaram. Animals are kept at animal 
house, National Institute of Siddha, Chennai.  
 
Description of The Method  
Selection of the animals:  
             Animals were selected as per guidelines. Healthy adult animals of Wister albino 
rat, both male and female sex were used for acute oral toxicity study. The female animals 
used in the studies were nulliparous and non-pregnant.  
 
Housing and feeding conditions:  
 The temperature in the experimental animal room: 22ºC (± 3ºC) 
 Humidity: 60 ± 10 %  
 Lighting   : Artificial, the sequence being 12 hours light, 12 hours dark. 
         The animals were housed in polypropylene cages provided with bedding of husk. 
The animals had free access to RO water. For feeding, Standard pellet diet (bought from 
Sai Meera foods pvt. Ltd, Bangalore) was used.  
 
Preparation of animals:                      
              The animals are randomly selected, to permit individual identification by cage 
number and individual marking on the fur of each animals was made with picric acid. 
The animals were kept in their cages for 7 days prior to dosing to allow for 
acclimatization to the laboratory conditions. The principles of laboratory animal care 
were followed.  
 
Test Substance:         
         Kurunthotti  Kudineer (KK) is pale yellowish in colour, free flowing- greasy and 
slightly pungent. 
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Route of administration:     
          Oral route was selected, because it is the normal route of clinical administration.   
 
Procedure:  
Acute Oral Toxicity Study  
Experimental Animals: 
• Species and strain                   : Wister Albino rat 
• Sex                                       : Male and Female  
• Age, Weight                         : 6-8 weeks, 150-175 gm 
• Test guideline                       : WHO guideline   
• Groups/treatment                  : Grouped by randomization  
• Duration of exposure to the   : Kurunthotti Kudineer (KK) : Single dose  
• Study duration                      : 14 days 
• Number of animals                : 10 male, 10 female 
• Route of administration         : Oral 
 
Number of animals and dose levels:  
                 Animals are divided into two groups, each group containing 5 male and 5 
female rats. One group as control and the other as test group. Control group is treated 
with Palm sugar and other groups were treated with test drug Kurunthotti Kudineer (KK) 
ten times the therapeutic dose (5000mg per kg b.wt). 
 
Groups No. of Rats 
 
Group I  Vehicle control (Palm sugar) 
5 male, 5 female 
Group II  Test drug – Kurunthotti Kudineer (KK)    
(5000mg per kg b.wt) 
5 male, 5 female 
 
Administration of doses:  
            The test drug was administered in a single dose by using oral gavage. Animals 
were fasted prior to drug administration. Following the period of fasting, the animals 
were weighed and test drug was administered.  
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The control groups received equal volume saline. The test drug was administered 
at 10 times the therapeutic dose (5000 mg per kg b.wt). The food was withheld for 3-4 
hours after dosing the animal.  
Observations:  
       Observations were made and recorded systematically and continuously observed 
after the substance administration as per the guidelines.  
 ½ hour, 1 hour, 2 hours, 4 hours and up to 24 hours observation 
 All rats were observed twice daily for 14 days  
 Body weight  were Calculated weekly once   
 Feed & water intake  were Calculated daily 
 
Cage side observation   
The animals were monitored for behavioural parameters like Alertness, 
Aggressiveness, piloerection, Grooming, Gripping, Touch Response, Motor Activity, 
Tremors, Convulsions, Muscle Spasm, Catatonia, Muscle relaxant, Hypnosis Analgesia, 
Lacrimation, Exophthalmus, Diarrhoea, Writhing,  Respiration, Mortality  
Gross Necropsy:  
At the end of the 14
th  
day, all the animals were sacrificed by using the injection 
of Pentothal sodium. Gross necropsy includes examinations of the external surface of the 
body, all orifices, cranial, thoracic and abdominal cavities and their contents brain, eye, 
lungs, heart, spleen, liver, kidneys, adrenals, uterus of all animals. 
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4.3 Clinical Studies 
In our NIS OPD, 70% of cases are approaching Kuzhandhai Maruthuvam 
department daily with the Symptoms of Siravatham. Hence it was proposed to study about 
the disease. A Protocol was prepared and submitted before IEC of  National Institute of 
Siddha .The IEC approval was obtained No: NIS/IEC/2016/11-23/14-10-2016. The trial 
was registered in Clinical trial Registry of India with Reg.No.CTRI/2018/04/013322. After 
obtaining approval from  the committee, the clinical study  on Siravatham ( Cerebral palsy) 
in  children with drug  Kurunthotti kudineer (Internal)  and, Vasuvu Ennai for thokkanam 
and Kollu Podithimirthal therapy as external carried out as per the protocol.  30 cases 
were selected from the OPD & IPD of Kuzhandhai Maruthuvam Department,  
 
National Institute of Siddha. They were treated with the trial drug with Kurunthotti 
kudineer and observed for prognosis clinically. 
 
4.3.1 Medications/Methodologies, Dose and Procedure for clinical trial 
S.No Medicine/Methodology Dose Procedure 
1. 
Kurunthotti Kudineer 
Internal (Twice a Day) 
2yrs to 4 yrs    - 30 ml 
5yrs to 7yrs     - 40 ml 
 
Oral Administration 
2. 
Kollu Podithimirthal 
External (Once a Day) 
 
Procedure as per the Siddha literature external 
therapy 
3. 
Vasvu Ennai Thokkanam 
(Once in a Day) 
 
 The sample consists of patient within 2-7 years of age group fulfilling all the 
inclusion and none of the exclusion criteria. 
 Treatment period: 90days. 
 Study centre: National Institute of Siddha. 
 
4.3.2 Inclusion criteria: 
 Children of age group under 2- 7 year 
 Clinically diagnosed as a cerebral palsy (spastic) 
 Not attained head control 
 Drooling of saliva 
 Abnormal gait 
  
89 
 
 spastic Hemiplegia 
 spastic Diplegia 
 spastic Quadriplegia 
 spastic Monoplegia    
  Child were include 4 or more criteria for this clinical trial study.              
 
4.3.3 Exclusion criteria: 
 Ataxic cp 
 Flaccidity 
 Associated with Seizure disorder 
 Associated with Autism(ASD) 
 Associated with ADHD 
 Any other serious illness      
 
4.3.4 Withdrawal criteria 
 Intolerance to the drug and development of adverse reactions during trial  
 Poor patient compliance and defaulters 
 Patient turned unwilling to continue in the course of clinical trial. 
 
4.4 Clinical assessment Parameters: 
4.4.1 Modified Ashworth Scale 
 
Score Description 
0 No increase in muscle tone 
1 
Slight increase in muscle tone manifested by a catch and relese at end of range 
of motion 
1+ 
Slight increase in muscle tone, manifested by a catch followed by minimal 
resistance throughout the reminder (less than ½) of the range of motion 
2 
More marked increase in tone through most of the  range of motion but joined 
easily moved  
3 Considerable increase in muscle tone; passive movement is difficult 
4 Affected part is rigid in flexion or extension. 
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4.4.2 Modified Tardieu Test 
 
Score Description 
0 No resistance throughout the course of the passive movement 
1 
Slight increase throughout the course of the passive movement with no clear 
catch at precise angle 
2 
Clear catch at a precise  angle interrupting the passive movement, followed 
by a release 
3 
Fatigable clonus, less than 10s when maintaining the pressure, appearing at a 
precise angle 
4 
Non-fatigable clonus, more than 10s when maintaining the pressure, at 
precise angle  
 
 
4.4.3 Dynamic Gait Index 
 
Score Description 
0 Severe Impairment: Cannot step over box without assistance. 
1 
Moderate Impairment: Steps over box, but must stop before stepping 
over. May require verbal queing. 
2 
Mild impairment: Steps over box, but must slow down and adjust steps to 
clear box safely. 
3 Normal: Steps over box without changing gait, no evidence of imbalance. 
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4.4.4 Medical Research Council Grading 
 
Grade Description 
0 no movement 
1 palpable contraction, no visible movement 
2 movement but only with gravity eliminated 
3 movement against gravity 
4 movement against resistance but weaker than normal 
5 normal power 
 
4.4.5 Gross Motor Function Classification System (GMFCS) 
 
Sl.no Levels Description 
           
1            
Level I Walks and runs independently 
           
2 
Level II Walks independently 
           
3 
Level III Walks with assistance 
           
4 
Level IV Stands for transfers 
           
5 
Level V Absent head control and sitting balance 
 
  
92 
 
4.4.6 Posture Assessment Scale 
 
Score   Description 
Excellent Perfect alignment; movement is balanced and fluid. 
Good Aligned; movement balanced by not as fluid. 
Average 
Head is forward, misaligned pelvis; rounded upper back; movement is strong 
but with little hip motion.  
Poor  
Misaligned and imbalanced throughout the spine; weak lower back, 
buttocks; movement is stilted and more one-sided. 
Very 
Poor 
Very unbalanced frame; pain evident; movement cautious with overly soft 
knees; some limping. 
 
4.4.6  Disability Assessment Scale 
 
Score Description 
0 No disability 
1 Mild 
2 Moderate 
3 Severe Disability 
 
4.5  Siddha Method of Assessment 
1. Nilam 
2. Kaalam 
3. Uyir thathukkal 
4. Udal thaathukkal 
5. Envagai thervugal 
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4.6 Study Enrollment: 
1.  In this study, patients reporting at the NIS OPD with the three or more clinical 
symptoms were examined clinically for enrolling in this study based on the 
inclusion and exclusion criteria. 
2. The patients who are to be enrolled would be informed (Form VI) about the 
study, experimental medicine, possible outcomes and the objectives of the study 
in the language and terms understandable to them and to their informants. 
3. After ascertaining the patient and informant willingness, informed consent would 
be obtained in writing from them in the consent form (Form II). 
4. All these patients were given unique registration card in which patients‟ 
Registration number of the study; Address, Phone number and Doctors phone 
number etc. were given, so as to report easily communication for the sake of the 
patient. 
5. Complete clinical history, complaints and duration, examination findings-- all 
would   be recorded in the prescribed Proforma in the history and clinical 
assessment forms (form IV) separately. Screening Form- I will be filled up; Form 
III were used for recording the patients‟ history, clinical examination of 
symptoms and signs respectively. 
6. Patient would be advised to take the trial drug and appropriate dietary advice        
    (Form X) were given according to the patients‟ perfect understanding. 
 
4.7 Conduct of the Study: 
The trial drug Kurunthotti Kudineer is given for 1 day. For OP patients before 
and after treatment the clinical assessments were done and prognosis is noted on 3
rd
 day. 
For IP patients the drug is provided and prognosis is noted and clinical assessment were 
done on 1
st
 day itself..   
 
4.8 Data Management: 
               After enrolling the patient in the study, a separate file for each patient was 
opened and all forms will be filed in the file. When study patient visits OPD during the 
study period, the respective patient file were taken and necessary recordings were made 
at the assessment form or other suitable form. The screening forms were filed separately. 
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The Data recordings were monitored for completion and adverse event by HOD 
and data logical recording and completeness were monitored by statistician (Sr.Research 
Officer (Statistics)).All forms were further scrutinized in presence of Investigator by 
Sr.Research Officer (Statistics) for logical errors and incompleteness of data before 
entering on to computer to avoid any bias. No modification in the results is permitted for 
unbiased report. 
 
Any missed data found in during the study, it were collected from the patient, but 
the time related data will not be recorded retrospectively all collected data were entered 
using MS access software onto computer.  
 
4.9 Adverse Effect/Serious Effect Management: 
If the trial patient develops any adverse reaction, he/she were immediately 
withdrawn from the trial and proper management were given in OPD of National 
institute of Siddha and the same were reported to regional pharmacovigilance center. 
 
Ethical Issues: 
1.   No other external or internal medicines were used.  
2.  The data collected from the patient‟s informant were recorded. The patient‟s   
      informant was informed about the diagnosis, treatment and follow-up.  
3.   After the consent of the patient‟s informant (through consent form), patient were  
     enrolled in the study.  
4. Informed consent was obtained from the patient‟s informant explaining in the 
understandable language to the patient‟s informant. 
5. Treatment were provided free of cost. 
6. In conditions of treatment failure, adverse reactions, patients were given             
alternative treatment at the National Institute of Siddha with full care. 
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4.10 Data Collection Forms 
 
• Form I       Screening & Selection Proforma 
• Form II      Consent Form 
• Form III     Case report form 
• Form IV     Assessment Form 
 
• Form V      Drug compliance 
• Form VI     Patient information sheet 
• Form VII    Withdrawal 
• Form VIII   Adverse reaction 
• Form IX     Pharmacovigilance 
• Form X     Dietary form 
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5. RESULTS AND OBSERVATIONS 
 
5.1 Preclinical studies: 
5.1.2 Physicochemical analysis of Kurunthotti kudineer  
 
SL.No. Parameters Results 
1 Loss on Drying 5.61% 
2 TotalAsh 6.78% 
3 Acid insoluble Ash 1.53% 
4 Water soluble Ash 2.02% 
5 Water Soluble Extrative 12.75% 
6 Alcohol Soluble Extrative 11.48% 
 
5.1.3 Phytochemical Analysis of Kurunthotti Kudineer 
 
SL.No 
Phytochemicals Test Name H2O Extract 
1 
Alkaloids 
Mayer’s Test +ve 
Wagner’s Test +ve 
Dragendroff’sTest -ve 
Hager’s Test -ve 
2 
Carbohydrates 
Molisch’s Test +ve 
Benedict’s Test +ve 
3 
Glycoside 
Modified 
Borntrager’s Test 
-ve 
Keller Killaini -ve 
4 
Saponin 
Froth Test +ve 
Foam Test -ve 
5 
Phytosterol Salkowski’s Test -ve 
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6 
Phenols 
Ferric Chloride 
Test 
-ve 
7 
Tannins Gelatin Test -ve 
8 
Flavonoids 
Alkaline Reagent 
Test 
+ve 
Lead acetate Test +ve 
9 
Proteins and 
amino acids 
Xanthoproteic 
Test 
-ve 
10 
Diterpenes 
Copper Acetate 
Test 
+ve 
11 
Gum & Mucilage Extract + Alcohol -ve 
12 
Fat & Fixed Oil Spot Test -ve 
13 
Quinones NAOH + Extract +ve 
 
+   Indicates positive 
-    Indicates Negative 
5.1.4 Biochemical analysis of Kurunthotti  Kudineer: 
Results of Acid radicals studies 
SL. 
NO 
Parameter Observation Result 
1 Test for Sulphate 
Cloudy appearance 
Present 
Positive 
2 Test for Chloride 
-  
Negative 
3 Test For Phosphate 
-  
Negative 
4 Test For Carbonate 
 
- 
 
Negative 
5 Test For Nitrate 
 
- 
Negative 
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6 Test for Sulphide 
 
- 
Negative 
7 Test For Fluoride &oxalate 
 
- 
Negative 
8 Test For Nitrite 
- 
 
Negative 
9 Test For Borax - Negative 
 
Interpretation 
  The acidic radicals test shows the presence of   Sulphate. 
Results of basic radicals studies: 
SL.NO Parameter Observation Result 
1 Test for Lead - Negative 
2 Test for Copper - Negative 
3 
Test For Aluminium 
. 
Brown precipitate is 
formed 
Positive 
4 Test For Iron. - Negative 
5 Test For Zinc 
White precipitate is 
formed 
Positive 
6 Test for Calcium 
Cloudy appearance and 
white precipitate  present 
Positive 
7 
Test For Magnesium 
 
White precipitate       
obtained 
Positive 
8 Test For Ammonium - Negative 
9 Test For Potassium - Negative 
10 Test For Sodium - Negative 
11 Test For Mercury - Negative 
12 Test For Arsenic - Negative 
99 
 
Interpretation: 
 The basic radical test shows the presence of calcium, Aluminium, Zinc, 
Magnesium, and absence of heavy metals such as lead, Iron, arsenic and mercury. 
Miscellaneous: 
SL.NO Parameter Observation Result 
1 Test for Starch - Negative 
2 Test for Reducing sugars - Negative 
3 Test For Alkaloids. Yellow colour developed Positive 
4 
Test For Tannic acid. Blue-black precipitate 
obtained 
Positive 
5 
Test for unsaturated 
compounds 
- Negative 
6 Test for Amino acid                     - Negative 
7 
Test For Type of compounds  Blue colour developed  Phenol cresol and 
hydroquinone are 
present 
 
Interpretation: 
The Miscellaneous test shows the presence of Alkaloids, Tannic acid, Phenol 
cresol and hydroquinone.  
 
5.1.5   Acute Toxicity Study  
Behavioural Signs of Acute Toxicity Study of  Kurunthotti kudineer. 
Parameters 30 mints 
 
      4 hrs     24 hrs 1
st
 week 2
nd
 week 
C E C E C E C E C E 
Skin & Fur N N N N N N N N N N 
Mucous 
Membrane 
N N N N N N N N N N 
Respiratory rate N N N N N N N N N N 
100 
 
 
N – Normal, C – control, E – Experimental  
            All the data were summarized in the form of  revealed that there was no abnormal 
signs and behavioural changes in all animals at the dose level of   5,000 mg/kg body 
weight administered orally, during the study period.   
            
There was no mortality observed after dosing of  Kurunthotti Kudineer upto 
5000mg/kg body weight during the study period of 14 days. This indicates that the LD50 
of Kurunthotti Kudineer is more than 5000mg/kg b.wt.  
            
There were no changes in skin and fur, eyes and mucous membranes of all 
animals.  The eating, drinking habit, sleep pattern, locomotion were normal in all animals 
and no changes in body weight as compared to control group.  
            
At the end of the 14 the day, necropsy was performed and there was no 
abnormality seen in test groups as compared to control group during the examination. 
 
Clinical Study:  
30 Patients with confirmed diagnosis of with satisfying the inclusion criteria were 
enrolled after obtaining written informed consent and were to receive Kurunthotti  
kudineer with External therapy Kollu podithimirthal and Vasavu ennai massage.  
Heart rate N N N N N N N N N N 
Salivation & 
Lacrimation 
N N N N N N N N N N 
Lethargy NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL 
Piloerection N N N N N N N N N N 
Urinary 
incontinence 
NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL 
Defecation N N N N N N N N N N 
Sleep & Gait N N N N N N N N N N 
Tremors 
&Convulsion 
NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL 
Mortality NIL NIL NIL NIL NIL NIL NIL NIL NIL NIL 
101 
 
A Protocol  was prepared and submitted before IEC of  National Institute of 
Siddha. The IEC approval was obtained  No: NIS/IEC/2016/11-23/14-10-2016. The trial 
was  registered in Clinical trial Registry of India with  Reg .No. CTRI/2018/04/013322 . 
5.2 Results were observed with respect to the following criteria: 
1. Age 
2. Sex          
3. Parent’s Socio Economic Status    
4. Diet 
5. Nilam 
6. Paruvakaalam 
7. Uyirthathukkal 
8. Ezhuudalkattugal 
9. Envagaithervugal 
10. Neikuri 
11. Clinical features 
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Table 5.2.1 
Distributions of patients with Siravatham according to Age  
Sl.no Age No.of.cases Percentage% 
1. 2-4Years 14 46 
2. 5.-7Years 16 54 
 
 
 
Fig 5.2.1 
Inference: 
 Out of 30 patients, 46 % of cases were within 2-4years, 54 % of cases were 
within 5-7 years. (Table5.2.1) 
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Table 5.2.2 
Distributions of patients with Siravatham according to Gender 
SL.No Sex No of Cases Percentage% 
1. Male Child 11 36 
2. Female Child 19 64 
 
 
Fig 5.2.2 
Inference: 
Out of 30 patients 36% were male children and 64% were female children. (Table 
5.2.2) 
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Table 5.2.3 
 Distribution of patients with Siravatham  according to socio-economic status 
SL.No 
Socio-economic 
Status 
No of Cases Percentage% 
1. High Income group 5 17 
2. 
Middle Income 
group 
10 33 
3. Poor Income group 15 50 
 
 
Fig 5.2.3 
Inference: 
 About 50 % patients were under lower income group, 33% patients were 
under middle income group and 17% patients were under high income group. (Table 
5.2.3). 
 
  
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
0.5
High Income 
group
Middle 
Income 
group
Poor Income 
group
17%
33%
50%
SOCIO-ECONOMIC STATUS
105 
 
Table 5.2.4 
Distribution of patients with Siravatham according to Diet reference. 
Sl.no Food habits No of cases Percentage% 
1. Vegeterian 5 17 
2. Non-Vegeterian 25 83 
 
 
Fig 5.2.4 
Inference: 
 According to diet, Vegeterian 17%, Mixed 83.5% were noted. (Table 5.2.4) 
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Table 5.2. 5 
 Distribution of patients with Siravatham according to Nilam 
Nilam No of cases Percentage% 
Kurinji  0 0 
Mullai  0 0 
Marutham  10 33 
Neithal  20 67 
Paalai  0 0 
 
 
Fig 5.2.5 
Inference: 
Among 30 patients, 67 % were from Neithal land, 33 % from Marutham land, 0 
% from Mullai land, and 0% from Kurinji land.(Table5.2.5) 
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Table 5.2.6 
 Distribution of patients with Siravatham according to Paruvakalam 
SL.No Paruvakaalam No. of cases Percentage 
1. Karkaalam (Avani – puratasi) 1 2.5 
2. Koothirkaalam (Iyppasi – karthikai) 1 2.5 
3. Munpani (Markazhi – Thai) 11 27.5 
4. Pin pani (Masi – Panguni) 16 54 
5. Elavenil (Chitirai, Vaigasi) 1 2.5 
6. Mudhuvenil (Aani, Aadi) 0 0 
 
 
 
Fig 5.2.6 
 
Inference: 
According to paruva kaalam, high incidence of cases 65% were reported in 
Pinpanikalam ,54% cases were reported in Mun pani kalam, 27.5% cases were reported 
in elavenil kaalam and 2.5% were from Karkalamand 2.5% from koothirkalam, 2.5% 
were from Mudhuvenil . (Table5.2.6) 
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Table 5.2.6 
 Distribution of patients with Siravatham according to derangement of Vatham 
 
 
Fig 5.2.7 
Inference:  
According to vatham, derangement of Pranan was 0%, Abanan was 50%,Viyanan 
100%,Uthanan 70%,Samanan 100%,Kirukaran 100%,Devathathan 100%. (Table 5.2.7) 
  
SL.no Vatham No of cases Percentage 
1 Piranan 0 0 
2. Abanan 15 50 
3. Viyanan 30 100 
4. Uthanan 30 70 
5. Samanan 30 100 
6. Nagan 0 0 
7. Koorman 0 0 
8. Kirukaran 30 100 
9. Devathathan 30 100 
10. Thananjeyan 0 0 
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Table 5.2 8 
Distribution of patients with Siravatham according to derangement of Pitham 
SL.No Types of pitham No.of Cases Percentage 
1. Analapitham 15 50 
2. Ranjagam 20 10 
3. Saathagam 30 67 
4. Prasagam 0 0 
5. Alosagam 0 0 
 
 
Fig 5.2.8 
 
Inference: 
According to Pitham, derangement of Analapitham was 50%and Ranjagam was 
10% ,Saathagam was 67%(Table 5.2.8). 
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Table 5.2.9 
b. Distribution of patients with Siravatham according to dearrangement of Kabam 
SL.No Types of Kabham No.of Cases Percentage 
1. Avalambagam                0 0 
2. Kilethagam 30 100 
3. Pothagam 0 0 
4. Tharpagam 0 0 
5. Santhigam 30 100 
 
 
Fig 5.2.9 
Inference:  
According to Kabam, derangement of Kilethagam was deranged in 100% of 
cases  and  Santhigam was  affected in 100% cases  (Table5.2.9). 
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Table 5.2.10 
 Distribution of patients with Siravatham according to derangement of Ezhu 
Udarkattugal 
S.No Udarkattugal No.of Cases Percentage 
1. Saaram 30 100 
2. Senneer 20 67 
3. Oon 30 100 
4. Kozhuppu 30 100 
5. Enbu 20 67 
6. Moolai 0 0 
7. Sukkilam  / Suronitham  0                  0 
 
 
Fig 5.2.10 
Inference:  
  Seneer was affected in 100% of cases and Enbu was affected 100% of 
cases.(table 5.2.10) 
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Table 5.2.11 
Distribution of patients with Siravatham according to derangement of Enn vagai 
thervugal 
SL.No Enn Vagai Thervugal Percentage% 
1 Naa 10 
2 Niram 10 
3 Mozhi 100 
4 Vizhi 10 
5 Sparisam 15 
6 Malam  67 
7 Moothiram 10 
8 Naadi 100 
 
 
Fig 5.2.11 
Inference: 
Out of 30 cases Malam was affected in100% of cases, Sparism was affected in  
15% of cases ,Naa, Niram, Vizhi and moothiram  was affected in 10% of the cases. 
(Table 5.2.11) 
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Table 5.2.12 
 Distribution of patients with Siravatham according to observation of Neikuri 
analysis. 
SL.No 
Character of 
urine 
Neikuri 
Reference 
No.of Cases Percentage 
1. 
Spreads like 
snake 
Vatha Neer 
10 
33.3 
2. 
Spreads like 
ring 
Pitha Neer 
5 
16.6 
3. Static as pearl Kaba Neer 15 50 
 
 
Fig 5.2.12 
Inference 
According to Neikuri, Vatha neer was observed in 33.3   % of cases, pitha neer 
was observed in 16.6 % of cases, Kaba neer was observed in 50 % of cases. (Table 
5.2.12) 
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Table –5.2.13 
Distribution of clinical symptoms of Siravatham 
 
 
Fig 5.2.13 
Inference 
Among the 30 cases, 100% of the patients   have 2-7 years , Abnormal gait and 
clinically dignosed spastic cp, 33.3% Spastic hemeplegia and Spastic Diaplegia, 6.66% 
have spastic Quadriplegia, spastic Monoplegia,15% have fever,  16.6% have Spastic 
Triplegia. (Table 5.2.13). 
SL.NO Signs and Symptoms 
No.of cases 
(out of 30) 
Percentage 
1 Children of age group under 2- 7 year 30 100 
2 
Clinically diagnosed as a cerebral palsy 
(spastic) 
30 100 
3 Not attained head control 15 50 
4 Drooling of saliva 20 66.6% 
5 Abnormal gait 30 100 
6 spastic Hemeplegia 10 33.3 
7 spastic Diplegia 10 33.3 
8 spastic Quadriplegia 3 6.66 
9 spastic Monoplegia 2 6.66 
10 spastic Triplegia 5 16.6 
115 
 
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
0.00%
13.30% 13.30%
23.30%
30% 30%
3.33%
6.66%
16.60%
2 .30%
26.30%
23.30%
6.66%
10%
1 .60%
26.30%
23.30% 2 .30%
13.30%
16.60%
23.30%
30%
16.60%
6.66%
0th day
30th day
60th day
90th day
5.3 Clinical Assessment 
Table 5.3.1 
  
 
Fig 5.3.1 
Inference 
 From the above table 0.% of children had Grade-0 on 0
th
 day and 13.3% of 
children had on 90
th
 day. 13.3% of children had Grade-1+ on 0
th
 day and 16.6% of 
children had on 90
th
 day. 13.3% of children had Grade-1 on 0
th
 day and 23.3% of 
children had on 90
th
 day. 23.3% of children had Grade-2 on 0
th
 day and 30% of children 
had on 90
th
 day. 30% of children had Grade-3 on 0
th
 Day and 16.6% of children had on 
90
th
 day. 23.3% of children had Grade-4 on 0
th
 Day and 6.66% of children had on 90
th
 
day.  
Modified Ashworth Scale 
Grade 0th day 30th day 60th day 90th day 
N % N % N % N % 
0 0 0.00% 2 6.66% 3 10% 4 13.3% 
1+ 3 10% 4 13.3% 5 16.6% 6 20% 
1 4 13.3% 3 10% 7 23.3% 10 33.3% 
2 7 23.3% 5 16.6% 4 13.3% 3 10% 
3 9 30% 8 26.3% 6 20% 5 16.6% 
4 7 23.3% 8 26.3% 5 16.6% 2 6.66% 
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 Table 5.3..2 
 
 
 
 
 
 
 
 
 
 
 
Fig 5.3.2 
Inference 
 From the above table 0.% of children had Grade-0 on 0
th
 day and 30% of children 
had on 90
th
 day. 10% of children had Grade-1 on 0
th
 day and 20% of children had on 90
th
 
day. 13.3% of children had Grade-2 on 0
th
 day and 33.3% of children had on 90
th
 day. 
20% of children had Grade-3 on 0
th
 day and 10% of children had on 90
th
 day. 30% of 
children had Grade-4 on 0
th
 Day and 16.6% of children had on 90
th
 day. 26.3% of 
children had Grade-5 on 0
th
 Day and 6.66% of children had on 90
th
 day. 
 
 
 
 
Modified Tardieu Scale 
Grade 0th day 30th day 60th day 90th day 
N % N % N % N % 
0 0 0.00% 2 6.66% 3 10% 4 13.3% 
1 3 10% 4 13.3% 5 16.6% 6 20% 
2 4 13.3% 3 10% 7 23.3% 10 33.3% 
3 6 16.6% 5 16.6% 4 13.3% 3 10% 
4 9 30% 8 26.3% 6 20% 5 16.6% 
5 8 26.3% 8 26.3% 5 16.6% 2 6.66% 
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Table 5.3.3 
 
 
Fig 5.3.3 
Inference 
     From the above table 0.% of children had Level-1 on 0
th
 day and 16.6% of 
children had on 90
th
 day. 23.3% of children had Level-2 on 0
th
 day and 30% of children 
had on 90
th
 day. 13.3% of children had Level 3 on 0
th
 day and 36.6% of children had on 
90
th
 day. 30% of children had Level-4 on 0
th
 day and 13.3% of children had on 90
th
 day. 
16.6% of children had Level-5 on 0
th
 Day and 33.3% of children had on 90
th
 day.  
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Gross Motor Function Classification System (GMFCS) 
Grade 0th day 30th day 60th day 90th day 
N % N % N % N % 
1 0 0.00% 2 6.66% 3 10% 5 16.6% 
2 7 23.3% 7 23.3% 8 26.6% 9 30% 
3 9 13.3% 9 30% 11 36.6% 11 36.6% 
4 7 30% 7 23.6% 5 16.6% 4 13.3% 
5 5 16.6% 5 16.6% 3 10% 1 33.3% 
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Table 5.3.4 
Medical Reserch Council Grading 
Grade 0th day 30th day 60th day 90th day 
N % N % N % N % 
5 3 10% 3 10% 4 13.3% 6 20% 
4 5 16.6% 6 20% 6 20% 8 26.3% 
3 6 20% 7 23.3% 10 33.3% 9 30% 
2 8 26.6% 6 20% 5 16.6% 4 13.3% 
1 5 16.6% 5 16.6% 3 10% 2 6.66% 
0 3 10% 3 10% 2 16.6% 1 3.33% 
 
 
Fig 5.3.4 
Inference 
 From the above table 10.% of children had Grade-5 on 0
th
 day and 20% of 
children had on 90
th
 day. 16.6% of children had Grade-4 on 0
th
 day and 26.3% of 
children had on 90
th
 day. 20% of children had Grade-3 on 0
th
 day and 30% of children 
had on 90
th
 day. 26.3% of children had Grade-2 on 0
th
 day and 13.3% of children had on 
90
th
 day. 16.6% of children had Grade-1 on 0
th
 Day and 6.66% of hildren had on 90
th
 
day. 10% of children had Grade-0 on 0
th
 Day and 3.33% of Children had on 90
th
 day. 
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Table 5.3.5 
 
 
Fig 5.3.5 
Inference 
From the above table 3.33.% of children had Normal on 0
th
 day and43. 3% of 
children had on 90
th
 day. 20% of children had Mild impairment on 0
th
 day and 30% of 
children had on 90
th
 day. 60% of children had Moderate impairment on 0
th
 day and 
23.3% of children had on 90
th
 day. 16.6% of children had Severe impairment on 0
th
 day 
and 3.33% of children had on 90
th
 day.  
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                         Dynamic Gait Index 
 
Grade 0th day 30th day 60th day 90th day 
N % N % N % N % 
Normal 1 3.33% 2 6.66% 5 16.6% 13 43.3% 
Mild 
Impairment 
 
6 20% 8 26.3% 12 40% 9 30% 
Moderate 
Impairment 
 
9 60% 15 50% 10 33.3% 7 23.3% 
severe 
Impairment 
 
12 16.6% 5 16.6% 3 10% 1 3.33% 
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Table 5.3.6 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 5.3.6 
  
3.33%
16.60%
30%
33.30%
16.60%
BEFORE TREATMENT
Excellent
Good
Average -
Poor
Very Poor
Posture Assessment 
Grade  Before Treatment      After Treatment 
          N % N % 
Excellent 
 
         1 3.33% 6 20% 
Good 
 
 
          5 16.6% 7 23.3% 
Average 
 
          9 30% 6 50% 
Poor 
 
         10 33.3% 8 26.3% 
Very Poor 
 
         5 16.6 3 10% 
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Inference 
 From the above results out of 30 Childrens  3(20%) patients had Excellent 
improvement.7(23.30%) patients had good improvement. Only 6(20%) patients 
responsed Average improvement. 8(26.30%) patients had poor improvement, 3(10%) 
patients had very poor improvement 
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122 
 
 
Table 5.3.7 
 
 
 
 
 
 
 
 
 
Fig 5.3.7 
  
3.33%
20%
60%
16.66%
BeforeTreatment
Score 0
Score 1
Score 2
Score 3
Disability Assessment Scale 
Score          Before Treatment                 After Treatment 
          N % N % 
0          1 3.33% 8 26.3% 
1           6 20% 11 36.6% 
2           18 60% 9 30% 
3            5 16.6% 2 6.66% 
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Fig 5.3.7 
Inference  
From the above table 3.33.% of children had score 0 on 0
th
 day and 26.3% of 
children had on 90
th
 day. 20% of children had Score 1 on 0
th
 day and 36.6% of children 
had on 90
th
 day. 60% of children had Score 2 on 0
th
 day and 30% of children had on 90
th
 
day. 16.6% of children had score 3 on 0
th
 day and 6.66% of children had on 90
th
 day.  
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5.4  STATISTICAL ANALYSIS: 
 
        All collected data were entered into MS Excel software using different 
columns as variables and rows as patients. SPSS software was used to perform 
statistical analysis. Basic descriptive statistics include frequency distributions and 
cross-tabulations were performed. The quantity variables were expressed as Mean ± 
Standard Deviation and qualitative data as percentage. A probability value of <0.05 
was considered to indicate as statistical significance. Paired “t” test was performed for 
determining the significance between before and after treatment. 
 
5.4.1.Modified Ashworth Scale Before And After Treatment: 
MAS scale  
Sample 
size  
Mean  
Standard 
deviation 
“t”  value “p” value 
Before 
treatment 
30  2.6 1.003 
7.870 < 0.0001 
After 
treatment 
30  0.93  0.583 
  
Observation: 
Statistical analysis reveals that there has been a significant reduction in MAS 
scale after treatment indicating the improvement in children doing their daily activities. 
 
5.4.2 Modified Tarideu Scale Before And After Treatment 
MTS scale  
Sample 
size  
Mean  
Standard 
deviation 
“t” value “p” value 
Before 
treatment 
30  2.6 1.003 
7.870 < 0.0001 
After 
treatment 
30  0.93  0.583 
 
Observation: 
Statistical analysis reveals that there has been a significant reduction in MTS 
scale after treatment indicating the improvement in children doing their daily activities. 
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5.4.3 Gross Motor Function Classification System (GMFCS) Before And After 
Treatment 
GMFCS 
scale  
Sample 
size  
Mean  
Standard 
deviation 
“t” value “p”  value 
Before 
treatment 
30  3.2 1.349 
6.112 < 0.0001 
After 
treatment 
30  1.333 0.994 
 
 
Observation: 
Statistical analysis reveals that there has been a significant reduction in GMFCS 
scale after treatment indicating the improvement in children doing their daily activities. 
 
 
5.4.4  Medical Reserch Council Grading Before And After Treatment 
MRCG 
scale  
Sample 
size  
Mean  
Standard 
deviation 
“t” value “p”  value 
Before 
treatment 
30  3.2 1.349 
6.112 < 0.0001 
After 
treatment 
30  1.333 0.994 
 
 
Observation: 
Statistical analysis reveals that there has been a significant reduction in MRCG 
scale after treatment indicating the improvement in children doing tr daily activities. 
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5.4.5  Posture Assessment Before And After Treatment 
PAS scale 
Sample 
size  
Mean  
Standard 
deviation 
“t” value “p” value 
Before 
treatment 
30  3.2 1.349 
6.112 < 0.0001 
After 
treatment 
30  1.333 0.994 
 
Observation: 
Statistical analysis reveals that there has been a significant reduction in PAS scale 
after treatment indicating the improvement in children doing their daily activities. 
5.4.6 Dynamic Gait Index Before And After Treatment 
 
DGI scale  
Sample 
size  
Mean  
Standard 
deviation 
“t” value “p” value 
Before 
treatment 
30  1.133 0.681 
8.029 < 0.0001 
After 
treatment 
30  2.433 0.568 
 
Observation: 
Statistical analysis reveals that there has been a significant reduction in DGI scale 
after treatment indicating the improvement in children doing their daily activities. 
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5.4.7 Disability Assessment Scale Before And After Treatment 
 
DAS scale  
Sample 
size  
Mean  
Standard 
deviation 
“t” value “p” value 
Before 
treatment 
30  1.133 0.681 
8.029 < 0.0001 
After 
treatment 
30   2.433 0.568 
 
Observation: 
Statistical analysis reveals that there has been a significant reduction in DAS 
scale after treatment indicating the improvement in children doing their daily activities. 
 
5.4.8  Total scales Before And After Treatment” 
Total scale  
Sample 
size  
Mean  
Standard 
deviation 
Standard 
error 
 
“t”  
value 
“p” value 
Before 
treatment 
30  17.06  4.848 0.885 
5.831 < 0.0001 
After 
treatment 
30   10.73  3.453 0.630 
 
Observation: 
Statistical analysis reveals that there has been a significant reduction in total 
scales after treatment indicating the improvement in children doing their daily activities. 
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CASE – I  (IPD No.0228-17) 
Age 2-FCH 
PROCEDURE – 90 Days Treatment 
1. KOLLU PODITHIMIRTHAL 
 
 
 
 
 
 
 
 
 
 
 
 
2. VASAVU ENNAI MASSAGE 
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CASE – I  (IPD No.0228-17) 
Age 2-FCH 
IMPROVEMENTS 
 
   0
th
 Day       60
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         30
th
 Day     90
th
 Day 
 
 
 
130 
 
CASE –II  (IPD No.0089-18) 
Age 7-MCH 
PROCEDURE – 90 Days Treatment 
1. KOLLU PODITHIMIRTHAL 
 
 
 
 
 
 
 
 
 
 
2. VASAVU ENNAI MASSAGE 
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CASE – II  (IPD No.0089-18) 
Age 7-MCH 
IMPROVEMENTS 
BEFORE TREATMENT 
 
 
 
 
 
 
 
 
 
 
 
 
AFTER TREATMENT  
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6. DISCUSSION 
“Siravatham” is a functional Cerebral palsy.  It is defined as persistent but not 
unchanging disorder of movement and posture due to a defect or lesion of the developing 
brain. It is accepted that children, who acquire permanent motor impairment due to non-
progressive neurological insults, have cerebral palsy. There are many causes, a wide 
range of manifestations of the motor disorder and various associated problems. Cerebral 
palsy is not a single disorder but a group of disorders with diverse implications for 
children and their families 
 
               In our Siddha classical pediatric book, the definition for Siravatham has been 
described as “Siravatham enbathu thalai nadukkam, kaium kaalum asaithidathu, nadakka 
siramam, mulai unnathu”(57). The symptoms of Siravatham are nearly correlated with 
Cerebral palsy. Signs and symptoms of cerebral palsy vary between people. Often, 
symptoms include poor coordination, stiff muscles, weak muscles, and tremors. There 
may be problems with sensation, vision, hearing, swallowing, and speaking disorder. 
            
The prevalence of cerebral palsy is estimated to be 1.5-3 per 1000 live births, 
with variations possibly reflecting true differences, or differences in ascertainment and 
classification (Andersen et al., 2008; Blair, 2010) 
(58)
.. During the last years, focus of 
care for children with cerebral palsy has shifted from a main emphasis on motor 
function, towards participation and minimizing limitations of activity, in line with the 
World Health Organization (WHO) frame work; the International Classification of 
Functioning, Disability and Health (ICF). Around 8,000 to 10,000 babies and infants are 
diagnosed per year with Cerebral Palsy. About all, spastic cerebral palsy is common in 
children and its range is 61%.  
 
There is paucity of clinical management and to improve the children with 
cerebral palsy, potentially compromising both research and clinical practice in this area. 
In the view of the above great efforts made to find out Siddha medicines and 
methodologies to improve quality of life to children with cerebral palsy. It is in the 
context that we have undertaken a review of the Siddha formulation which could help 
treatment of cerebral palsy. The particular aim of this reach work was to investigate the 
use of Siddha medicines and methodologies with including Podithimirthal and 
Thokkanam in children with cerebral palsy. 
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      Therefore, for the treatment of cerebral palsy much attention has been focused on the 
use of herbal drugs from alternative medicines. Practices of traditional medicines vary 
greatly from every country, and every region, as they are influenced by factors such as 
culture, history, personal attitudes and philosophy. Long historical uses of many 
practices of traditional medicine, including experience passed on from generation to 
generation, have demonstrated the safety and efficacy of traditional medicine in India.        
 In India, Siddha system of medicine owes its origin to medicinal ideas and practices of a 
class of Tamil sages. In the Siddha system of medicine, herbs, minerals, metals and salts 
all have been used for pediatric population. However, scientific research, using modern 
techniques is needed to provide additional evidence on the drug standardization. The 
major challenges include the authentication as to the quality, quantity i.e. dosage, safety 
and efficacy, especially in regard to single or minimal drug combinations of herbal 
products. In this context, the need exists to evaluate many Siddha drugs and therapies in 
contemporary use. In conducting research and evaluating traditional medicine, 
knowledge and experience obtained through the long history of established practices 
have to be retained. 
             
There has been much discussion about the role of Siddha System of Medicine in 
the evaluation, management and treatment of special children. 
 
Siddha literature suggested the use of compositions such as Kurunthotti 
Kudineer, Kollu Podithimirthal and Vasavu ennai, Thokkanam (Massage) external 
therapies. The history of usage of these formulations and procedures are very old.  
However, the exact standard methodologies in the treatment are unavailable till now. A 
number of individual formulations and procedures currently used in the management of 
cerebral palsy have been shown to have minimal action when it used alone. However, 
combinations of internal and external therapies have been reported successfully. In this 
view, the study was undertaken to evaluate the combined therapy for the management of 
cerebral palsy. This study made quantitative measure of different clinical parameters. 
Efforts have been made to reduce the Spasticity, Muscle tone, stiffness in the joints. 
through the use of Siddha medicines in cerebral palsy children.  The outcomes of the 
three treatments were compared at intervals of up to 90 days.  Additionally, analytical 
standardization, Acute and 28 days repeated oral toxicity studies of internal medicine 
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Kurunthotti Kudineer were also been studied. With these above objectives, a detailed 
study plan was undertaken as detailed earlier with materials and methods described. 
The trial drugs were prepared in Gunapadam lab of National Institute of 
Siddha after the authentication of the raw drugs by Assistant professor of Medicinal 
Botany NIS, Chennai. 
 
The trial drug was prepared by standard operating procedure as mentioned in 
the Protocol. i.e. Internal Medicine: Kurunthotti Kudineer and External therapy:  Kollu 
Podithimirthal & Vasavu Ennai. 
 
Preclinical studies of Kurunthotti Kudineer: 
The Bio chemical analysis of trial medicine shows presence of calcium, magnesium, 
aluminium, sulphate, zinc, alkaloids, phenol, hydro quinine and tannic acid.  Calcium 
ions significantly increase the drug release. It enhances the drug to absorb well and 
strengthen the bones
(59)
. Magnesium by mouth is helpful as a laxative for constipation and 
to prepare the bowel for medical procedures. Taking magnesium by mouth as an antacid 
reduces symptoms of heartburn
(59)
. Aluminium in the gastrointestinal tract inhibits  
absorption of electrolytes. It is found in nature in different hydrated forms that have 
pharmaceutical or dental uses. Tannins has also been reported to exert many     
physiological effects, reduce blood pressure, decrease the serum lipid level and modulate 
immune responses
.
 
 
Physicochemical analysis: 
 Physicochemical analysis was done as preliminary evaluation of   Kurunthotti 
Kudineer. The method of measuring the moisture content in solid or semi-solid materials 
is loss on drying at 105 C
0
 was found to be it falls in between the limit range (1-20%)  
The method of measuring the moisture content in solid materials is loss on drying 
(LOD). Low moisture content is always desirable for higher stability of drugs. In 
Kurunthotti Kudineer showed Loss of drying at 105C
0
 was found to be 5.67 % it falls in 
between the limit range (1-20%).so the moisture content shows the good stability of the 
drug Kurunthotti Kudineer.  
 
 The ash value represents the purity of the drugs. The total ash includes both 
physiological ash, which is derived from the organic matter, and non physiological ash 
which is the residue of the extraneous matters like sand/soil, inorganic materials.  
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 The non physiologic ash is represented by acid soluble ash. The total ash in 
Kurunthotti Kudineer found to be 6.78% and the acid insoluble ash to be 1.53%.  The 
both ash value were under limits. The minimal level of acid insoluble ash shows the less 
inorganic residue and purity of the Kurunthotti Kudineer. 
  
 The extractive values help to indicate the nature of chemical constituents present 
in the drug. The water soluble substance is polar in nature and the alcohol has the ability 
to dissolve non-polar substance .The water soluble extract value of  Kurunthotti 
Kudineer is 12.75% and the Alcohol soluble extractive is 11.48 % its shows the 
possibility of water soluble constituents such as tannins, sugars, plant acids and 
mucilage, and alcohol soluble substance such as tannins, resins, and alkaloids to be 
present in the drug. As the drug Kurunthotti  Kudineer  having more water soluble 
constituents than alcohol soluble, it would be non polar .So the trial drug shows good 
absorption & intracellular distribution without possible of accumulation inside the cells. 
The good water solubility may rapid the drug absorption and action. 
 
Phytochemical analysis: 
The Phytochemical analysis shows the presence of Alkaloids, Quinones. 
Diterpenes, Flavanoids, Saponin, Carbohydrates. 
  
  Saponin control blood cholesterol levels, bone health, cancer and build up the 
immune system. When added to the diet saponins pass through the digestive tract 
unabsorbed and are excreted in the feces. Improve H2O penetration
(60)
. carbohydrates is 
important that you eat an appropriate amount of healthy carbohydrates in order to meet 
your body’s nutritional needs and maintain a healthy weigh. Quinones are involved 
in blood coagulation, bone formation, and other processes. Presence of  Flavanoids 
which is an  important antioxidants and promote  
 
 Several health effects. Aside from antioxidant activity, these molecules provide 
the following beneficial effects like anti-inflammatory, anti-allergic.  
 
Acute Toxicity Study:   
           All the data were summarized in the form of revealed that there were no 
abnormal signs and behavioural changes in all animals at the dose level of   5,000 mg/kg 
body weight administered orally, during the study period.   
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             There was no mortality observed after dosing of Kurunthotti Kudineer upto 
5000mg/kg body weight during the study period of 14 days. This indicates that the LD50 
of  Kurunthotti  Kudineer is more than 5000mg/kg b.wt.  
            There were no changes in skin and fur, eyes and mucous membranes of all 
animals.  The eating, drinking habit, sleep pattern, locomotion were normal in all animals 
and no changes in body weight as compared to control group.  
           At the end of the 14 the day, necropsy was performed and there was no 
abnormality seen in test groups as compared to control group during the examination. No 
adverse effects were reported in trial drug during the entire study. 
 
Clinical Study: 
       30 Patients with confirmed diagnosis of with satisfying the inclusion criteria were 
enrolled after obtaining written informed consent and were to receive Kurunthotti  
Kudineer with External therapy Kollu podithimirthal and Vasavu ennai massage. A 
Protocol was prepared and submitted before IEC of  National Institute of  Siddha. 
The IEC approval was obtained No: NIS/IEC/2016/11-23/14-10-2016. The trial was 
registered in Clinical trial Registry of India with Reg .No. CTRI/2018/04/013322 and 
informed about the study, trial drug, possible outcomes and the objectives of the study in 
the language and terms understandable to them. Signed the informed consent obtained.  
                
 The criteria were family history, sex predominance, age distribution, occupation, 
dietary habits and incidence of the disease with reference to thinai, seasonal variation, 
clinical manifestations and assessment of the improvement in the prognosis of the 
disease with the trial drug. After obtaining approval from  the committee, the clinical 
study on Siravatham ( Cerebral palsy ) in  children treated with drug kurunthotti kudineer 
(Internal) and Vasuvu Ennai for thokkanam and Kollu  Podithimirthal therapy as 
external carried out as per the protocol. Kudineer prescribed for children based on the 
age i.e. 2 to 4years - 30 ml (bds), 5 to 7 years - 40 ml (bds) for 90 days.  
 Total treatment period was 90 days. Clinical assessments were recorded on 0
th
 day and 
followed by every 30
th
 days. 
 Age: 
In the present study, Out of 30 patients, 46 % of cases were within 2-4years, 54 % of 
cases were within 5-7 years.   
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 Sex: 
     Out of 30 patients 36% were male children and 64% were female children. 
    Female children are affected more than male children. 
 Socio-economic status: 
        About 50 % patients were under lower income group, 33% patients were under 
middle income group and 17% patients were under high income group.  The highest 
incidence occurred in middle income group. 
 Seasonal variation:  
    According to paruva kaalam, high incidence of cases 65% were reported in 
Pinpanikalam , 54% cases were reported in Munpani kalam, 27.5% cases were 
reported in elavenil kaalam and 2.5% were from Karkalam and 2.5% from 
koothirkalam, 2.5% were from Mudhuvenil. 
 Food habits: 
 According to diet, Vegetarian 17%, Mixed 83.5% were noted. The highest 
incidence of cases was observed in mixed diet.  
 Nilam: 
     Among 30 patients, 67 % were from Neithal land,33 % from Marutham land,  0 % 
from Mullai land, and 0% from Kurinji  
 Vali (Vatham) 
          Due to the derangement of   vatha the following symptoms occur. Derangement     
of Pranan was 0%, Abanan was 50%, Viyanan 100%,Uthanan 70%,Samanan 100%, 
Kirukaran 100%, Devathathan 100%. 
 Azhal (Pitham) 
      According to Pitham. Derangement of Analapitham was 50% and Ranjagam was 
10%, Saathagam was 67%. 
 Iyyam (Kabam) 
According to Kabam. Derangement of Kilethagam was deranged in 100% of 
cases and Santhigam was affected in 100% cases   
 Ezhu udarkattugal 
In Ezhu udal kattukal, Seneer was affected in 100% of cases and Enbu was 
affected in 100%. 
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 Envagai thervugal 
According to this study Out of 30 cases Malam was affected in100% of cases, 
Sparisam was affected in  15% of cases,  Naa, Niram, Vizhi and moothiram  was affected 
in 10% of the cases. 
 
 Neikuri 
According to Neikuri, Vatha neer was observed in 33.3   % of cases, Pitha neer 
was observed in 16.6 % of cases, Kaba neer was observed in 50 % of cases. 
 
Clinical symptoms: 
      The clinical features of Siravatham may be correlated with general clinical 
manifestations of Cerebral palsy. In accordance with the clinical features of Siravatham 
among the 30 cases, 100% of the patients   have 2-7 years , abnormal gait and clinically 
diagnosed spastic cp, 33.3% Spastic hemiplegia and Spastic diaplegia, 6.66% have 
spastic Quadriplegia, spastic Monoplegia,15% have fever,  16.6% have Spastic triplegia.  
 
Internal Medicine: Kurunthotti Kudineer 
 Kurunthotti Kudineer pacifies the aggravated vatha dosha which was given to 
these patients for 90 days. Ephedrine which is the main alkaloid present in sida cordifolia 
strengthens and tones the muscles and also acts as energy enchancer. Root is regarded as 
cooling, astringent, stomachic and tonic, aromatic, bitter, diuretic. It is also a 
rejuvunative, nutritive and stimulant to the heart.  It also promotes healing of tissue in 
chronic infectious diseases
(62)
. 
 
Cleodendrum phlomidis was found to cause significant reduction in spontaneous 
activity, the extract exhibit significantly reduction in muscle relaxant activity. 
Thazhuthazhai is indicated for 80 Vatha diseases. It is also used for ailments involving 
swellings, joint pains and inflammation. Root decoction is used as aromatic, astringent 
and demulcent. Root is used for body ache, head ache and unconsciousness 
(63)
.. 
 
Devadaru is indicated for Nadukku Vatha diseases, Suram. Traditionally the 
heartwood of Cedrus deodara plant was used to enhance cerebral function, balance the 
mind, body connection, nervous system and strengthen the brain. It was reported to 
possess CNS depressant and neuroleptic activity.  Himachalol is one of the major 
constituent of wood of plant, which is having antispasmodic activity.  
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The pharmacological studies of himachalol on various isolated smooth muscles 
and against different agonists (acetylcholine, histamine, serotonin, nicotine, and barium 
chloride) indicated spasmolytic activity. The wood of Cedrus deodara has himachalol 
identifed as the major antispasmodic constituent
(64)
. Mimusops elengi is effect of 
alcoholic extract of flower was evaluated for congestive enhancing activity. Tonic, 
astringent which cures biliousness, diseases of the gums and teeth
(65)
.. 
 
Zingiberine officinale is indicated for Vatha diseases, sinusitis, and headache.  
Some active components of ginger are reported to stimulate digestion, absorption, relieve 
constipation and flatulence by increasing muscular activity in the digestive tract. The 
antispasmodic effect of ginger was apparent in vitro experiment on rat jejunum as it 
reduced the magnitude of ACh induced contraction
(66)
. The ginger has been listed in 
document “Generally Recognized as Safe”. The British Herbal Compendium reported 
ginger action as carminative, anti-emetic, spasmolytic, peripheral circulatory stimulant 
and anti inflammatory. The ginger contains minerals like iron, calcium and phosphorous 
and also contains vitamins such as thiamine, riboflavin, niacin, vitamin A and vitamin C. 
Majorana hortensis is indicated for Udalukku oottathaium, miguntha pasiyaium 
undakkum. And Linalool, Limonene which is the main alkaloid present in Majorana 
hortensis strengthens and tones the muscles, the leaves are employed to cure insomnia, 
catarrh, asthma and nervousness. The leaf extracts have been scientifically proved to be 
effective as an antioxidant
(67)
. 
 
External therapy:  
1. Kollu podithimirthal
(68)
 
          The seeds of Macrotyloma uniflorumare used in traditional medicine as letter, 
thermo genic, astringent, anthelmintic, diaphoretic, diuretic, expectorant, ophthalmic and 
tonic.   
Kollu podithimirthal which is given to these children pacified the aggravated 
Kaba dosha. Horse gram powder improves mobility of joints and reduces spasticity. 
Reduces the excess fat accumulated in the subcutaneous tissues. Softens and exfoliates 
dead skin cells there by giving a lustrous glow to skin. Detoxification, purification, 
toning the skin. Eliminates bad body odour. Improves mobility of joints. Strengthens and 
tones the muscles Refreshes and rejuvenates the body. 
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2. Vasavu Ennai thokkanam 
        Castor oil is used topically to soften skin, bunions and corns; and to dissolve cysts, 
growths, and warts
(69)
.Sesame oil is rich in vitamin E (potent antioxidant), iron, omega-6 
fatty acids, vitamin B6, magnesium, calcium, zinc, copper, dietary fiber and flavanoids,  
phenolic antioxidants. All these enriching nutrients make Sesame oil as a powerful Anti 
Spasmolytic activity with cardiac, dermatologic, laxative, emollient, carminative, tonic 
warming properties
(70)
.The oleoresin exuded from the plant has astringent, carminative 
and stomachic properties
(71)
. Cow Ghee is excellent for balancing Vatha (air) and Pitha 
(fire) related doshas (humors)
 (72)
. 
 
 External massage therapy with medicinal oils is gaining importance now a days 
because of its effective results.  Massage with Vasavu ennai which soothe the sensory 
nerve endings, they produce a hyperemic effect causing the arterioles dilate in 
musculature, and reduce stiffness. Massage is considered to enhance muscle relaxation, 
reduce muscle tension and soreness and post- sequently,  improve performance. Massage 
is also thought to provide a soothing, sedative, invigorating feeling and can give the 
comfort
(72)
. As spasticity is an important phenomenon of CP therapeutic approach 
concentrates on reducing spasticity. In this way, Vasavu ennai can give fruitful results in 
the treatment of CP. 
 
Experimental period was 90 days and the clinical parameters such as spasticity, 
muscle tone, stiffness in the joints and to improve the gait was recorded 0
th
 day and 
followed by every 30
th
 day.  Subsequently, all children were examined by the physician 
at every visit and every day during the trial. Use of any other therapy that does not 
interfere with the study drug will also be permitted. Patients were allowed to continue 
with their ongoing lifestyle and diet. Information about study subjects were kept 
confidential and managed.  
The mean and standard deviation of Kurunthotti kudineer and  
Kollupodithimirthal and Vasavu Annai Massage  before and after treatment were 4.848 
and 3.453 respectively .Which is statistically significant t-value =5.831p value p<0.0001. 
Statistical analysis reveals that there has been a significant reduction in total scales after 
treatment indicating the improvement in children doing their daily activities. 
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Statistical analysis reveals that there has been a significant (P< 0.0001) reduction 
in MAS, MTS, MRCG, GMFCSPAS, DGI, DAS scale after treatment indicating the 
improvement in children doing their daily activities. 
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7. SUMMARY 
“Special children” is an umbrella term used to classify conditions that childhood 
disability caused by neuronal damage. The proportion of disabled children in developing 
countries is generally higher than in developed countries, it is estimated that 6 to 10% of 
children in India are born disabled. A child who has been determined to require special 
attention is called as Special Children. Children with multiple disabilities associated with 
impairments which range across sensory, motor, physical, socio emotional, behavior and 
cognitive domains known as “Special children” 
There are many physical disabilities that can affect children. But cerebral palsy is the 
most common mental disability in childhood. 
 
Cerebral palsy is a non progressive disorder of posture and movement often 
associated with epilepsy and abnormalities of speech, vision and intellect. It results from 
a defect or lesion of the developing brain. Cerebral palsy occurs in about 1.5 per 1000 
live births. Oral Baclofen, Tizanidine, Dantrolene, Diazepam and Gabapentin are widely 
used for cerebral palsy. Not all patients beneﬁt from this treatment. However this drug 
was shown to have undesirable other effects such as sedation, respiration problems and 
muscular weakness, dry mouthl and hallucinations. Patients with localized or multifocal 
Botulinum toxin injections have risk for antibody formation must be restricted.  
 
However, modern drugs can be said to partially fulfill desirable requirements in 
some extent. It is in the context that we have undertaken a review of the Siddha 
formulation which could help management of CP. In the view of the above, great efforts 
have been made to find out the alternate Siddha medicines and methodologies to improve 
the life style of special children with cerebral palsy.   
 
Siddha literature suggested the internal and external therapies which include the 
Kurunthotti Kudineer, Kollu Podithimirthal and Vasavu Ennai Thokkanam. The history 
of usage of these medicines and methodologies are very old.  In this view, the study was 
undertaken to evaluate the combined management of internal medicine and external 
therapies for the management of special children with spastic cerebral palsy. 
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Preclinical studies of Kurunthotti Kudineer: 
Biochemical analysis: 
Biochemical Qualitative analysis of trial drug was done in Biochemistry 
laboratory, Department of Biochemistry, National Institute of Siddha, Chennai.  
The Bio chemical analysis of trial medicine shows presence of calcium, 
magnesium, aluminium, sulphate, zinc, alkaloids phenol, hydro quinine and tannic acid.  
 
Physicochemical analysis: 
Physicochemical analysis and Photochemical of Kurunthotti kudineer was done 
in The Tamil Nadu Dr.MGR Medical University-Chennai. 
 
The physicochemical analysis showed the trial drug is in appropriate consistency 
for trial study 
 
In Kurunthotti Kudineer showed Loss of drying at 105C
0
 was found to be 5.67 % 
it falls in between the limit range (1-20%).so the moisture content shows the good 
stability of the drug Kurunthotti Kudineer. 
 
            The total ash in Kurunthotti Kudineer found to be 6.78% and the acid insoluble 
ash to be 1.53%. The both ash value were under limits. The minimal level of acid 
insoluble ash shows the less inorganic residue and purity of the Kurunthotti Kudineer. 
 The water soluble extract value of Kurunthotti Kudineer is 12.75% and the Alcohol 
soluble extractive is 11.48 % its shows the possibility of water soluble constituents such 
as tannins, sugars, plant acids and mucilage, and alcohol soluble substance such as 
tannins, resins, and alkaloids to be present in the drug. As the drug Kurunthotti Kudineer 
having more water soluble constituents than alcohol soluble, it would be non polar .So 
the trial drug shows good absorption & intracellular distribution without possible of 
accumulation inside the cells. The good water solubility may rapid the drug absorption 
and action. 
 
Photochemical analysis: 
            Phytochemical of Kurunthotti Kudineer was done in The Tamil Nadu Dr.MGR 
Medical University-Chennai. 
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The Phytochemical analysis shows the presence of Alkaloids, Quinones. 
Diterpenes, Flavanoids, Saponin, Carbohydrates. 
 
Preclinical safety: 
 Children to get the desired advantage, who must take adequate amount of 
Kurunthotti Kudineer over a certain length of time, the general opinion that herbal drugs 
are very safe and the from adverse effects is not true and it can produce undesirable side 
effects. In our preclinical (NIS/IAEC-IV/07/05012017) acute and 14 days repeated oral 
toxicity study of  Kurunthotti Kudineer  showed no mortality of rats up to the higher 
dose. No behavioural changes or abnormal clinical signs were observed. No treatment 
related toxicity signs or mortality were observed.  The gross necropsy study on the 
organs showed no abnormal pathological morphology.  
 
Clinical Study: 
The present study was a prospective, open label, non-randomized, outpatient and 
inpatient based, single centred drug trial conducted in the department of Kuzhanthai  
Maruthuvam (Paediatric), National institute of Siddha, Chennai. It was conducted during 
2016 to December 2018 after obtaining approval from the Institute Ethics Committee  
(NIS/IEC/2016/11-23/14-10-2016) The trial registered in Clinical trial Registry of India 
with  Reg .No. CTRI/2018/04/013322 was obtained. 
 
 Single batch of  Kurunthotti Kudineer (Internal), Kollu Podithimirthal and 
Vasavu ennai (External) were prepared for the entire study. The first 30 children with 
spastic cerebral palsy were screened during the study period. Children of either sex 
between the age group of 2 to 7yrs, who were diagnosed with spastic cerebral palsy, 
were identified to include the study. Other type of cerebral palsies and along with seizure 
disorder, Spinal deformities, impaired vision Autistic Spectrum Disorders, ADD/ADHD 
(Hyper activity), Mental Retardation, Visual Impairments and Blindness, Hearing Loss 
and Deafness, Down Syndrome, Spina Bifida, Traumatic Brain Injury were excluded 
from the study. 30 children satisfied the inclusion criteria and were willing to participate 
in the study, signed the informed consent. The parents of children who were enrolled was 
informed about the study, trial drug, possible outcomes and the objectives of the study in 
the language and terms understandable for them.  
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Children were received internal medicine Kurunthotti Kudineer (2 yrs to 4 yrs - 
30 ml, 5 yrs to 7 yrs - 40 ml) twice a day along with external therapies such as massage 
with Vasavu ennai and Kollu Podithimirthal. Experimental period was 90 days and 
spasticity was recorded 0
th
 day and followed by every 30
th
 day. Experimental 
formulations were assigned to each subject and regular study drug reconciliation was 
performed to document the drug assigned, consumed, and remaining are logged on the 
drug reconciliation form with sign & date. 
 
CLINICAL EFFICACY; 
The major objective of the work described in this thesis was to elucidate internal 
medicine Kurunthotti Kudineer  alone, combination of internal medicine along with 
external therapies such as  Kollu podithimirthal and Thokkanam  compared with positive 
control  routine OPD advice  in children with CP influence on assessment of spasticity  
MAS, MTS  muscle tone, Dynamic gait index, Gross Motor Function Classification 
System (GMFCS), Functional Performance (Disability Assessment Scale), Posture 
Assessment on upper limb and lower limb assessment of language. In clinical analysis 
we observed motor function like spasticity, muscle tone, Gross motor function analysis , 
Gait analysis showed significant improvement in childrens. But the results had shown 
significantly differed each other.  However children had shown significant improvement 
in all clinical parameters in children. 
 
The mean and standard deviation of Kurunthotti kudineer before and after 
treatment were 4.848 and 3.453 respectively .Which is statistically significant t-value 
=5.831p value p<0.0001. Statistical analysis reveals that there has been a significant 
reduction in total scales after treatment indicating the improvement in children doing 
their daily activities. 
 
Statistical analysis reveals that there has been a significant (P< 0.0001) reduction 
in MAS, MTS, MRCG, GMFCSPAS, DGI, DAS scale after treatment indicating the 
improvement in children doing their daily activities. 
 
The clinical efficacy of the drug was analyzed statistically on all the symptoms 
mentioned in the assessment criteria.  
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The observation made during the clinical study showed that the trail drug 
Kurunthotti kudineer (Internal),Kollu Podithimirthal and Vasavu ennai Thokkanam 
(External)  was clinically effective. 
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8. CONCLUSION: 
In Siddha literature CP is under the Vatha disease therefore, the therapeutic 
management is considered to be internal medicine, Kollu podithimirthal and 
(Thokkanam) massaging. Siddha system of medicines has certainty with safer 
medications to treat children. Children with CP have multiple symptoms for which no 
curative treatment exists. Manipulative and body based methods such as Thokkanam, 
Podithimirthal to improve the quality of life of CP children. The trial drug Kurunthotti 
kudineer along with kollu podi thimirthal and Vasavu ennai massage was treated to the 
children. Kurunthotti Kudineer’s  primary use is to enhance cognitive function. Research 
has been focused on the mechanism behind these properties.  
 
The Alkaloids, Quinones, Diterpenes, Flavanoids, Saponin, Carbohydrates are 
responsible for increase in the muscle tone through enhancing the nerve impulse 
transmission. Kollu podithimirthal which is given to these Children is for pacifying the 
aggravated Kaba dosha. Podithimirthal with horse gram powder improves mobility of 
joints and reduces spasticity, reduces the excess fat accumulated in the subcutaneous 
tissues. softens and exfoliates dead skin cells , improves mobility of joints, strengthens 
and tones the muscles, refreshes and rejuvenates the body. Massage with Vasavu ennai 
which soothe the sensory nerve endings, they produce a hyperaemic effect causing the 
arterioles dilate in musculature, and reduce stiffness .  Massage is also thought to provide 
a soothing, sedative, invigorating feeling and can give the comfort. In clinical analysis 
we observed motor function like spasticity, muscle tone, Gross motor function analysis 
and Gait analysis showed significant improvement in children. But the results had shown 
significantly differed each other.  However children had shown significant improvement 
in all clinical parameters in children.  
 
Thus, Siddha protocol of management can provide some benefit by giving 
possible improvement in the present condition and minimize the disability of those 
innocent children and improve their quality of life and give active and self supporting 
happy life.  
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9. RECOMMENDATIONS 
 
 As with research work presented in this thesis has answered many questions of 
Siddha medicine and methodologies in clinical parameters however, in doing so it has 
created even more questions and areas for further research. Further research not only 
must the outcome measures to be valid and reliable, but they must be relavant to the 
child and family concerened. 
 
1. Further studies of the efficacy of the combined use of kurunthotti kudineer as 
Internal, Kollu Podithimirthal and Vasavu ennai massage as External in the 
management of children with Cerebral Palsy should use a randomized controlled 
study design in multicentre which is the gold standard for clinical research. 
 
2. We are strongly recommended need for further research as there are not reported 
studies are available on effect of Siddha medicines which focuses on Speech and 
language, Cognition, Social relationship, behavioural patterns and Sensory 
aspects in Children with Cerebral Palsy. This research has shown the value of 
providing siddha medicines with these children and they have developed some 
scope for further research in above aspects. 
 
3. Need to scrutinize and produce the siddha philosophical guidelines towards the 
management of children with Cerebral palsy which consists of complete full 
information and management of these children with traditional approach for 
physicians and parents 
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APPENDIX 
S.No Forms 
1 Form I       Screening & Selection Proforma 
2 Form II      Consent Form 
3 Form III     Case report form 
4 Form IV     Assessment Form 
5 Form V      Drug compliance 
6 Form VI     Patient information sheet 
7 Form VII    Withdrawal 
8 Form VIII   Adverse reaction 
9 Form IX     Pharmacovigilance 
10 Form X     Dietary form 
 
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
(POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM) 
“PRECLINICAL AND CLINICAL EVALUATION OF SIRAVATHAM 
(CEREBRAL PALSY) WITH SIDDHA THERAPEUTIC MANAGEMENT  
IN CHILDREN” 
FORM 1- SCREENING AND SELECTION FORM 
1. S.l.No:                                   2. OP/ IP No:                             3. Name: 
4. Age:                                       5. Gender:                                  6. Date of Enrollment: 
7. Date of completion:               8. Informant:                              9. Reliability:  
 
S.NO INCLUSION CRETERIA YES NO 
1 Children of age group under 2- 7 year   
2 Clinically diagnosed as a cerebral palsy(spastic)   
3 Not attained head control   
4 Drooling of saliva   
5 spastic Hemiplegic   
6 spastic Diplegia   
7 spastic Quadriplegia   
8 spastic Monoplegia   
9 spastic Triplegia   
 
Child will be  include  4 or more criteria for this clinical trial study.   
S.NO EXCLUSION CRITERIA YES NO 
1 Ataxic cp   
2 Flaccidity   
3 Associated with Seizure disorder   
4 Associated with Autism(ASD)   
5 Associated with ADHD   
6 Any other serious illness   
 
ADMITTED TO TRIAL: YES             NO                          IF YES, OPD/ IPD NO: 
Date &Station:                                                                       Signature of the Guide: 
Signature of the HOD:                                                           Signature of the Investigator: 
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
(POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM) 
FORM II -CONSENT FORM 
 
CERTIFICATE BY INVESTIGATOR 
 I certify that I have disclosed all the details about the study in the terms readily 
understood by the parent/guardian 
Signature  _________________ 
  
Name  _________________ 
 
 Date  _________________ 
 
CONSENT BY PARENT 
 I have been informed to my satisfaction, by the attending physician, the purpose 
of the clinical trial, and the nature of drug treatment and follow-up including the 
laboratory investigations to be performed to monitor and safeguard my son/daughter 
body functions. 
 I am aware of my right to opt my son/daughter out of the trail at any time during 
the course of the trail without having to give the reasons for doing so.  
 I exercising my free power of choice, hereby give my consent to include my 
son/daughter as a subject in the clinical trial of “Preclinical and Clinical Evaluation of 
Siravatham (Cerebral Palsy) With Siddha Therapeutic Management in Children.” 
 
Date:      Signature           :__________________ 
 
Place:     Name             :__________________ 
 
       Signature of witness  :__________________ 
 
     Name   :__________________ 
 
  
தேசிௌ சித்ே ோருத்துவ ைிறுவ௉ம் 
அதௌோத்ேிேோச ொண்டிேர் ோருத்துவோன௉, சசன்ன௉-47 
குழந்னே ோருத்துவத்துன௎. 
சி்வோேதைோய்க்கோ௉ குறுந்சேோட்டிகுடிைீர் (உள்ோருந்து) ோற்றும் சகோள்ளு 
சொோடிேிோிர்ேல் , வசசவண்செய்   (சவளிோருந்து) ொோிகோிப்புத் 
ேி௎ன௉கண்ட௎ியும் ோருத்துவ ஆய்வு. 
ஒப்புேல்ொடிவம் 
ஆய்வோள்ோல் சோன்௎ளிக்கப்ொட்டது.  
ைோன் இந்ே ோருத்துவ ஆய்னவ கு௎ித்ே அன௉த்து விொ்ங்கனளயும் 
தைோௌோளிௌின் சொற்த௎ோருக்கு புோியும் வனகௌில் எடுத்துன்த்தேன் எ௉ உறுேி 
அளிக்கித௎ன். 
தேேி:                                            னகசௌோப்ொம்: 
இடம்:                                              சொௌர்: 
                        தைோௌோளிௌின்சொற்த௎ோர்ஒப்புேல்ொடிவம் 
என்௉ிடம் இந்ே ோருத்துவ ஆய்வின் கோ்ெத்னேயும், ோருந்ேின் ேன்னோ 
ோற்றும் ோருத்துவ வழிமுன௎ப் ொற்௎ியும், இந்ே ோருத்துவத்னே சேோடர்ந்து எ௉து 
குழந்னேௌின் உடல் இௌக்கத்னேக் கண்கோெிக்கவும், அேன௉ ொோதுகோக்க 
ொௌன்ொடும் ோருத்துவ ஆய்வுக் கூடப் ொோிதசோேன௉கள் ொற்௎ியும் ேிருப்ேி 
அளிக்கும் வனகௌில் ஆய்வு ோருத்துவ்ோல் விளக்கிக்கூ௎ப்ொட்டது. ைோன் இந்ே 
ோருத்துவ ஆய்வின் தொோது கோ்ெம் எதுவும் கூ௎ோோல் எப்தொோது 
தவண்டுோோ௉ோலும் என் குழந்னேனௌ விடுவித்துக் சகோள்ளும் உோினோனௌ 
சேோிந்ேிருக்கித௎ன். 
ைோன் என்னுனடௌ சுேந்ேி்ோோக தேர்வு சசய்யும் உோினோனௌக் சகோண்டு 
சி்வோே தைோய்க்கோ௉ குறுந்சேோட்டிகுடிைீர் (உள்ோருந்து) ோற்றும் சகோள்ளு 
சொோடிேிோிர்ேல், வசசவண்செய்   (சவளிோருந்து) ொோிகோிப்புத் ேி௎ன௉கண்ட௎ியும் 
ோருத்துவ ஆய்வுக்கு எ௉து குழந்னேனௌ உட்ொடுத்ே ஒப்புேல் அளிக்கித௎ன். 
 
தேேி:                               சொற்த௎ோர் சொௌர் : 
 
இடம்:                                                        னகசௌோப்ொம்:   
 
                                                                        சோட்சிக்கோ்ர் சொௌர்: 
  
                  னகசௌோப்ொம்: 
 NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
(POST GRADUATE DEPARTMENT OF KUZHANDHAI 
MARUTHUVAM) 
“PRECLINICAL AND CLINICAL EVALUATION OF SIRAVATHAM 
(CEREBRAL PALSY) WITH SIDDHA THERAPEUTIC MANAGEMENT 
IN CHILDREN” 
FORM III CASE REPORT FORM 
Patient Id : OP/IP No. Visit Date : (__/__/___)   
Name : 
Age    : 
Gender Male                 Female 
Father/ Mother 
/Guardian Name  
 
Father’s   Occupation   
Religion   
Patient   Informant   
 
Postal Address  
 
 
 
Permanent Address 
 
 
Contact no.  
 
  
 Immunisation  history:  
Complete     Incomplete        Complete but time lag     
 
Complaints and duration: 
 
 
History of present illness: 
 
 
 
History of past illness: 
 
 
Familial history: 
Any Hereditary/ Familial Disease     Yes     No  
 If Yes, Details -------------------------------------------------------------------------
-  
Family H/O similar condition        ------------------------------------------ 
 
Socio Economic Status: 
 
Dietetic History: 
Appetite 
Types of diet 
 
  
 
 
 
S.no 
 
Habit 
 
Yes 
 
No 
 1 Picca   
2 Nail Biting   
3 Bowel and 
micturition                           
  
4 Thumb sucking                                      
5 Enuresis   
6 Sleep   
 
S.no 
 
General 
examination 
 
Yes 
 
No 
1 Pallor   
2 Jaundice   
3 Cyanosis   
4 Clubbing   
5 Pedal oedema   
6 Lymph adenopathy   
 
S.no 
 
Vital signs 
1 Pulse  rate   
2 Heart  rate  
3 Respiratory  rate  
4 Temperature  
 
S.no 
 
Anthropometry 
1 Height  
2 Weight  
3 Head 
Circumference 
 
4 Mid -arm 
circumference 
 
5 Chest 
Measurement 
 
  
  
Developmental History (Mile Stones) Remarks 
1. Cry at birth:  
2. Smile ( 2
nd
 month):  
3. Head control (3
rd
month):  
4. Laughed outloud ( 4
th
 month):  
5. Sit with support (5
th
 month):  
6. Rolled over (6
th
 month):  
7. Transfer (7
th
 month):  
8. 
Sit without support & crawl (8
th
 
month): 
 
9. 
First words & walk with support  
 (10
th
 month): 
 
10. Stand (11
th
 month):  
11. Walk without support (13
th
 month):  
12. Put words together (1year):  
13. Ride tricycle (3year):  
14. Hops on one foot (4 years):  
15. Known  (R)or(L) (6years):  
  
                   HISTORY OF ANTENATAL, NATAL,POST NATAL 
                          Ante natal Yes No Remarks 
1 Medication:    
2 Infection (STARCH):    
3 Irradiation:    
4 Toxaemia:    
5 Abortion:    
6 Hemorrhage:    
7 Sever Anaemia:    
8 Eclampsia:    
9 H/O Decreased foetal movements:    
10 Maternal malnutrition:    
11 Maternal Diabetes mellitus:    
12 Maternal Hypertension:    
                                                                             Natal 
13 Breech Presentation:    
14 Forceps/-C-section:    
15 Home/Hospital:    
16 History of Prolonged labour:    
                                                                          Post natal 
17 Post Partum Haemorrhage:    
18 Sepsis:    
  
S.No Neonatal history Yes No Remarks 
1 
Birth weight    
2 
Term/pre term baby:    
3 
Congenital   
malformations: 
   
  4 
Birth asphyxia, APGAR-
score: 
   
5 
Neonatal convulsions:    
6 
Kernicterus:    
7 
Diarrhoea:    
8 
Birth injury / head  injury:    
9 
Time of cry after birth:    
10 
Respiratory 
distress/cyanosis: 
   
11 
Fever/altered sensorium:    
12 
Feeding  after  birth:    
  
  
SYSTAMIC EXAMINATION 
CENTRAL NERVOUS SYSTEM EXAMINATION 
        Higher functions Normal Affected Remarks 
1 Consciousness    
2 Speech    
3 Orientation    
4 Memory    
5 Language    
6 Handedness    
7 Sleep pattern    
Cranial nerve examination 
8 Olfactory Nerve    
9 Optic Nerve    
10 Oculo motor  Nerve    
11 Trochlear Nerve    
12 Abducent Nerve     
13 Trigeminal Nerve    
14 Facial Nerve    
15 Vestibulo cochlear Nerve    
16 Glossopharangeal Nerve    
17 VagusNerve    
18 Spinal accessory Nerve    
19 Hypoglossal Nerve    
 EXAMINATION OF MOTOR SYSTEM: 
 
Nutrition & bulk of muscles: 
 
Tone of the muscles: 
 
Power: 
 
S.no                  Power           Right side          Left side 
1 Arm   
2 Forearm   
3 Hand   
4 Foot   
5 Leg   
6 Thigh   
 
Grip: 
 
 Gait: 
 
 
 
 
 
 
 
 Reflexes: 
 
S.no Superficial reflex Right side Left side 
1 Corneal   
2 Congectival   
3 Abdominal   
4 Jaw jerk   
5 Plantar    
 
 
 
 
 
 
 
S.no Deep reflex Right  side Left  side 
1 Biceps   
2 Triceps   
3 Supinator   
4 Knee Jerk   
5 Ankle Jerk   
6 Jaw Jerk   
  
Examination of sensory  system Yes No Remarks 
             A.Superficial sensation    
     1 
Touch:    
     2 
Pain:    
    3 
Temperature    
 
B.Deepsensation:    
4 
Position sense:    
      5 
Joint sense:    
6 Vibration sense: 
   
 
C.Cortical sensation:    
     7 
Tactile localization:    
     8 
Two point discrimination:    
     9 Stereognosis: 
   
    10 
Graphasthesia    
  
  
 
  D.Cerebellar examinations 
 
 Yes 
 
    No 
 
                           Remarks 
1 Rhombergs sign    
2 Nystagmus    
3 Unsteadiness    
4 Intentional tremors    
5 Pendular jerk    
6 Slurring of speech    
7 Ataxia    
8 Meningeal signs    
Autonomic system examination 
          9 Bladder movements    
10 Bowel movements    
         11 Sweating    
  
S.no Other system Normal Affected Remarks 
1 Respiratory system    
2 
Cardio vascular 
system 
   
3 
Gestro intestinal 
system 
   
4 
Musculo skeletal 
system 
   
5 Endocrine system    
                                           
                                      
 SIDDHA ASSESSMENT 
 
 
  
S.no Nilam 
1 Kurinji  
2 Mullai  
3 Marutham  
4 Neithal  
5 Paalai  
S.no Gunam 
1 Sathuvam  
2 Rasatham  
3 
Thamasam  
  
 
S.no Pori / Pulangal Normal Affected Remarks 
1 Mei / unarvu    
2 Vaai / suvai    
3 Kan / parvai    
4 
Mooku / 
natram 
   
5 Sevi / olli    
 
  
S.no                                    Kaalaiyalbu  
1 Kaarkaalam  
2 Koothirkaalam  
3 Munpanikaalam  
4 Pinpanikaalam  
5 Illavenirkaalam  
6 Muthuvenirkaalam  
  
S.no 
Kanmendhirium 
/Kanmavidayam 
Normal Affected Remarks 
1 Kai / Dhanam    
2 Kaal / Ghamanam    
3 Vaai / vaaku    
4 Eruvaai / visarkam    
5 
Karuvaai / 
Anantham 
   
 
UYIR THATHUKKAL: 
S.no        Vatham Normal Affected       Remarks 
1 Pranan    
2 Abaanan    
3 Viyanan    
4 Uthanan    
5 Samanan    
6 Nagan    
7 Koorman    
8 Kirukaran    
9 Devathathan    
10 Dhanan jeyan    
    
S.no Kabam Normal Affected Remarks 
1 
Avalambagam    
2 
Kilethagam    
3 
Pothagam    
4 
Tharpagam    
5 
Santhigam    
 
  
S.no Pitham Normal Affected Remarks 
1 Analam    
2 Ranjagam    
3 Saathagam    
4 Alosagam    
5 Prasagam    
  
S,no 
 
Udalthathukkal 
 
Normal 
 
Affected 
 
Remarks 
1 Saaram    
2 Senneer    
3 Oon    
4 Kozhuppu    
5 Enbu    
6 Moolai    
7 
Sukilam / 
Suronitham 
   
S.no Envagaithervugal Normal Affected              Remarks 
1 Naa    
2 Niram    
3 Mozhi    
4 Vizhi    
5 Sparisam    
                                                     Malam 
6 Niram    
7 Nurai    
8 Elagal    
9 Erugal    
                                                   Moothiram 
10 Niram    
11 Edai    
  
CLINICAL ASSESSMENT PARAMETERS 
(0
th 
Day, 30
th
 Day, 60
th
 day, 90
th
 Day) 
 
Name Patient Id OP/IP No 
Assessment  
Date 
    
 
S.No Parameter 0 1 2 3 4 5 
1 Modified Asworth 
scale 
      
2 Modified Tardieu 
Scale 
      
3 Gross Motor 
Function 
Classification 
System (GMFCS) 
      
4 Medical Research 
Council Grading 
      
5 Posture Assessment 
Scale 
      
6 Dynamic Gait Index       
7 Disability 
Assessment Scale 
      
 
Date & Station:                                              Signature of the Guide: 
 
Signature of the HOD:                                  Signature of the Investigator: 
12 Nurai    
13 Manam    
14 Enjal    
15 Neikuri    
16 Naadi  
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
            POST GRADUATE  DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
 “PRECLINICAL AND CLINICAL EVALUATION OF SIRAVATHAM 
(CEREBRAL PALSY) WITH SIDDHA THERAPEUTIC MANAGEMENT IN CHILDREN” 
 
1. S.I. No:                                     2.OP/IP No:                                  3.Name: 
4. Age:                                         5.Gender:                                       6.Date of Enrollment: 
7. Date of Completion:              8.Informant:                                   9.Reliablity: 
                                    FORM IV-CLINICAL ASSESSMENT 
Name Patient Id OP/IP No 
Assessment  
Date 
    
 
S.No Parameter 0 1 2 3 4 5 
1 Modified Asworth 
scale 
      
2 Modified Tardieu 
Scale 
      
3 Gross Motor 
Function 
Classification 
System (GMFCS) 
      
4 Medical Research 
Council Grading 
      
5 Posture 
Assessment Scale 
      
6 Dynamic Gait 
Index 
      
7 Disability 
Assessment Scale 
      
 
Date & Station:                                                       Signature of the Guide: 
Signature of the HOD:                                            Signature of the Investigator: 
 
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI - 600 047. 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
PRECLINICAL AND CLINICAL EVALUATION OF SIRAVATHAM 
(CEREBRAL PALSY) WITH SIDDHA THERAPEUTIC MANAGEMENT IN 
CHILDREN. 
 
Form V – DRUG COMPLIANCE 
 
1. S.l. No:     2. OP/ IP  No  :                          3.Name:                                                   
4. Age:               5.Gender:      6.Date of Enrollment :  
7.  Date of completion:  8.Informant:       9.Reliablity:  
 
INTERNAL MEDICINE : 
NAME OF THE DRUG : kurunthotti kudineer 
FORM OF THE DRUG    : liquid 
ADMINISTRATION        : PER ORAL 
DOSE & DURATION       : 2 to 4years - 30 m l(bds) 
                                               5 to 7year- 40ml (bds) for 90 days 
NO. OF DRUG PACKETS GIVEN:   ______ 
NO. OF DRUG PACKETS RETURNED: _____   
 
EXTERNAL MEDICINE : 
i)NAME OF THEMETHOD  : Kollu Podithimirthal 
ADMINISTRATION   : Powder massage 
ii) NAME OF THE METHOD : Vasavu Ennai 
ADMINISTRATION   : Thokkanam 
DURATION      : 90 days 
 
Date &Station:                                                                       Signature of the Guide: 
 
Signature of the HOD:                                                           Signature of the Investigator: 
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI-47 
FORM V- PATIENT INFORMATION SHEET 
 
Name of principle investigator: Dr.B.Shalini  
 
I  Dr.B.Shalini Studying as PG Scholar at National Institute of Siddha, Tambaram 
Sanatorium is doing a open clinical trail on “Siravatham” (Cerebral Palsy). Cerebral 
Palsy is a most common disease. In this regard, I am in a need to ask you few questions 
about your child illness. I will maintain confidentiality of your comments and data 
obtained. There will be no risk of disclosing your identity and no physical, psychological 
or professional risk is involved by taking part in this study. Taking part in this study is 
voluntary. No compensation will be paid to you for taking part in this study. 
 
           You have the liberty in choosing to take part in the study or not to take part. You 
can choose not to answer a specific question. You may be benefited if you take part in 
the study. Moreover, taking part in the study may be of benefit to the community, as it 
may help us to understand the problem of defaulters and potential solutions.. 
 
             If you agree to be a participant in this study, you will be included in the study 
primarily by signing the consent form and then you will be given the internal medicine 
“Kurunthotti Kudineer” External Medicine  Kollu podithimirthal and Vasavu ennai 
Thokkanam (90 days). 
 
The information I am collecting in this study will remain you and myself. The 
questionnaire will take approximately 20 minutes of your time. If you wish to find out 
more about this study before taking part, you can contact me (Dr.B.Shalini) through 
9962700199, PG Scholar  National Institute of Siddha, Chennai-47.  
 
You can also contact the Member-secretary of Ethics committee, National 
Institute Siddha, Chennai 600047, Tel no: 91-44-22380789, for rights and participation 
in the study.  
 
Name:        Signature: 
Date: 
 
தேசிௌ சித்ே ோருத்து௒ ைிறு௒௉ம் 
அதௌோத்ேிேோச ொண்டிேர் ோருத்து௒ோன௉, சசன்ன௉-47 
கு௑ந்னே ோருத்து௒த்துன௎. 
சி்௒ோே தைோய்க்கோ௉ குறுந்சேோட்டிகுடிைீர் (உள்ோருந்து) ோற்றும் சகோள்ளு 
சொோடிேிோிர்ேல் , ௒சச௒ண்செய்  (ச௒ௐிோருந்து) ொோிகோிப்புேி௎ன௉க் கண்ட௎ியும் 
ோருத்து௒ ஆய்௒ிற்கோ௉ ேக௒ல்ொடி௒ம். 
ேக௒ல்ொடி௒ம் 
ஆ்ோய்ச்சிௌோௐர் சொௌர் :  Dr. பூ. ௓ோலி௉ி 
ைிறு௒௉த்ேின் சொௌர் தேசிௌ சித்ே ோருத்து௒ ைிறு௒௉ம் 
ேோம்ொ்ம் ச௉ட்தடோோிௌம், சசன்ன௉-47. 
தேசிௌ சித்ே ோருத்து௒ ைிறு௒௉த்ேில் ொட்ட தோற்ொடிப்பு ொௌின்று ௒ரும் ைோன் 
சி்௒ோேம் என்னும் தைோௌில் ோருத்து௒ ஆ்ோய்ச்சிௌில் ஈடுொட்டுதௐன்.          . 
இந்ே ஆ்ோய்ச்சி சம்ோந்ேோோக சி௏ தகள்௒ிகள் தகட்கவும், தேன௒ௌோ௉ ஆய்௒க 
ொோிதசோேன௉க்கு ேங்கௐது கு௑ந்னேனௌ உட்ொடுத்ேவும் உள்தௐன். 
இது சம்ோந்ேோோ௉ ேங்கௐது கு௑ந்னேௌின் அன௉த்து ௒ி௒்ங்களும் ்கசிௌோோக 
ன௒க்கப்ொடும் எ௉ உறுேி அௐிக்கித௎ன். இேில் ொௌெப்ொடி ப௃ேலிௌஎந்ே 
உே௒ி சேோனகயும் ௒௑ங்கப்ொடோோட்டோது. 
இந்ே ஆ்ோய்ச்சிௌின் தொோது ேங்கௐது கு௑ந்னேௌின் உடலுக்கு த௒று ொோேிப்பு 
ஏற்ொடும் ொட்சத்ேில் தேசிௌ சித்ே ோருத்து௒ோன௉ௌில் ேக்க சிசிச்னச 
அௐிக்கப்ொடும். 
இந்ே ஆ்ோய்ச்சிக்கு ேங்கள் ௒ிருப்ொத்ேின் தொோில் கு௑ந்னேனௌ உட்ொடுத்தும் 
ொட்சத்ேில் உள்ோருந்ேோக குறுந்சேோட்டி குடிைீர் (உள்ோருந்து) 90 ைோட்கள் எடுக்க 
த௒ண்டும். 
இந்ே ஆ்ோய்ச்சிௌில் தைோௌி௉்ோக தசர்ந்ே ொி௎கு உங்களுக்கு ௒ிருப்ொம் 
இல்ன௏சௌ௉ில் எப்தொோது த௒ண்டுோோ௉ோலும் ேங்கௐது கு௑ந்னேனௌ ௒ி௏க்கிக் 
சகோள்ௐ௏ோம். 
  
இந்ே ஆ்ோய்ச்சி சம்ோந்ேோோக ோற்௎ ௒ிொ்ங்களுக்கும் தைோௌின்ேன்னோ ொற்௎ியும் 
அ௎ி௒ேற்கும் ப௃ேன்னோ ஆ்ோய்ச்சிௌோௐ்ோ௉  Dr.பூ. ௓ோலி௉ி.  
 (ொட்ட தோற்ொடிப்ொோௐர் கு௑ந்னே ோருத்து௒ ொிோிவு) னகதொசி எண் 9962700199 
எப்தொோதும் சேோடர்பு சகோள்ௐ௏ோம். 
தோலும் இந்ே ஆ்ோய்ச்சிக்கு  IEC  (ைிறு௒௉ ைீேிசை௎ி குழு) சோன்று 
சொ௎ப்ொட்டுள்ௐே இந்ே ோருத்து சி௎ப்ொோக சி்௒ோே தைோய்க்கோக 
அங்கீகோிக்கப்ொட்ட சித்ே ோருத்து௒ நூலில் கூ௎ப்ொட்டுள்ௐது. ஏற்க௉த௒ 
உொதௌோகத்ேில் உள்ௐது தொோன்௎ இது௒ன் தைோௌோௐிகௐிடம் எந்ே௒ிே 
ொக்க௒ினௐவுகனௐ ஏற்ொடுத்ே௒ில்ன௏ தோலும் உெவு ப௃ன௎ௌில் ொத்ேிௌம் 
கோக்குோோறு அ௎ிவுறுத்ேொடுகி௎து.    
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL,CHENNAI - 600 047. 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
PRECLINICAL AND CLINICAL EVALUATION OF SIRAVATHAM 
(CEREBRAL PALSY) WITH SIDDHA THERAPEUTIC MANAGEMENT IN 
CHILDREN. 
 
1.  S.I No:                   2. OP/ IP No:                            3.Name:                                                
4. Age:          5.Gender:       6.Date of Enrollment:                              
7. Date of completion:               8.Informant:       9.Reliablity:  
FORM VI1   WITHDRAWAL 
 
Date of trial commencement    : 
Date of withdrawal from trial   : 
Reason(s) for withdrawal   :  
Long absence at reporting   : Yes/ No 
Irregular treatment                 : Yes/ No 
Shift of locality                 : Yes/ No 
Complication adverse reactions if any : Yes/ No 
Exacerbation of symptoms   : Yes/ No 
 Patient not willing to continue             : Yes/ No 
 
 
Date &Station:                                                                  Signature of the Guide: 
 
Signature of the HOD:                                                      Signature of the Investigator: 
 
 
 
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM  
“PRECLINICAL AND CLINICAL EVALUATION OF SIRAVATHAM 
(CEREBRAL PALSY) WITH SIDDHA THERAPEUTIC MANAGEMENT IN CHILDREN” 
 
       Form VIII – ADVERSE REACTION FORM   
1. S.l. No: 2. OP/ IP No  : 3. Name: 
4. Age: 5. Gender: 6. Date of Enrollment: 
7. Date of completion: 8. Informant: 9. Reliability: 
 
Name       : 
Age       : 
Gender    : 
OPD/ IPD No    : 
Registration No    : 
Date of trial commencement  : 
Date of withdrawal from trial   : 
Description of adverse reaction  : 
 
 
Date:        Signature of Investigator 
Station :       Signature of Guide                                     
 
                                     FORM  IX - PHARMACOVIGILANCE 
1. Patient / consumer identification (please complete or tick boxes below 
 as appropriate) 
        NATIONAL PHARMACOVIGILANCE PROGRAMME FOR SIDDHA DRUGS 
 
 
Please note:  i.All consumers / patients and reporters information will remain 
confidential. 
                        ii. It is requested to report all suspected reactions to the concerned, even if 
it  does not have complete data, as soon as possible. 
Peripheral Centre code:     State: 
 
Name  Father name Patient / Record 
No. 
Ethnicity  Occupation 
Address  
Village / Town 
Post / Via 
District / State    
Date of Birth / 
Age: 
Sex:     M / F  
Weight : 
Degam: 
 
2. Description of the suspected Adverse Reactions (please complete boxes below) 
 
Date and time  of 
initial observation 
 Season: 
Description of 
reaction   
 Geographical area: 
 
  
Reporting Form for Suspected Adverse Reactions to Siddha 
Drugs 
 
3. List of all medicines / Formulations including drugs of other systems used by the 
patient during the reporting period: 
Medicine Daily 
dose 
Route of 
administration 
& Vehicle - 
Adjuvant 
Date  Diagnosis for 
which medicine 
taken  Starting Stopped 
Siddha      
Any other 
system of 
medicines 
     
 
4. Brief details of the Siddha Medicine which seems to be toxic : 
Details Drug – 1 Drug – 2 Drug - 3 
a) Name of the medicine    
b) Manufacturing unit 
and batch No. and date 
   
c) Expiry date    
d) Purchased and 
obtained from 
   
e) Composition of the 
formulation / Part of the 
drug used 
   
 
b) Dietary Restrictions if any 
c) Whether the drug is consumed under institutionally qualified medical supervision or 
used    as self medication.  
d) Any other relevant information. 
 
 
 
5. Treatment provided for adverse reaction: 
 
6. The result  of the adverse reaction / side effect / untoward effects (please complete 
the boxes below) 
Recovered:           Not 
recovered: 
 Unknown: Fatal: If Fatal 
Date of death: 
Severe:   Yes   /   
No. 
Reaction abated after drug stopped or dose reduced: 
Reaction reappeared after re introduction: 
 
 
Was the patient admitted to hospital? 
If yes, give name and address of 
hospital 
 
 
7. Any laboratory investigations done to evaluate other possibilities?  If Yes specify:  
 
8. Whether the patient is suffering with any chronic disorders? 
Hepatic    Renal    Cardiac    Diabetes    Malnutrition  
 
Any Others  
 
9. H/O previous allergies / Drug reactions:  
 
 
 
10. Other illness (please describe): 
 
11. Identification of the reporter: 
Type (please tick):  Nurse / Doctor / Pharmacist / Health worker / Patient / 
Attendant / Manufacturer /                                                                      
                                Distributor / Supplier / Any others (please specify) 
Name: 
 
Address: 
 
Telephone / E – mail if any : 
 
 
 
Signature of the reporter:          Date: 
 
 
Please send the completed form to:  
                            The Director, 
                            National Institute of Siddha, 
(Pharmacovigilance Regional                         ( Centre For Siddha Medicine), 
                                                                        Tambaram Sanatorium, Chennai-600 047. 
 (O) 044-22381314                          Fax : 044 – 22381314 
 
          Website : www.nischennai.org 
Email: nischennaisiddha@yahoo.co.in 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ** * * * *  
 
 
Name & address of the RRC-
ASU/ PPC-ASU 
This filled-in ADR report may be sent within one month of observation /occurrence 
of ADR   
 
 
 
 
 
 
 
 
Date:                                                                              
Station:  
 
Signature of the Investigator:     
 
Signature of the Lecturer:        
 
Signature of the HOD    
 
 
Who Can Report? 
 Any Health care professionals like Siddha Doctors /  
Nurses / Siddha Pharmacists / Patients etc.  
What to Report?  
 All reactions,  Drug interactions,  
Confidentiality  
 The patient’s identity will be held in strict confidence 
and protected to the fullest extent.  
 Submission of report will be taken up for remedial 
measures only not for legal claim  
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
POST GRADUATE DEPARTMENT OF  
KUZHANDHAI MARUTHUVAM 
“PRECLINICAL AND CLINICAL EVALUATION OF SIRAVATHAM 
(CEREBRAL PALSY) WITH SIDDHA THERAPEUTIC MANAGEMENT  
IN CHILDREN” 
FORM X  -  DIETARY ADVICE FORM 
THINGS TO TAKE THINGS TO AVOID 
Non animal source of protein (Grain, Nuts 
and Seeds)  
Animal fat (meat) 
Foods that are high in calcium (Soya 
products, nuts, nut milks)  
Acidic foods 
Healthy fats (Olive oil, Walnuts, Canola 
oil) 
Milk and Dry Products 
Fresh fruits and Vegetables  Refined food like Bakery items  
Vitamin B rich foods (Nuts, Carrots) Oily and greasy food 
 
நருத்துயஅ஫ிவுரபநற்றும்உணவுஅ஫ிவுரப-கரைப்஧ிடிக்க: 
 
• உணயில் நி஭கு, இஞ்சி, சுக்கு, நஞ்சள் அதிகநாக சசர்க்கவும். 
• ஧சும்஧ா஬ில் ஧஦ங்கற்கண்டு, ஏ஬க்காய் இட்டு காய்ச்சிதபவும். 
• ஧ப்஧ா஭ி, ககாய்னா, சப்ச஧ாட்ைா, நாதுர஭ ச஧ான்஫ ஧மயரககர஭ கார஬ 
அல்஬து நதின சயர஭னில் தபவும். 
• காய்க஫ி கீரப யரககர஭ தி஦மும் உணயில் சசர்க்கவும் 
• நிதநா஦ சுடு஥ீரில் கு஭ிப்஧ாட்ைவும் 
தயிர்க்க: 
• தூசி, ஒட்ைரை, நாசு஧டிந்த சூமர஬ தயிர்க்கவும் 
• கு஭ிர்ந்த காற்று,கு஭ிர்சாத஦ க஧ட்டி உணவுகர஭ தயிர்க்கவும். 
• கசனற்ரக இ஦ிப்பு திண்஧ண்ைங்க஭ா஦ நிட்ைாய், கிரீம்  சசர்ந்த சகக், 
஧ிஸ்கட்டுகர஭ ஥ீக்கவும். 
• உணவு உண்ை ஧ின் கு஭ிப்஧ாட்டுயரத தயிர்க்கவும். 
• நாநிச உணயில் ஧ிபாய்஬ர் சகாமிரன தயிர்க்கவும். 





